data_2mia_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mia _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 34.5 mm . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.805 0.336 . . . . 72.319999999999993 111.159 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.96 160.15 26.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 72.120000000000005 111.099 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.29 120.54 7.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 73.530000000000001 110.872 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 56.14 29.79 15.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 72.430000000000007 110.913 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.34 150.64 18.93 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 71.040000000000006 112.524 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.09 153.61 2.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.778 0.323 . . . . 74.200000000000003 110.938 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 m -114.96 164.57 13.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 62.020000000000003 110.871 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.79 -18.11 29.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 72.0 110.808 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.87 -92.64 0.6 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.767 -0.73 . . . . 70.239999999999995 112.49 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.81 -17.09 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 74.349999999999994 111.151 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.9 mt -99.22 102.65 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 74.310000000000002 111.179 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.88 31.85 1.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 75.219999999999999 110.901 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -80.11 69.59 6.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 75.239999999999995 110.941 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.7 t -110.3 103.55 12.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 75.25 110.879 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.9 m -46.7 -72.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 73.109999999999999 110.838 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.48 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -116.35 162.43 26.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.563 0.697 . . . . 64.400000000000006 110.883 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.77 -49.01 0.25 Allowed 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.701 -1.791 . . . . 74.099999999999994 112.308 0.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -127.76 -93.0 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 74.239999999999995 110.923 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -124.09 162.4 23.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 75.230000000000004 110.887 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 15.3 t -93.38 104.28 16.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 54.310000000000002 110.846 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.49 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.6 m -139.52 130.54 14.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.589 0.709 . . . . 74.0 111.14 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.67 170.84 56.11 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.7 -1.792 . . . . 74.120000000000005 112.383 -0.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 -53.63 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.698 2.265 . . . . 73.120000000000005 112.358 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 mt -96.17 119.27 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 74.109999999999999 111.13 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.4 mm 65.96 65.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 73.019999999999996 111.173 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.02 179.38 38.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.741 . . . . 63.219999999999999 112.502 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -130.3 140.44 50.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 74.420000000000002 110.877 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.5 p -74.54 128.73 36.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 75.239999999999995 110.921 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 75.239999999999995 110.898 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.9 mm . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.821 0.344 . . . . 74.439999999999998 111.093 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.97 158.63 30.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 72.239999999999995 111.13 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -54.35 120.53 6.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 74.219999999999999 110.884 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 55.4 35.18 24.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 74.150000000000006 110.923 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.95 150.59 19.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.78 -0.724 . . . . 63.100000000000001 112.508 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.55 153.43 5.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.822 0.344 . . . . 72.019999999999996 110.888 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.3 m -115.45 166.11 12.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 70.219999999999999 110.881 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.1 -17.98 31.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 72.519999999999996 110.937 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.41 -92.64 0.63 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 75.239999999999995 112.477 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -61.94 -16.74 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.335 . . . . 75.299999999999997 111.154 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.4 mt -99.61 102.64 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 73.319999999999993 111.114 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.97 31.84 1.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 110.91 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.26 70.81 6.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 72.319999999999993 110.879 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.6 t -109.66 103.6 12.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 71.340000000000003 110.851 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 m -47.58 -65.41 0.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 70.409999999999997 110.895 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.482 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -123.85 161.63 45.51 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.58 0.705 . . . . 63.130000000000003 110.886 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.73 -49.1 0.24 Allowed 'Cis proline' 0 C--O 1.231 0.158 0 C-N-CA 122.723 -1.782 . . . . 74.430000000000007 112.33 0.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -128.06 -92.86 0.47 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 72.540000000000006 110.93 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.05 162.23 23.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 64.420000000000002 110.935 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 9.0 t -93.3 104.57 16.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 110.874 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.2 m -138.62 130.15 15.52 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.587 0.708 . . . . 75.540000000000006 111.093 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.4 Cg_endo -69.76 170.73 57.07 Favored 'Cis proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 -1.8 . . . . 64.540000000000006 112.314 -0.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -55.02 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.706 2.271 . . . . 73.400000000000006 112.348 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.1 mt -94.07 118.53 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 73.25 111.16 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.1 mm 65.99 63.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 75.430000000000007 111.125 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.3 178.92 35.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 73.109999999999999 112.496 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -130.35 139.74 50.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 74.120000000000005 110.871 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.4 p -75.01 128.35 35.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 53.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 74.219999999999999 110.887 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.8 mm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.867 0.365 . . . . 72.239999999999995 111.127 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.64 159.81 26.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 55.200000000000003 111.073 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -55.54 120.54 7.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 110.878 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 55.92 34.99 24.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 75.310000000000002 110.907 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.6 149.93 19.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.751 . . . . 55.229999999999997 112.46 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.38 153.24 5.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 74.340000000000003 110.865 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 m -115.41 165.95 12.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 110.906 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -59.16 -17.67 29.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 72.439999999999998 110.886 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.24 -92.62 0.63 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 41.039999999999999 112.497 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -61.91 -16.75 16.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.788 0.328 . . . . 74.200000000000003 111.169 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 43.9 mt -99.55 102.59 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 73.329999999999998 111.116 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.94 31.79 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 74.310000000000002 110.879 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.1 70.85 6.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 75.230000000000004 110.883 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.3 t -110.04 103.35 12.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 63.399999999999999 110.852 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.3 m -47.94 -64.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 71.400000000000006 110.904 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.477 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -124.01 161.87 44.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.589 0.709 . . . . 64.109999999999999 110.889 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.74 -49.19 0.24 Allowed 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.74 -1.775 . . . . 71.310000000000002 112.354 0.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -127.55 -92.93 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 75.430000000000007 110.95 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -124.49 162.01 24.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 74.150000000000006 110.969 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 8.0 t -93.13 104.69 16.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.340000000000003 110.896 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.485 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.1 m -138.99 130.14 15.08 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.559 0.695 . . . . 64.200000000000003 111.153 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.73 170.75 56.82 Favored 'Cis proline' 0 C--O 1.231 0.149 0 C-N-CA 122.692 -1.795 . . . . 73.510000000000005 112.348 -0.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -55.37 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.664 2.243 . . . . 73.340000000000003 112.346 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mt -93.32 117.7 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 73.140000000000001 111.17 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.0 mm 66.17 65.9 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 75.439999999999998 111.143 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.37 179.42 36.8 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 64.319999999999993 112.463 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.34 139.64 50.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.881 0.372 . . . . 73.120000000000005 110.874 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.7 p -75.04 128.96 36.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 63.020000000000003 110.898 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 72.219999999999999 110.89 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.7 mm . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.802 0.334 . . . . 73.299999999999997 111.118 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.28 160.11 31.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 71.420000000000002 111.094 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -54.42 120.47 6.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 74.519999999999996 110.896 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 55.9 31.62 18.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 74.519999999999996 110.945 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.39 150.29 18.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 74.319999999999993 112.49 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.34 153.19 3.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 72.340000000000003 110.914 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.0 m -115.3 163.51 15.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 110.857 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -58.73 -17.91 26.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 71.030000000000001 110.887 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.84 -92.26 0.6 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.72 . . . . 73.209999999999994 112.494 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -61.7 -16.82 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.89 0.376 . . . . 75.329999999999998 111.158 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 27.7 mt -100.33 102.77 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 74.329999999999998 111.132 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.35 31.83 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 75.040000000000006 110.859 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -79.34 69.56 5.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 74.230000000000004 110.893 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.2 t -110.44 103.86 12.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 74.239999999999995 110.912 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.3 m -47.27 -72.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 72.420000000000002 110.895 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.482 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.81 162.31 27.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.595 0.712 . . . . 74.030000000000001 110.875 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.74 -49.05 0.24 Allowed 'Cis proline' 0 C--N 1.341 0.138 0 C-N-CA 122.681 -1.799 . . . . 72.349999999999994 112.321 0.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -128.04 -92.9 0.46 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 75.230000000000004 110.936 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.9 162.35 23.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.428 . . . . 74.209999999999994 110.923 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.429 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 9.0 t -93.33 104.36 16.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 74.310000000000002 110.842 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.486 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.9 m -138.75 130.55 15.53 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.606 0.717 . . . . 74.540000000000006 111.104 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.77 170.82 56.64 Favored 'Cis proline' 0 C--N 1.342 0.202 0 C-N-CA 122.706 -1.789 . . . . 73.140000000000001 112.331 -0.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -54.41 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.244 . . . . 73.409999999999997 112.33 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mt -94.54 118.32 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 74.140000000000001 111.165 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.5 mm 65.95 66.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 111.157 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.05 179.21 38.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.749 -0.739 . . . . 65.120000000000005 112.466 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -130.46 140.21 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 75.239999999999995 110.861 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.3 p -74.55 128.6 35.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 72.540000000000006 110.906 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 72.450000000000003 110.937 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 34.0 mm . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.822 0.344 . . . . 70.140000000000001 111.124 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.41 160.16 30.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 73.230000000000004 111.087 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -55.74 120.55 7.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 70.010000000000005 110.886 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 55.58 30.55 15.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 73.219999999999999 110.912 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.52 150.5 18.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.76 -0.733 . . . . 61.310000000000002 112.478 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.91 153.62 2.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.835 0.35 . . . . 73.010000000000005 110.914 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.8 m -114.89 164.84 13.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 73.150000000000006 110.9 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -58.65 -18.46 30.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 70.219999999999999 110.847 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.55 -92.57 0.6 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.731 -0.747 . . . . 74.430000000000007 112.481 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -62.13 -16.47 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.74 0.305 . . . . 75.219999999999999 111.091 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 64.3 mt -100.25 102.81 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 65.409999999999997 111.11 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.7 31.82 1.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 55.509999999999998 110.905 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -80.13 69.76 6.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 74.310000000000002 110.919 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.5 t -110.1 103.94 12.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 74.329999999999998 110.91 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.4 m -46.16 -73.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.099999999999994 110.941 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.48 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -115.57 162.39 25.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.601 0.715 . . . . 64.409999999999997 110.912 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.77 -49.35 0.23 Allowed 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.663 -1.807 . . . . 72.409999999999997 112.322 0.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -128.11 -93.06 0.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 74.140000000000001 110.955 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.55 162.71 21.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 62.100000000000001 110.917 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 18.4 t -94.45 104.1 16.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 72.140000000000001 110.897 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.49 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.3 m -138.69 131.09 15.81 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.585 0.707 . . . . 74.329999999999998 111.162 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.7 170.72 56.86 Favored 'Cis proline' 0 C--O 1.231 0.172 0 C-N-CA 122.711 -1.787 . . . . 71.129999999999995 112.357 -0.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -54.18 0.23 Allowed 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.69 2.26 . . . . 64.230000000000004 112.373 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mt -95.44 118.35 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 61.399999999999999 111.17 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.0 mm 66.4 63.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 74.439999999999998 111.152 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.36 178.82 35.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 74.310000000000002 112.48 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -130.45 140.24 50.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.875 0.369 . . . . 74.340000000000003 110.89 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.425 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.0 p -74.61 128.56 35.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 75.200000000000003 110.905 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.409999999999997 110.917 179.982 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.82 0.343 . . . . 74.450000000000003 111.149 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.46 160.11 33.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 74.109999999999999 111.101 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -52.1 120.55 5.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 72.209999999999994 110.877 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 54.86 34.02 21.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.219999999999999 110.944 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.19 150.76 19.0 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 74.310000000000002 112.513 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.89 151.89 3.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.837 0.351 . . . . 73.140000000000001 110.92 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.7 m -117.21 163.09 16.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 65.549999999999997 110.888 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -59.26 -16.59 22.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 74.329999999999998 110.853 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.01 -90.66 0.64 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.75 . . . . 64.140000000000001 112.512 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.06 -19.51 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.796 0.331 . . . . 75.430000000000007 111.127 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.2 mt -98.7 103.42 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 74.109999999999999 111.122 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.34 31.09 0.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 74.230000000000004 110.873 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.61 69.87 8.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 74.019999999999996 110.927 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.1 t -110.05 104.41 13.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 72.310000000000002 110.906 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.6 m -46.68 -68.97 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 65.400000000000006 110.885 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.491 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -121.06 160.91 43.18 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.565 0.698 . . . . 74.340000000000003 110.884 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.75 -48.69 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.144 0 C-N-CA 122.705 -1.79 . . . . 71.409999999999997 112.352 0.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -128.98 -92.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 75.140000000000001 110.94 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.33 161.98 24.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 110.947 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 4.8 t -92.92 104.5 16.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 62.5 110.921 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.514 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -138.93 132.46 16.04 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.587 0.708 . . . . 74.099999999999994 111.145 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.514 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.78 170.78 56.91 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 -1.8 . . . . 74.549999999999997 112.366 -0.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -87.26 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.67 2.247 . . . . 71.140000000000001 112.326 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -54.7 105.75 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 75.230000000000004 111.146 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.9 mm 65.84 84.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.430000000000007 111.14 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.71 -178.16 39.05 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 73.019999999999996 112.502 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -130.14 136.97 49.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 64.400000000000006 110.837 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 13.7 p -78.29 129.12 34.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 65.299999999999997 110.911 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 74.430000000000007 110.935 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.4 mm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.877 0.37 . . . . 75.340000000000003 111.109 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.61 158.56 31.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 74.409999999999997 111.083 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -53.0 120.47 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 74.030000000000001 110.858 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 54.9 35.3 24.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 71.540000000000006 110.877 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.67 149.94 19.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 73.030000000000001 112.501 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 152.15 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.323 . . . . 74.409999999999997 110.907 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.9 m -117.04 165.75 13.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 65.219999999999999 110.893 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.43 -16.09 32.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 72.129999999999995 110.843 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.36 -90.97 0.7 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.718 -0.753 . . . . 75.409999999999997 112.489 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -58.87 -20.91 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 74.230000000000004 111.127 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.4 mt -98.94 103.01 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 73.109999999999999 111.14 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -90.29 30.82 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 71.099999999999994 110.865 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.73 70.49 8.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 64.150000000000006 110.864 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.4 t -108.85 104.13 13.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 60.329999999999998 110.87 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.0 m -46.86 -68.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 75.209999999999994 110.909 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.492 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -120.89 160.38 45.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.599 0.714 . . . . 55.310000000000002 110.861 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.8 -48.6 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.677 -1.801 . . . . 72.329999999999998 112.332 0.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -128.41 -92.47 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.929 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.09 161.92 26.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.276 -0.42 . . . . 71.030000000000001 110.942 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.0 t -92.03 104.64 17.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 70.310000000000002 110.866 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.51 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.7 m -139.24 131.53 15.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.59 0.71 . . . . 72.109999999999999 111.131 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.76 170.79 56.76 Favored 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.72 -1.783 . . . . 63.009999999999998 112.369 -0.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -87.48 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.667 2.245 . . . . 74.120000000000005 112.344 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.32 106.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 73.519999999999996 111.101 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.1 mm 66.09 84.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 111.147 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.59 -179.05 40.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 74.319999999999993 112.484 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -129.14 137.06 50.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 71.120000000000005 110.858 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.5 p -78.36 129.16 34.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 64.0 110.926 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 72.430000000000007 110.907 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.876 0.37 . . . . 71.25 111.154 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.87 158.52 34.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 73.140000000000001 111.118 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -52.15 120.5 5.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 75.099999999999994 110.87 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 55.28 35.28 24.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 74.219999999999999 110.93 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.93 150.25 19.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.741 -0.742 . . . . 73.519999999999996 112.531 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 152.42 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 72.329999999999998 110.892 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 m -116.92 165.24 13.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 74.310000000000002 110.908 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.02 -16.45 31.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 72.129999999999995 110.879 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.68 -91.08 0.7 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 72.209999999999994 112.459 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -59.43 -19.41 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.34 . . . . 74.25 111.191 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.24 103.13 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 75.530000000000001 111.138 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -90.34 30.98 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 74.040000000000006 110.867 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -81.52 70.86 8.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 74.400000000000006 110.91 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -109.21 104.09 13.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 72.439999999999998 110.899 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.0 m -47.39 -65.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 73.510000000000005 110.873 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.479 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -123.96 161.41 46.98 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.573 0.701 . . . . 65.510000000000005 110.912 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.0 Cg_endo -69.79 -48.66 0.26 Allowed 'Cis proline' 0 C--O 1.231 0.159 0 C-N-CA 122.675 -1.802 . . . . 64.010000000000005 112.337 0.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -127.82 -92.55 0.48 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 74.010000000000005 110.912 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.86 161.94 26.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 73.430000000000007 110.913 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.8 t -92.41 104.74 17.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 65.400000000000006 110.859 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.506 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.4 m -138.87 131.45 15.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.607 0.717 . . . . 74.319999999999993 111.154 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.1 Cg_endo -69.74 171.12 55.07 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.727 -1.781 . . . . 74.099999999999994 112.359 -0.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.44 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.9 Cg_endo -69.8 -83.5 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.692 2.261 . . . . 72.109999999999999 112.335 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.44 ' H ' ' HG2' ' A' ' 24' ' ' PRO . 5.8 mt -60.41 106.76 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 74.310000000000002 111.154 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.5 mm 67.63 84.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 70.109999999999999 111.103 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.63 -178.58 41.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 65.430000000000007 112.476 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -129.3 137.18 50.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.367 . . . . 72.530000000000001 110.892 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.9 p -78.16 128.91 34.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.299999999999997 110.893 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 64.329999999999998 110.922 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.0 mm . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.833 0.349 . . . . 73.310000000000002 111.172 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.37 158.67 33.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 73.129999999999995 111.091 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -53.01 120.64 6.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.150000000000006 110.862 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 55.58 35.34 24.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 72.519999999999996 110.966 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.81 150.65 19.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 73.019999999999996 112.491 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.18 152.53 3.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.836 0.351 . . . . 74.209999999999994 110.903 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.6 m -117.0 165.32 13.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 51.409999999999997 110.855 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -59.89 -16.54 30.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 53.240000000000002 110.853 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.8 -90.93 0.71 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.716 -0.754 . . . . 52.219999999999999 112.526 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.52 -19.47 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 75.310000000000002 111.116 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 52.4 mt -101.26 103.14 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 74.540000000000006 111.117 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.65 31.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 64.200000000000003 110.856 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -81.34 69.84 8.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 110.918 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.7 t -109.77 104.03 12.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 71.530000000000001 110.873 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.4 m -47.22 -70.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.439999999999998 110.909 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -117.36 160.7 36.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.566 0.698 . . . . 70.420000000000002 110.849 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.76 -48.69 0.26 Allowed 'Cis proline' 0 C--O 1.231 0.167 0 C-N-CA 122.743 -1.774 . . . . 75.439999999999998 112.29 0.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -128.94 -92.47 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 74.549999999999997 110.901 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.56 162.01 24.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 75.319999999999993 110.945 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.401 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 8.2 t -93.06 104.58 16.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 72.209999999999994 110.862 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.512 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.9 m -139.18 131.92 15.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.569 0.7 . . . . 73.409999999999997 111.135 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.75 171.15 54.97 Favored 'Cis proline' 0 C--N 1.342 0.186 0 C-N-CA 122.64 -1.817 . . . . 72.209999999999994 112.384 -0.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 54.0 Cg_endo -69.76 -85.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.69 2.26 . . . . 73.230000000000004 112.364 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.419 ' H ' ' HG2' ' A' ' 24' ' ' PRO . 6.1 mt -59.11 107.38 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 74.349999999999994 111.115 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.8 mm 66.9 83.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 75.420000000000002 111.114 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.89 -178.14 40.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 75.040000000000006 112.48 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -130.01 137.39 50.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 75.019999999999996 110.865 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.0 p -78.24 128.93 34.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 73.510000000000005 110.888 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 73.5 110.912 179.982 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.4 mm . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.835 0.35 . . . . 75.430000000000007 111.134 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.44 160.04 28.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 75.040000000000006 111.138 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -55.06 120.68 7.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 72.140000000000001 110.856 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 55.86 35.36 25.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 110.918 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.03 152.54 19.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.797 -0.716 . . . . 71.200000000000003 112.501 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.7 152.5 5.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.888 0.375 . . . . 73.299999999999997 110.861 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.0 m -116.94 165.07 13.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 72.109999999999999 110.882 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.69 -16.67 28.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 75.329999999999998 110.903 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.23 -91.15 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 71.510000000000005 112.529 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.59 -19.25 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.791 0.329 . . . . 74.0 111.124 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -100.96 103.08 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 111.161 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -90.1 30.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 74.200000000000003 110.894 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.22 69.58 7.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 72.400000000000006 110.897 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.3 t -108.96 103.97 13.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 75.420000000000002 110.877 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.1 m -47.57 -68.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.868 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.478 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -120.12 161.49 38.41 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.577 0.704 . . . . 74.120000000000005 110.903 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.8 -48.43 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.147 0 C-N-CA 122.635 -1.819 . . . . 71.430000000000007 112.359 0.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -128.08 -92.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 74.540000000000006 110.902 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -125.9 161.8 26.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 65.530000000000001 110.945 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.5 t -92.35 104.42 16.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 75.439999999999998 110.911 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.508 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.5 m -139.55 131.61 15.02 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.545 0.688 . . . . 64.310000000000002 111.143 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.79 171.1 55.38 Favored 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.645 -1.814 . . . . 72.530000000000001 112.354 -0.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.5 Cg_endo -69.75 -85.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.708 2.272 . . . . 71.430000000000007 112.349 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.41 ' H ' ' HG2' ' A' ' 24' ' ' PRO . 6.3 mt -58.45 107.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 71.239999999999995 111.134 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.8 mm 67.41 84.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 74.310000000000002 111.139 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.74 -178.07 41.15 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.719 -0.753 . . . . 73.519999999999996 112.456 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -130.02 137.32 50.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.381 . . . . 75.319999999999993 110.89 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.4 p -78.17 129.46 35.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 71.099999999999994 110.902 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 65.439999999999998 110.939 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.854 0.359 . . . . 75.430000000000007 111.118 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.16 157.92 34.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 64.540000000000006 111.12 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -52.58 120.6 5.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 75.140000000000001 110.884 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 55.81 35.38 25.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 74.549999999999997 110.926 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.83 150.48 19.05 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 64.140000000000001 112.479 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.29 152.53 3.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 74.329999999999998 110.927 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.1 m -116.75 164.94 13.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 71.239999999999995 110.874 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.48 -17.22 29.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 71.430000000000007 110.852 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.84 -91.34 0.68 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 73.099999999999994 112.489 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -60.08 -18.9 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 74.400000000000006 111.138 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 53.3 mt -100.38 103.15 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 75.450000000000003 111.123 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -90.39 30.95 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 71.430000000000007 110.845 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -81.31 69.89 8.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 75.129999999999995 110.926 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.1 t -109.06 103.91 13.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 73.030000000000001 110.907 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.6 m -47.5 -68.26 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 71.129999999999995 110.929 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.486 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -120.31 160.84 41.94 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.568 0.699 . . . . 74.450000000000003 110.841 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.0 Cg_endo -69.74 -48.73 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.167 0 C-N-CA 122.698 -1.793 . . . . 65.329999999999998 112.347 -0.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -128.05 -92.53 0.47 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 110.924 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.88 161.82 26.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 73.329999999999998 110.923 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.6 t -91.92 104.43 16.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 72.040000000000006 110.885 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.507 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.6 m -139.1 131.31 15.42 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.569 0.699 . . . . 74.209999999999994 111.163 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.79 171.06 55.6 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.672 -1.803 . . . . 74.329999999999998 112.351 0.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.9 Cg_endo -69.77 -85.09 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.698 2.265 . . . . 62.119999999999997 112.339 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.419 ' H ' ' HG2' ' A' ' 24' ' ' PRO . 5.2 mt -59.24 107.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 75.530000000000001 111.105 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.8 mm 67.42 83.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 74.319999999999993 111.095 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.61 -178.46 40.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.758 -0.734 . . . . 71.319999999999993 112.49 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -129.87 137.25 50.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 75.230000000000004 110.818 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.2 p -77.98 128.92 34.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 74.109999999999999 110.889 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 75.150000000000006 110.879 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.7 mm . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.842 0.353 . . . . 75.420000000000002 111.142 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.5 159.92 9.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 72.239999999999995 111.123 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -55.4 120.02 6.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 72.209999999999994 110.851 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 51.84 34.28 13.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 74.530000000000001 110.923 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.25 153.03 19.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 71.140000000000001 112.496 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 153.13 8.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.84 0.352 . . . . 74.340000000000003 110.893 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.8 m -113.71 170.7 8.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 74.319999999999993 110.861 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.21 -16.88 23.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.478 . . . . 74.319999999999993 110.903 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.2 -89.91 0.61 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 74.140000000000001 112.451 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -58.61 -19.88 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.333 . . . . 63.32 111.135 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 34.9 mt -101.25 103.17 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 73.030000000000001 111.106 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.15 30.81 0.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 75.209999999999994 110.875 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -81.56 69.41 8.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 64.450000000000003 110.936 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.7 t -110.06 104.24 13.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 73.319999999999993 110.879 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.5 m -47.14 -72.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.420000000000002 110.863 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -115.1 161.02 31.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.55 0.691 . . . . 73.209999999999994 110.882 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.3 Cg_endo -69.74 -48.43 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.661 -1.808 . . . . 70.150000000000006 112.35 -0.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -129.23 -92.54 0.45 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 72.230000000000004 110.934 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.41 162.0 23.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 73.310000000000002 110.972 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.0 t -93.35 104.43 16.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 73.349999999999994 110.827 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.514 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.71 132.49 15.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.599 0.714 . . . . 74.239999999999995 111.12 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.514 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.76 171.07 55.4 Favored 'Cis proline' 0 C--O 1.232 0.178 0 C-N-CA 122.702 -1.791 . . . . 75.430000000000007 112.299 -0.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.409 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 54.4 Cg_endo -69.78 -85.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.704 2.269 . . . . 72.409999999999997 112.373 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.409 ' H ' ' HG2' ' A' ' 24' ' ' PRO . 8.1 mt -59.08 108.41 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 74.540000000000006 111.13 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.1 mm 66.04 78.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 75.109999999999999 111.187 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.11 -179.02 37.37 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.745 -0.74 . . . . 53.240000000000002 112.475 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.13 137.39 50.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.37 . . . . 75.209999999999994 110.878 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.8 p -78.01 128.82 34.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 52.229999999999997 110.875 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 71.409999999999997 110.912 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.7 mm . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.796 0.332 . . . . 65.040000000000006 111.147 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.4 160.09 9.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 73.219999999999999 111.062 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.84 120.14 7.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 110.844 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 54.31 35.17 22.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 64.540000000000006 110.947 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.3 156.81 19.52 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.737 -0.744 . . . . 73.409999999999997 112.433 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.21 152.79 27.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.836 0.351 . . . . 74.519999999999996 110.867 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.2 m -113.77 170.34 8.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 74.439999999999998 110.898 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -59.72 -16.41 26.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 75.420000000000002 110.849 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.22 -89.67 0.6 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.719 -0.753 . . . . 65.400000000000006 112.49 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -58.34 -20.55 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 72.540000000000006 111.138 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 53.3 mt -100.34 103.13 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 75.109999999999999 111.136 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.55 30.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 75.420000000000002 110.91 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.78 69.39 8.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 75.120000000000005 110.893 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 t -110.19 104.2 13.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 73.329999999999998 110.87 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.9 m -48.05 -70.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 74.310000000000002 110.926 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.487 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.16 160.83 34.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.591 0.71 . . . . 62.100000000000001 110.903 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 52.9 Cg_endo -69.82 -48.35 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.154 0 C-N-CA 122.658 -1.809 . . . . 64.450000000000003 112.307 0.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -128.58 -92.65 0.46 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 72.530000000000001 110.915 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -124.62 161.89 25.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.914 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 4.6 t -93.06 104.8 16.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 75.329999999999998 110.879 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.517 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.6 m -141.4 132.69 13.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.522 0.677 . . . . 72.140000000000001 111.2 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.75 170.83 56.54 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 122.712 -1.787 . . . . 74.540000000000006 112.361 -0.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -87.43 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.686 2.257 . . . . 75.099999999999994 112.359 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.85 107.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 75.209999999999994 111.109 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.4 mm 65.3 82.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 72.049999999999997 111.123 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.84 -178.73 39.52 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.732 . . . . 72.129999999999995 112.483 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -129.99 137.34 50.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.936 0.398 . . . . 72.310000000000002 110.884 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.7 p -77.91 129.5 35.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 64.120000000000005 110.926 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.459 . . . . 75.340000000000003 110.91 179.975 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.1 mm . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.828 0.347 . . . . 75.120000000000005 111.106 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.7 160.17 32.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 55.219999999999999 111.091 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -53.93 120.76 6.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 70.310000000000002 110.869 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 55.72 32.4 19.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 73.5 110.878 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.21 152.0 19.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.796 -0.716 . . . . 74.329999999999998 112.501 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.4 151.67 2.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 74.340000000000003 110.876 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.3 m -117.19 165.31 13.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 72.450000000000003 110.844 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.73 -16.25 25.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 74.430000000000007 110.907 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.61 -91.33 0.66 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.701 -0.761 . . . . 62.149999999999999 112.482 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -61.61 -17.34 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 74.219999999999999 111.093 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 34.2 mt -99.42 103.4 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 71.150000000000006 111.095 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.545 ' N ' HD21 ' A' ' 13' ' ' ASN . 1.2 m-80 -88.17 31.77 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 62.049999999999997 110.853 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -80.75 69.23 7.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.239999999999995 110.943 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.3 t -110.45 104.35 13.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 31.120000000000001 110.862 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.4 m -45.57 -64.86 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 73.450000000000003 110.857 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.479 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 2.0 m-20 -125.82 162.07 47.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.618 0.723 . . . . 71.239999999999995 110.856 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.78 -48.91 0.25 Allowed 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.639 -1.817 . . . . 65.329999999999998 112.345 0.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -130.1 -92.73 0.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.229 -0.442 . . . . 73.409999999999997 110.927 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.59 162.57 18.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 73.409999999999997 110.915 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.9 t -94.86 104.56 16.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 70.200000000000003 110.899 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.52 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.3 m -138.12 133.76 17.52 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.635 0.731 . . . . 62.420000000000002 111.12 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.77 171.62 52.84 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.715 -1.786 . . . . 74.329999999999998 112.331 -0.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -86.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.688 2.259 . . . . 75.5 112.347 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.4 mt -58.69 106.57 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 74.430000000000007 111.114 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.2 mm 67.43 83.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 72.540000000000006 111.082 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.88 -177.37 39.14 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 62.200000000000003 112.493 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -130.14 137.5 50.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.852 0.358 . . . . 75.109999999999999 110.929 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 13.4 p -77.87 128.53 34.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 73.099999999999994 110.846 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 74.109999999999999 110.886 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.6 mm . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.848 0.356 . . . . 74.200000000000003 111.094 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.11 160.4 26.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 65.209999999999994 111.125 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -56.34 120.79 8.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 65.109999999999999 110.854 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 55.94 30.01 15.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 75.310000000000002 110.942 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.39 149.97 18.76 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 73.430000000000007 112.439 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 152.32 7.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 74.010000000000005 110.892 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.4 m -114.27 170.36 8.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 72.319999999999993 110.889 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -59.65 -16.33 25.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.852 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.52 -89.49 0.58 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.733 . . . . 72.129999999999995 112.474 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -58.84 -19.36 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.794 0.33 . . . . 73.129999999999995 111.125 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 42.4 mt -100.63 103.5 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 75.230000000000004 111.082 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -88.87 30.98 0.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 72.129999999999995 110.915 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -81.57 69.29 8.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 54.32 110.907 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.9 t -110.46 104.73 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 61.409999999999997 110.871 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.9 m -47.28 -72.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 74.120000000000005 110.845 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.487 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.42 161.34 32.15 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 75.299999999999997 110.855 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.81 -48.52 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.669 -1.804 . . . . 75.420000000000002 112.301 0.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -128.91 -92.63 0.45 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 75.200000000000003 110.868 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.99 162.07 24.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 70.310000000000002 110.898 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 3.8 t -93.12 104.19 16.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 74.109999999999999 110.922 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.517 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.54 132.78 15.48 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.588 0.709 . . . . 73.200000000000003 111.141 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.5 Cg_endo -69.73 170.77 56.74 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.713 -1.786 . . . . 54.0 112.343 -0.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -87.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.697 2.265 . . . . 72.25 112.385 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.13 107.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 64.439999999999998 111.103 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 mm 65.4 83.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 75.099999999999994 111.173 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.7 -178.99 39.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.688 -0.768 . . . . 75.510000000000005 112.481 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.17 137.84 50.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.951 0.405 . . . . 74.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.416 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 12.3 p -78.15 129.29 34.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 63.140000000000001 110.887 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 71.340000000000003 110.94 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.6 mm . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.87 0.367 . . . . 63.539999999999999 111.113 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.73 158.07 33.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 74.329999999999998 111.093 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -53.12 120.79 6.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 72.129999999999995 110.848 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 55.69 35.27 24.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 73.329999999999998 110.955 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.1 150.5 18.97 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.75 -0.738 . . . . 64.409999999999997 112.5 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.69 152.48 2.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.812 0.339 . . . . 75.519999999999996 110.895 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.7 m -116.87 165.19 13.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 74.519999999999996 110.858 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -59.67 -16.39 26.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 71.340000000000003 110.868 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.14 -90.93 0.73 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 71.209999999999994 112.516 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.39 -19.14 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.874 0.369 . . . . 74.0 111.199 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.1 mt -102.04 103.3 14.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 72.430000000000007 111.114 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.58 31.27 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 75.209999999999994 110.916 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -81.26 69.76 7.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 75.430000000000007 110.893 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 t -109.99 103.99 12.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 70.230000000000004 110.848 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.1 m -47.62 -70.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 75.450000000000003 110.886 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.483 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -117.85 161.03 36.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 74.540000000000006 110.902 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.77 -48.66 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.698 -1.793 . . . . 74.120000000000005 112.317 0.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -128.75 -92.6 0.46 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 72.430000000000007 110.923 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -124.5 161.93 25.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 73.430000000000007 110.926 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.0 t -93.19 104.74 16.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 70.209999999999994 110.876 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.509 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.9 m -139.35 131.9 15.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.559 0.695 . . . . 73.409999999999997 111.12 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.7 171.15 54.74 Favored 'Cis proline' 0 C--N 1.341 0.159 0 C-N-CA 122.706 -1.789 . . . . 74.109999999999999 112.336 -0.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.44 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.7 Cg_endo -69.76 -83.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.686 2.257 . . . . 74.230000000000004 112.359 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.44 ' H ' ' HG2' ' A' ' 24' ' ' PRO . 6.5 mt -60.67 107.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 64.420000000000002 111.123 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.6 mm 67.14 83.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 65.129999999999995 111.178 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.97 -177.87 40.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 72.129999999999995 112.49 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -130.21 137.41 50.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.402 . . . . 74.349999999999994 110.906 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.0 p -77.98 129.4 35.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 72.129999999999995 110.916 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 73.200000000000003 110.903 179.995 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.8 mm . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.85 0.357 . . . . 73.319999999999993 111.112 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.26 160.04 32.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 74.299999999999997 111.099 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.03 120.3 5.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 70.430000000000007 110.862 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 53.58 33.99 17.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 55.030000000000001 110.892 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.33 152.61 19.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.712 -0.756 . . . . 75.409999999999997 112.476 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.66 152.62 3.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.353 . . . . 75.019999999999996 110.894 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.6 m -116.36 164.13 14.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 72.150000000000006 110.892 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -16.42 28.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.409999999999997 110.867 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.35 -90.93 0.64 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.728 . . . . 64.219999999999999 112.444 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.22 -19.87 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 75.540000000000006 111.172 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 52.8 mt -99.56 103.16 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 64.209999999999994 111.105 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.92 31.05 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 63.420000000000002 110.886 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -81.5 70.25 8.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 74.340000000000003 110.961 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.9 t -110.02 104.45 13.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 72.140000000000001 110.878 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.1 m -45.97 -74.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 75.329999999999998 110.867 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -114.84 161.02 31.22 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.555 0.693 . . . . 64.329999999999998 110.925 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.78 -48.7 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.155 0 C-N-CA 122.671 -1.804 . . . . 74.230000000000004 112.326 0.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -129.05 -92.52 0.45 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 110.967 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.91 162.3 23.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 75.120000000000005 110.917 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 7.9 t -93.41 104.75 16.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 72.439999999999998 110.907 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.512 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.0 132.37 15.92 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.602 0.715 . . . . 72.450000000000003 111.118 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.81 171.19 55.07 Favored 'Cis proline' 0 C--N 1.342 0.191 0 C-N-CA 122.701 -1.791 . . . . 72.319999999999993 112.287 0.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.7 Cg_endo -69.76 -84.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.655 2.237 . . . . 75.099999999999994 112.375 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.422 ' H ' ' HG2' ' A' ' 24' ' ' PRO . 5.1 mt -59.45 106.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 71.230000000000004 111.149 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.0 mm 68.08 85.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 72.030000000000001 111.094 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.71 -178.12 41.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 54.32 112.469 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -130.18 137.64 50.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.36 . . . . 74.519999999999996 110.926 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.9 p -77.93 128.98 34.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.818 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 73.420000000000002 110.962 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.8 mm . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.843 0.354 . . . . 64.540000000000006 111.159 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.9 160.37 32.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 73.109999999999999 111.117 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -50.84 120.44 4.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.43 . . . . 70.209999999999994 110.856 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 55.16 35.04 23.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 73.510000000000005 110.959 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.82 151.22 19.48 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.747 -0.74 . . . . 73.230000000000004 112.466 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.04 148.79 29.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 73.219999999999999 110.902 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.2 p -120.35 171.84 8.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 64.430000000000007 110.869 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -57.5 -19.22 23.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 74.239999999999995 110.852 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.9 -92.09 0.6 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.731 -0.747 . . . . 72.040000000000006 112.463 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.71 -18.76 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 74.349999999999994 111.165 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.6 mt -90.31 103.65 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 111.13 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.454 ' N ' HD21 ' A' ' 13' ' ' ASN . 1.1 m-80 -86.62 30.51 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 70.329999999999998 110.927 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.38 66.91 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.483 . . . . 75.120000000000005 110.921 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.4 t -111.83 104.68 13.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 74.209999999999994 110.864 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 m -43.51 -63.62 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 72.140000000000001 110.868 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 2.0 m-20 -130.13 161.71 58.43 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.581 0.705 . . . . 71.310000000000002 110.886 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.8 -47.6 0.3 Allowed 'Cis proline' 0 C--O 1.231 0.167 0 C-N-CA 122.722 -1.783 . . . . 72.340000000000003 112.343 0.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -127.77 -92.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 75.409999999999997 110.925 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.98 162.18 27.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 72.319999999999993 110.897 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.431 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -84.79 104.48 14.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 73.420000000000002 110.883 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.508 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 98.4 m -137.64 132.35 17.47 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.558 0.694 . . . . 70.400000000000006 111.127 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.8 172.49 48.88 Favored 'Cis proline' 0 C--N 1.341 0.141 0 C-N-CA 122.646 -1.814 . . . . 74.239999999999995 112.333 -0.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 23' ' ' PRO . 53.3 Cg_endo -69.79 -88.66 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.643 2.229 . . . . 61.039999999999999 112.342 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -52.5 102.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.200000000000003 111.092 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.6 mm 65.17 85.79 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 73.019999999999996 111.097 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.02 175.49 42.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 74.340000000000003 112.478 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -121.14 138.65 54.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.916 0.388 . . . . 75.340000000000003 110.842 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.431 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 19.9 p -77.04 128.8 35.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 73.430000000000007 110.876 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 74.540000000000006 110.981 179.94 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.4 mm . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.849 0.357 . . . . 71.409999999999997 111.139 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.78 160.04 33.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 72.430000000000007 111.085 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -51.04 120.43 4.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 75.230000000000004 110.905 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 55.21 35.08 24.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 74.430000000000007 110.919 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.09 150.14 19.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.739 -0.743 . . . . 62.399999999999999 112.504 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.18 149.18 24.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.854 0.359 . . . . 75.439999999999998 110.831 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.2 p -120.01 171.8 8.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 54.329999999999998 110.919 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -57.73 -19.01 24.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 63.310000000000002 110.821 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.49 -92.23 0.61 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 72.319999999999993 112.471 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.54 -18.63 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 72.230000000000004 111.124 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 64.5 mt -91.04 103.59 14.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 71.439999999999998 111.107 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.457 ' N ' HD21 ' A' ' 13' ' ' ASN . 1.1 m-80 -86.23 30.66 0.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 65.109999999999999 110.914 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.38 66.93 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 65.319999999999993 110.887 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.5 t -111.77 104.78 13.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 74.340000000000003 110.885 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.1 m -43.55 -63.66 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 75.310000000000002 110.87 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 5.6 m-20 -130.01 161.72 58.15 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.612 0.72 . . . . 73.230000000000004 110.853 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.79 -48.53 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.17 0 C-N-CA 122.68 -1.8 . . . . 72.120000000000005 112.363 0.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -126.8 -92.99 0.48 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 74.150000000000006 110.925 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.57 162.28 26.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 73.129999999999995 110.921 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -85.01 104.36 14.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 73.409999999999997 110.892 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.509 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 98.5 m -137.52 132.41 17.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.584 0.707 . . . . 64.150000000000006 111.193 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.81 172.39 49.42 Favored 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.713 -1.786 . . . . 74.510000000000005 112.325 0.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 23' ' ' PRO . 53.9 Cg_endo -69.72 -88.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.693 2.262 . . . . 74.430000000000007 112.327 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.0 mt -52.94 102.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 111.142 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.8 mm 65.92 85.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 74.319999999999993 111.11 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.38 174.13 42.52 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 72.120000000000005 112.477 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -119.38 138.69 52.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.893 0.378 . . . . 64.299999999999997 110.934 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 18.1 p -77.02 128.69 34.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 63.329999999999998 110.889 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 64.129999999999995 110.957 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.9 mm . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.808 0.337 . . . . 75.340000000000003 111.153 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.91 160.04 32.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 70.150000000000006 111.116 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -53.0 120.52 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 73.510000000000005 110.828 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 55.24 32.51 18.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 73.450000000000003 110.924 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.27 150.38 18.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.755 -0.736 . . . . 72.209999999999994 112.475 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.14 152.35 2.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.363 . . . . 73.310000000000002 110.89 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.3 m -116.5 163.81 15.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.886 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -59.51 -16.37 24.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 71.340000000000003 110.893 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.8 -90.99 0.63 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 74.239999999999995 112.484 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -59.5 -19.94 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.756 0.312 . . . . 74.310000000000002 111.078 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 31.9 mt -98.99 103.25 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 75.439999999999998 111.16 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -90.34 31.1 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.926 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -81.31 69.88 8.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 74.329999999999998 110.898 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.4 t -110.02 104.19 13.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 73.019999999999996 110.896 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.4 m -46.66 -72.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 71.209999999999994 110.899 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -115.84 161.13 32.24 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.633 0.73 . . . . 75.310000000000002 110.867 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.71 -48.76 0.26 Allowed 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.664 -1.807 . . . . 75.120000000000005 112.369 -0.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -128.64 -92.46 0.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 75.200000000000003 110.886 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -124.45 161.88 25.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 73.340000000000003 110.912 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.8 t -92.88 104.8 17.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 73.340000000000003 110.872 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.51 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.42 132.26 15.41 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.55 0.69 . . . . 71.540000000000006 111.164 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.77 171.18 54.94 Favored 'Cis proline' 0 C--O 1.231 0.151 0 C-N-CA 122.68 -1.8 . . . . 73.319999999999993 112.329 -0.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.9 Cg_endo -69.73 -82.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.689 2.259 . . . . 74.439999999999998 112.39 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.446 ' H ' ' HG2' ' A' ' 24' ' ' PRO . 5.4 mt -61.34 106.64 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 72.140000000000001 111.115 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.3 mm 67.33 82.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 73.219999999999999 111.124 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.69 -178.0 39.47 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 62.329999999999998 112.452 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -130.21 137.43 50.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 71.219999999999999 110.87 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.0 p -77.89 129.31 35.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 72.329999999999998 110.915 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 74.430000000000007 110.887 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.778 0.323 . . . . 63.25 110.869 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 34.5 mm 64.19 130.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 111.159 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.96 160.15 26.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 72.120000000000005 111.099 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.29 120.54 7.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 73.530000000000001 110.872 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 56.14 29.79 15.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 72.430000000000007 110.913 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.34 150.64 18.93 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 71.040000000000006 112.524 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.09 153.61 2.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.778 0.323 . . . . 74.200000000000003 110.938 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 m -114.96 164.57 13.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 62.020000000000003 110.871 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.79 -18.11 29.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 72.0 110.808 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.87 -92.64 0.6 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.767 -0.73 . . . . 70.239999999999995 112.49 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.81 -17.09 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 74.349999999999994 111.151 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.9 mt -99.22 102.65 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 74.310000000000002 111.179 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.88 31.85 1.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 75.219999999999999 110.901 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -80.11 69.59 6.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 75.239999999999995 110.941 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.7 t -110.3 103.55 12.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 75.25 110.879 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.9 m -46.7 -72.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 73.109999999999999 110.838 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.48 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -116.35 162.43 26.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.563 0.697 . . . . 64.400000000000006 110.883 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.77 -49.01 0.25 Allowed 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.701 -1.791 . . . . 74.099999999999994 112.308 0.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -127.76 -93.0 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 74.239999999999995 110.923 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -124.09 162.4 23.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 75.230000000000004 110.887 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 15.3 t -93.38 104.28 16.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 54.310000000000002 110.846 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.49 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.6 m -139.52 130.54 14.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.589 0.709 . . . . 74.0 111.14 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.67 170.84 56.11 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.7 -1.792 . . . . 74.120000000000005 112.383 -0.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 -53.63 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.698 2.265 . . . . 73.120000000000005 112.358 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 2.7 mt -96.17 119.27 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 74.109999999999999 111.13 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.4 mm 65.96 65.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 73.019999999999996 111.173 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.02 179.38 38.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.741 . . . . 63.219999999999999 112.502 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -130.3 140.44 50.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 74.420000000000002 110.877 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.5 p -74.54 128.73 36.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 75.239999999999995 110.921 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 75.239999999999995 110.898 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.862 0.363 . . . . 72.439999999999998 110.897 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.9 mm 64.38 130.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 74.439999999999998 111.093 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.97 158.63 30.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 72.239999999999995 111.13 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -54.35 120.53 6.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 74.219999999999999 110.884 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 55.4 35.18 24.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 74.150000000000006 110.923 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.95 150.59 19.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.78 -0.724 . . . . 63.100000000000001 112.508 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.55 153.43 5.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.822 0.344 . . . . 72.019999999999996 110.888 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.3 m -115.45 166.11 12.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 70.219999999999999 110.881 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.1 -17.98 31.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 72.519999999999996 110.937 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.41 -92.64 0.63 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 75.239999999999995 112.477 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -61.94 -16.74 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.335 . . . . 75.299999999999997 111.154 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 48.4 mt -99.61 102.64 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 73.319999999999993 111.114 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.97 31.84 1.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 110.91 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.26 70.81 6.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 72.319999999999993 110.879 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.6 t -109.66 103.6 12.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 71.340000000000003 110.851 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 m -47.58 -65.41 0.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 70.409999999999997 110.895 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.482 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -123.85 161.63 45.51 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.58 0.705 . . . . 63.130000000000003 110.886 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.73 -49.1 0.24 Allowed 'Cis proline' 0 C--O 1.231 0.158 0 C-N-CA 122.723 -1.782 . . . . 74.430000000000007 112.33 0.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -128.06 -92.86 0.47 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 72.540000000000006 110.93 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.05 162.23 23.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 64.420000000000002 110.935 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 9.0 t -93.3 104.57 16.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 110.874 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.484 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.2 m -138.62 130.15 15.52 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.587 0.708 . . . . 75.540000000000006 111.093 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.484 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.4 Cg_endo -69.76 170.73 57.07 Favored 'Cis proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 -1.8 . . . . 64.540000000000006 112.314 -0.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -55.02 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.706 2.271 . . . . 73.400000000000006 112.348 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.1 mt -94.07 118.53 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 73.25 111.16 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.1 mm 65.99 63.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 75.430000000000007 111.125 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.3 178.92 35.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 73.109999999999999 112.496 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -130.35 139.74 50.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 74.120000000000005 110.871 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.4 p -75.01 128.35 35.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 53.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 74.219999999999999 110.887 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.815 0.341 . . . . 60.109999999999999 110.859 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.8 mm 64.31 130.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 72.239999999999995 111.127 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.64 159.81 26.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 55.200000000000003 111.073 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -55.54 120.54 7.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 110.878 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 55.92 34.99 24.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 75.310000000000002 110.907 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.6 149.93 19.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.751 . . . . 55.229999999999997 112.46 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.38 153.24 5.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 74.340000000000003 110.865 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 m -115.41 165.95 12.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 110.906 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -59.16 -17.67 29.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 72.439999999999998 110.886 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.24 -92.62 0.63 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 41.039999999999999 112.497 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -61.91 -16.75 16.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.788 0.328 . . . . 74.200000000000003 111.169 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 43.9 mt -99.55 102.59 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 73.329999999999998 111.116 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.94 31.79 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 74.310000000000002 110.879 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.1 70.85 6.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 75.230000000000004 110.883 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.3 t -110.04 103.35 12.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 63.399999999999999 110.852 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.3 m -47.94 -64.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 71.400000000000006 110.904 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.477 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -124.01 161.87 44.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.589 0.709 . . . . 64.109999999999999 110.889 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.477 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.74 -49.19 0.24 Allowed 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.74 -1.775 . . . . 71.310000000000002 112.354 0.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -127.55 -92.93 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 75.430000000000007 110.95 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -124.49 162.01 24.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 74.150000000000006 110.969 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 8.0 t -93.13 104.69 16.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 74.340000000000003 110.896 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.485 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.1 m -138.99 130.14 15.08 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.559 0.695 . . . . 64.200000000000003 111.153 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.73 170.75 56.82 Favored 'Cis proline' 0 C--O 1.231 0.149 0 C-N-CA 122.692 -1.795 . . . . 73.510000000000005 112.348 -0.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -55.37 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.664 2.243 . . . . 73.340000000000003 112.346 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mt -93.32 117.7 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 73.140000000000001 111.17 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.0 mm 66.17 65.9 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 75.439999999999998 111.143 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.37 179.42 36.8 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 64.319999999999993 112.463 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.34 139.64 50.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.881 0.372 . . . . 73.120000000000005 110.874 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.7 p -75.04 128.96 36.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 63.020000000000003 110.898 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 72.219999999999999 110.89 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.773 0.321 . . . . 74.549999999999997 110.886 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.7 mm 64.45 130.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 73.299999999999997 111.118 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.28 160.11 31.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 71.420000000000002 111.094 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -54.42 120.47 6.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 74.519999999999996 110.896 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 55.9 31.62 18.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 74.519999999999996 110.945 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.39 150.29 18.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 74.319999999999993 112.49 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.34 153.19 3.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 72.340000000000003 110.914 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.0 m -115.3 163.51 15.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 110.857 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -58.73 -17.91 26.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 71.030000000000001 110.887 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.84 -92.26 0.6 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.72 . . . . 73.209999999999994 112.494 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -61.7 -16.82 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.89 0.376 . . . . 75.329999999999998 111.158 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 27.7 mt -100.33 102.77 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 74.329999999999998 111.132 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.35 31.83 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 75.040000000000006 110.859 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -79.34 69.56 5.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 74.230000000000004 110.893 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.2 t -110.44 103.86 12.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 74.239999999999995 110.912 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.3 m -47.27 -72.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 72.420000000000002 110.895 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.482 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.81 162.31 27.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.595 0.712 . . . . 74.030000000000001 110.875 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.482 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.74 -49.05 0.24 Allowed 'Cis proline' 0 C--N 1.341 0.138 0 C-N-CA 122.681 -1.799 . . . . 72.349999999999994 112.321 0.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -128.04 -92.9 0.46 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 75.230000000000004 110.936 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.9 162.35 23.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.428 . . . . 74.209999999999994 110.923 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.429 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 9.0 t -93.33 104.36 16.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 74.310000000000002 110.842 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.486 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.9 m -138.75 130.55 15.53 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.606 0.717 . . . . 74.540000000000006 111.104 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.77 170.82 56.64 Favored 'Cis proline' 0 C--N 1.342 0.202 0 C-N-CA 122.706 -1.789 . . . . 73.140000000000001 112.331 -0.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -54.41 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.244 . . . . 73.409999999999997 112.33 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mt -94.54 118.32 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 74.140000000000001 111.165 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.5 mm 65.95 66.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 111.157 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.05 179.21 38.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.749 -0.739 . . . . 65.120000000000005 112.466 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -130.46 140.21 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 75.239999999999995 110.861 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.3 p -74.55 128.6 35.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 72.540000000000006 110.906 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 72.450000000000003 110.937 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.808 0.337 . . . . 73.319999999999993 110.882 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 34.0 mm 64.32 130.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 70.140000000000001 111.124 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.41 160.16 30.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 73.230000000000004 111.087 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -55.74 120.55 7.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 70.010000000000005 110.886 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 55.58 30.55 15.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 73.219999999999999 110.912 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.52 150.5 18.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.76 -0.733 . . . . 61.310000000000002 112.478 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.91 153.62 2.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.835 0.35 . . . . 73.010000000000005 110.914 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.8 m -114.89 164.84 13.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 73.150000000000006 110.9 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -58.65 -18.46 30.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 70.219999999999999 110.847 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.55 -92.57 0.6 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.731 -0.747 . . . . 74.430000000000007 112.481 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -62.13 -16.47 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.74 0.305 . . . . 75.219999999999999 111.091 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 64.3 mt -100.25 102.81 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 65.409999999999997 111.11 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.7 31.82 1.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 55.509999999999998 110.905 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -80.13 69.76 6.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 74.310000000000002 110.919 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.5 t -110.1 103.94 12.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 74.329999999999998 110.91 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.4 m -46.16 -73.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.099999999999994 110.941 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.48 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -115.57 162.39 25.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.601 0.715 . . . . 64.409999999999997 110.912 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.77 -49.35 0.23 Allowed 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.663 -1.807 . . . . 72.409999999999997 112.322 0.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -128.11 -93.06 0.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 74.140000000000001 110.955 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.55 162.71 21.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 62.100000000000001 110.917 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 18.4 t -94.45 104.1 16.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 72.140000000000001 110.897 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.49 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.3 m -138.69 131.09 15.81 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.585 0.707 . . . . 74.329999999999998 111.162 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.7 170.72 56.86 Favored 'Cis proline' 0 C--O 1.231 0.172 0 C-N-CA 122.711 -1.787 . . . . 71.129999999999995 112.357 -0.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -54.18 0.23 Allowed 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.69 2.26 . . . . 64.230000000000004 112.373 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.0 mt -95.44 118.35 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 61.399999999999999 111.17 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.0 mm 66.4 63.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 74.439999999999998 111.152 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.36 178.82 35.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 74.310000000000002 112.48 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -130.45 140.24 50.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.875 0.369 . . . . 74.340000000000003 110.89 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.425 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.0 p -74.61 128.56 35.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 75.200000000000003 110.905 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pp . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.409999999999997 110.917 179.982 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.834 0.349 . . . . 73.540000000000006 110.885 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm 64.34 130.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 74.450000000000003 111.149 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.46 160.11 33.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 74.109999999999999 111.101 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -52.1 120.55 5.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 72.209999999999994 110.877 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 54.86 34.02 21.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.219999999999999 110.944 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.19 150.76 19.0 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 74.310000000000002 112.513 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.89 151.89 3.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.837 0.351 . . . . 73.140000000000001 110.92 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.7 m -117.21 163.09 16.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 65.549999999999997 110.888 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -59.26 -16.59 22.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 74.329999999999998 110.853 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.01 -90.66 0.64 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.75 . . . . 64.140000000000001 112.512 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.06 -19.51 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.796 0.331 . . . . 75.430000000000007 111.127 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 33.2 mt -98.7 103.42 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 74.109999999999999 111.122 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.34 31.09 0.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 74.230000000000004 110.873 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.61 69.87 8.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 74.019999999999996 110.927 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.1 t -110.05 104.41 13.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 72.310000000000002 110.906 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.6 m -46.68 -68.97 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 65.400000000000006 110.885 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.491 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -121.06 160.91 43.18 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.565 0.698 . . . . 74.340000000000003 110.884 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.75 -48.69 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.144 0 C-N-CA 122.705 -1.79 . . . . 71.409999999999997 112.352 0.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -128.98 -92.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 75.140000000000001 110.94 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.33 161.98 24.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 110.947 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 4.8 t -92.92 104.5 16.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 62.5 110.921 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.514 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -138.93 132.46 16.04 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.587 0.708 . . . . 74.099999999999994 111.145 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.514 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.78 170.78 56.91 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 -1.8 . . . . 74.549999999999997 112.366 -0.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -87.26 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.67 2.247 . . . . 71.140000000000001 112.326 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -54.7 105.75 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 75.230000000000004 111.146 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.9 mm 65.84 84.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.430000000000007 111.14 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.71 -178.16 39.05 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 73.019999999999996 112.502 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -130.14 136.97 49.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 64.400000000000006 110.837 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.41 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 13.7 p -78.29 129.12 34.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 65.299999999999997 110.911 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 74.430000000000007 110.935 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.837 0.351 . . . . 75.439999999999998 110.914 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.4 mm 64.26 130.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 75.340000000000003 111.109 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.61 158.56 31.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 74.409999999999997 111.083 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -53.0 120.47 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 74.030000000000001 110.858 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 54.9 35.3 24.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 71.540000000000006 110.877 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.67 149.94 19.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 73.030000000000001 112.501 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 152.15 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.323 . . . . 74.409999999999997 110.907 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.9 m -117.04 165.75 13.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 65.219999999999999 110.893 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.43 -16.09 32.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 72.129999999999995 110.843 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.36 -90.97 0.7 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.718 -0.753 . . . . 75.409999999999997 112.489 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -58.87 -20.91 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 74.230000000000004 111.127 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.4 mt -98.94 103.01 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 73.109999999999999 111.14 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -90.29 30.82 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 71.099999999999994 110.865 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.73 70.49 8.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 64.150000000000006 110.864 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.4 t -108.85 104.13 13.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 60.329999999999998 110.87 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.0 m -46.86 -68.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 75.209999999999994 110.909 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.492 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -120.89 160.38 45.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.599 0.714 . . . . 55.310000000000002 110.861 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.8 -48.6 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.677 -1.801 . . . . 72.329999999999998 112.332 0.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -128.41 -92.47 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.929 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.09 161.92 26.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.276 -0.42 . . . . 71.030000000000001 110.942 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 6.0 t -92.03 104.64 17.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 70.310000000000002 110.866 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.51 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.7 m -139.24 131.53 15.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.59 0.71 . . . . 72.109999999999999 111.131 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.76 170.79 56.76 Favored 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.72 -1.783 . . . . 63.009999999999998 112.369 -0.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -87.48 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.667 2.245 . . . . 74.120000000000005 112.344 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.8 mp -55.32 106.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 73.519999999999996 111.101 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.1 mm 66.09 84.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 111.147 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.59 -179.05 40.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 74.319999999999993 112.484 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -129.14 137.06 50.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 71.120000000000005 110.858 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.5 p -78.36 129.16 34.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 64.0 110.926 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 72.430000000000007 110.907 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.853 0.358 . . . . 70.239999999999995 110.887 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.2 mm 64.06 130.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 71.25 111.154 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.87 158.52 34.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 73.140000000000001 111.118 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -52.15 120.5 5.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 75.099999999999994 110.87 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 55.28 35.28 24.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 74.219999999999999 110.93 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.93 150.25 19.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.741 -0.742 . . . . 73.519999999999996 112.531 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 152.42 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 72.329999999999998 110.892 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 m -116.92 165.24 13.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 74.310000000000002 110.908 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.02 -16.45 31.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 72.129999999999995 110.879 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.68 -91.08 0.7 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 72.209999999999994 112.459 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -59.43 -19.41 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.34 . . . . 74.25 111.191 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 54.4 mt -100.24 103.13 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 75.530000000000001 111.138 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -90.34 30.98 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 74.040000000000006 110.867 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -81.52 70.86 8.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 74.400000000000006 110.91 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -109.21 104.09 13.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 72.439999999999998 110.899 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.0 m -47.39 -65.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 73.510000000000005 110.873 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.479 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -123.96 161.41 46.98 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.573 0.701 . . . . 65.510000000000005 110.912 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.0 Cg_endo -69.79 -48.66 0.26 Allowed 'Cis proline' 0 C--O 1.231 0.159 0 C-N-CA 122.675 -1.802 . . . . 64.010000000000005 112.337 0.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 20.7 m95 -127.82 -92.55 0.48 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 74.010000000000005 110.912 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.86 161.94 26.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 73.430000000000007 110.913 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.8 t -92.41 104.74 17.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 65.400000000000006 110.859 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.506 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.4 m -138.87 131.45 15.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.607 0.717 . . . . 74.319999999999993 111.154 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.506 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.1 Cg_endo -69.74 171.12 55.07 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.727 -1.781 . . . . 74.099999999999994 112.359 -0.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.44 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.9 Cg_endo -69.8 -83.5 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.692 2.261 . . . . 72.109999999999999 112.335 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.44 ' H ' ' HG2' ' A' ' 24' ' ' PRO . 5.8 mt -60.41 106.76 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 74.310000000000002 111.154 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.5 mm 67.63 84.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 70.109999999999999 111.103 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.63 -178.58 41.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 65.430000000000007 112.476 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -129.3 137.18 50.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.367 . . . . 72.530000000000001 110.892 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.9 p -78.16 128.91 34.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.299999999999997 110.893 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 64.329999999999998 110.922 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.76 0.314 . . . . 74.340000000000003 110.87 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.0 mm 64.11 130.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 111.172 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.37 158.67 33.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 73.129999999999995 111.091 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -53.01 120.64 6.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.150000000000006 110.862 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 55.58 35.34 24.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 72.519999999999996 110.966 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.81 150.65 19.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 73.019999999999996 112.491 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.18 152.53 3.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.836 0.351 . . . . 74.209999999999994 110.903 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.6 m -117.0 165.32 13.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 51.409999999999997 110.855 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -59.89 -16.54 30.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 53.240000000000002 110.853 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.8 -90.93 0.71 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.716 -0.754 . . . . 52.219999999999999 112.526 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.52 -19.47 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 75.310000000000002 111.116 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 52.4 mt -101.26 103.14 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 74.540000000000006 111.117 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.65 31.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 64.200000000000003 110.856 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -81.34 69.84 8.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 110.918 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.7 t -109.77 104.03 12.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 71.530000000000001 110.873 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.4 m -47.22 -70.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.439999999999998 110.909 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -117.36 160.7 36.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.566 0.698 . . . . 70.420000000000002 110.849 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.76 -48.69 0.26 Allowed 'Cis proline' 0 C--O 1.231 0.167 0 C-N-CA 122.743 -1.774 . . . . 75.439999999999998 112.29 0.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 69.9 m95 -128.94 -92.47 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 74.549999999999997 110.901 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.56 162.01 24.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 75.319999999999993 110.945 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.401 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 8.2 t -93.06 104.58 16.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 72.209999999999994 110.862 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.512 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.9 m -139.18 131.92 15.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.569 0.7 . . . . 73.409999999999997 111.135 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.75 171.15 54.97 Favored 'Cis proline' 0 C--N 1.342 0.186 0 C-N-CA 122.64 -1.817 . . . . 72.209999999999994 112.384 -0.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 54.0 Cg_endo -69.76 -85.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.69 2.26 . . . . 73.230000000000004 112.364 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.419 ' H ' ' HG2' ' A' ' 24' ' ' PRO . 6.1 mt -59.11 107.38 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 74.349999999999994 111.115 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.8 mm 66.9 83.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 75.420000000000002 111.114 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.89 -178.14 40.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 75.040000000000006 112.48 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -130.01 137.39 50.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 75.019999999999996 110.865 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.0 p -78.24 128.93 34.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 73.510000000000005 110.888 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 73.5 110.912 179.982 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.804 0.335 . . . . 74.510000000000005 110.872 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.4 mm 64.21 130.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 75.430000000000007 111.134 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.44 160.04 28.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 75.040000000000006 111.138 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -55.06 120.68 7.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 72.140000000000001 110.856 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 55.86 35.36 25.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 110.918 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.03 152.54 19.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.797 -0.716 . . . . 71.200000000000003 112.501 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.7 152.5 5.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.888 0.375 . . . . 73.299999999999997 110.861 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.0 m -116.94 165.07 13.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 72.109999999999999 110.882 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.69 -16.67 28.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 75.329999999999998 110.903 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.23 -91.15 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 71.510000000000005 112.529 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.59 -19.25 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.791 0.329 . . . . 74.0 111.124 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.7 mp -100.96 103.08 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 111.161 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -90.1 30.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 74.200000000000003 110.894 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.22 69.58 7.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 72.400000000000006 110.897 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.3 t -108.96 103.97 13.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 75.420000000000002 110.877 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.1 m -47.57 -68.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 73.25 110.868 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.478 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -120.12 161.49 38.41 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.577 0.704 . . . . 74.120000000000005 110.903 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.8 -48.43 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.147 0 C-N-CA 122.635 -1.819 . . . . 71.430000000000007 112.359 0.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -128.08 -92.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 74.540000000000006 110.902 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -125.9 161.8 26.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 65.530000000000001 110.945 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.5 t -92.35 104.42 16.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 75.439999999999998 110.911 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.508 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.5 m -139.55 131.61 15.02 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.545 0.688 . . . . 64.310000000000002 111.143 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.79 171.1 55.38 Favored 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.645 -1.814 . . . . 72.530000000000001 112.354 -0.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.41 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.5 Cg_endo -69.75 -85.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.708 2.272 . . . . 71.430000000000007 112.349 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.41 ' H ' ' HG2' ' A' ' 24' ' ' PRO . 6.3 mt -58.45 107.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 71.239999999999995 111.134 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.8 mm 67.41 84.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 74.310000000000002 111.139 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.74 -178.07 41.15 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.719 -0.753 . . . . 73.519999999999996 112.456 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -130.02 137.32 50.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.381 . . . . 75.319999999999993 110.89 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.4 p -78.17 129.46 35.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 71.099999999999994 110.902 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 65.439999999999998 110.939 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.803 0.335 . . . . 55.299999999999997 110.914 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.2 mm 64.22 130.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 75.430000000000007 111.118 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.16 157.92 34.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 64.540000000000006 111.12 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -52.58 120.6 5.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 75.140000000000001 110.884 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 55.81 35.38 25.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 74.549999999999997 110.926 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.83 150.48 19.05 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 64.140000000000001 112.479 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.29 152.53 3.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 74.329999999999998 110.927 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.1 m -116.75 164.94 13.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 71.239999999999995 110.874 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.48 -17.22 29.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 71.430000000000007 110.852 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.84 -91.34 0.68 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 73.099999999999994 112.489 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -60.08 -18.9 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 74.400000000000006 111.138 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 53.3 mt -100.38 103.15 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 75.450000000000003 111.123 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -90.39 30.95 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 71.430000000000007 110.845 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -81.31 69.89 8.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 75.129999999999995 110.926 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.1 t -109.06 103.91 13.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 73.030000000000001 110.907 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.6 m -47.5 -68.26 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 71.129999999999995 110.929 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.486 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -120.31 160.84 41.94 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.568 0.699 . . . . 74.450000000000003 110.841 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.486 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.0 Cg_endo -69.74 -48.73 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.167 0 C-N-CA 122.698 -1.793 . . . . 65.329999999999998 112.347 -0.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -128.05 -92.53 0.47 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 110.924 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.88 161.82 26.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 73.329999999999998 110.923 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 7.6 t -91.92 104.43 16.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 72.040000000000006 110.885 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.507 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.6 m -139.1 131.31 15.42 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.569 0.699 . . . . 74.209999999999994 111.163 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.79 171.06 55.6 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.672 -1.803 . . . . 74.329999999999998 112.351 0.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.9 Cg_endo -69.77 -85.09 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.698 2.265 . . . . 62.119999999999997 112.339 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.419 ' H ' ' HG2' ' A' ' 24' ' ' PRO . 5.2 mt -59.24 107.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 75.530000000000001 111.105 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.8 mm 67.42 83.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 74.319999999999993 111.095 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.61 -178.46 40.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.758 -0.734 . . . . 71.319999999999993 112.49 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -129.87 137.25 50.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 75.230000000000004 110.818 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.2 p -77.98 128.92 34.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 74.109999999999999 110.889 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 75.150000000000006 110.879 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.785 0.326 . . . . 74.120000000000005 110.87 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.7 mm 64.29 129.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 75.420000000000002 111.142 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.5 159.92 9.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 72.239999999999995 111.123 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -55.4 120.02 6.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 72.209999999999994 110.851 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 51.84 34.28 13.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 74.530000000000001 110.923 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.25 153.03 19.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 71.140000000000001 112.496 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 153.13 8.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.84 0.352 . . . . 74.340000000000003 110.893 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.8 m -113.71 170.7 8.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 74.319999999999993 110.861 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.21 -16.88 23.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.478 . . . . 74.319999999999993 110.903 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.2 -89.91 0.61 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 74.140000000000001 112.451 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -58.61 -19.88 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.333 . . . . 63.32 111.135 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 34.9 mt -101.25 103.17 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 73.030000000000001 111.106 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.15 30.81 0.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 75.209999999999994 110.875 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -81.56 69.41 8.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 64.450000000000003 110.936 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.7 t -110.06 104.24 13.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 73.319999999999993 110.879 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.5 m -47.14 -72.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 73.420000000000002 110.863 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -115.1 161.02 31.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.55 0.691 . . . . 73.209999999999994 110.882 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.3 Cg_endo -69.74 -48.43 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.661 -1.808 . . . . 70.150000000000006 112.35 -0.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -129.23 -92.54 0.45 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 72.230000000000004 110.934 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.41 162.0 23.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 73.310000000000002 110.972 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.0 t -93.35 104.43 16.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 73.349999999999994 110.827 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.514 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.71 132.49 15.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.599 0.714 . . . . 74.239999999999995 111.12 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.514 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.76 171.07 55.4 Favored 'Cis proline' 0 C--O 1.232 0.178 0 C-N-CA 122.702 -1.791 . . . . 75.430000000000007 112.299 -0.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.409 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 54.4 Cg_endo -69.78 -85.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.704 2.269 . . . . 72.409999999999997 112.373 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.409 ' H ' ' HG2' ' A' ' 24' ' ' PRO . 8.1 mt -59.08 108.41 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 74.540000000000006 111.13 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.1 mm 66.04 78.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 75.109999999999999 111.187 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.11 -179.02 37.37 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.745 -0.74 . . . . 53.240000000000002 112.475 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.13 137.39 50.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.37 . . . . 75.209999999999994 110.878 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.8 p -78.01 128.82 34.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 52.229999999999997 110.875 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 71.409999999999997 110.912 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.794 0.33 . . . . 73.319999999999993 110.874 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.7 mm 64.26 130.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 65.040000000000006 111.147 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.4 160.09 9.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 73.219999999999999 111.062 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.84 120.14 7.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 110.844 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 54.31 35.17 22.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 64.540000000000006 110.947 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.3 156.81 19.52 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.737 -0.744 . . . . 73.409999999999997 112.433 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.21 152.79 27.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.836 0.351 . . . . 74.519999999999996 110.867 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.2 m -113.77 170.34 8.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 74.439999999999998 110.898 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -59.72 -16.41 26.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 75.420000000000002 110.849 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.22 -89.67 0.6 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.719 -0.753 . . . . 65.400000000000006 112.49 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -58.34 -20.55 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 72.540000000000006 111.138 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 53.3 mt -100.34 103.13 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 75.109999999999999 111.136 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.55 30.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 75.420000000000002 110.91 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -81.78 69.39 8.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 75.120000000000005 110.893 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 t -110.19 104.2 13.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 73.329999999999998 110.87 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.9 m -48.05 -70.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 74.310000000000002 110.926 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.487 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.16 160.83 34.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.591 0.71 . . . . 62.100000000000001 110.903 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 52.9 Cg_endo -69.82 -48.35 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.154 0 C-N-CA 122.658 -1.809 . . . . 64.450000000000003 112.307 0.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -128.58 -92.65 0.46 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 72.530000000000001 110.915 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -124.62 161.89 25.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 75.25 110.914 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 4.6 t -93.06 104.8 16.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 75.329999999999998 110.879 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.517 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.6 m -141.4 132.69 13.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.522 0.677 . . . . 72.140000000000001 111.2 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.75 170.83 56.54 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 122.712 -1.787 . . . . 74.540000000000006 112.361 -0.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -87.43 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.686 2.257 . . . . 75.099999999999994 112.359 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.85 107.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 75.209999999999994 111.109 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.4 mm 65.3 82.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 72.049999999999997 111.123 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.84 -178.73 39.52 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.732 . . . . 72.129999999999995 112.483 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -129.99 137.34 50.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.936 0.398 . . . . 72.310000000000002 110.884 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.7 p -77.91 129.5 35.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 64.120000000000005 110.926 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.459 . . . . 75.340000000000003 110.91 179.975 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.767 0.317 . . . . 72.400000000000006 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.1 mm 64.5 130.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 75.120000000000005 111.106 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.7 160.17 32.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 55.219999999999999 111.091 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -53.93 120.76 6.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 70.310000000000002 110.869 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 55.72 32.4 19.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 73.5 110.878 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.21 152.0 19.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.796 -0.716 . . . . 74.329999999999998 112.501 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.4 151.67 2.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 74.340000000000003 110.876 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.3 m -117.19 165.31 13.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 72.450000000000003 110.844 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.73 -16.25 25.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 74.430000000000007 110.907 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.61 -91.33 0.66 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.701 -0.761 . . . . 62.149999999999999 112.482 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -61.61 -17.34 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 74.219999999999999 111.093 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 34.2 mt -99.42 103.4 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 71.150000000000006 111.095 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.545 ' N ' HD21 ' A' ' 13' ' ' ASN . 1.2 m-80 -88.17 31.77 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 62.049999999999997 110.853 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -80.75 69.23 7.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.239999999999995 110.943 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.3 t -110.45 104.35 13.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 31.120000000000001 110.862 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.4 m -45.57 -64.86 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 73.450000000000003 110.857 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.479 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 2.0 m-20 -125.82 162.07 47.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.618 0.723 . . . . 71.239999999999995 110.856 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.78 -48.91 0.25 Allowed 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.639 -1.817 . . . . 65.329999999999998 112.345 0.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -130.1 -92.73 0.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.229 -0.442 . . . . 73.409999999999997 110.927 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.59 162.57 18.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 73.409999999999997 110.915 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.9 t -94.86 104.56 16.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 70.200000000000003 110.899 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.52 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.3 m -138.12 133.76 17.52 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.635 0.731 . . . . 62.420000000000002 111.12 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.77 171.62 52.84 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.715 -1.786 . . . . 74.329999999999998 112.331 -0.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -86.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.688 2.259 . . . . 75.5 112.347 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 5.4 mt -58.69 106.57 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 74.430000000000007 111.114 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.2 mm 67.43 83.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 72.540000000000006 111.082 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.88 -177.37 39.14 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 62.200000000000003 112.493 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -130.14 137.5 50.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.852 0.358 . . . . 75.109999999999999 110.929 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 13.4 p -77.87 128.53 34.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 73.099999999999994 110.846 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 74.109999999999999 110.886 179.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.847 0.356 . . . . 75.5 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 35.6 mm 64.56 130.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 74.200000000000003 111.094 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.11 160.4 26.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 65.209999999999994 111.125 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -56.34 120.79 8.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 65.109999999999999 110.854 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 55.94 30.01 15.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 75.310000000000002 110.942 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.39 149.97 18.76 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 73.430000000000007 112.439 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 152.32 7.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 74.010000000000005 110.892 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.4 m -114.27 170.36 8.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 72.319999999999993 110.889 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -59.65 -16.33 25.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.852 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.52 -89.49 0.58 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.733 . . . . 72.129999999999995 112.474 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -58.84 -19.36 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.794 0.33 . . . . 73.129999999999995 111.125 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 42.4 mt -100.63 103.5 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 75.230000000000004 111.082 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -88.87 30.98 0.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 72.129999999999995 110.915 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -81.57 69.29 8.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 54.32 110.907 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.9 t -110.46 104.73 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 61.409999999999997 110.871 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.9 m -47.28 -72.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 74.120000000000005 110.845 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.487 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.42 161.34 32.15 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 75.299999999999997 110.855 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.81 -48.52 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.669 -1.804 . . . . 75.420000000000002 112.301 0.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -128.91 -92.63 0.45 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 75.200000000000003 110.868 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.99 162.07 24.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 70.310000000000002 110.898 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 3.8 t -93.12 104.19 16.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 74.109999999999999 110.922 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.517 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.54 132.78 15.48 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.588 0.709 . . . . 73.200000000000003 111.141 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.5 Cg_endo -69.73 170.77 56.74 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.713 -1.786 . . . . 54.0 112.343 -0.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -87.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.697 2.265 . . . . 72.25 112.385 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.9 mp -55.13 107.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 64.439999999999998 111.103 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.0 mm 65.4 83.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 75.099999999999994 111.173 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.7 -178.99 39.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.688 -0.768 . . . . 75.510000000000005 112.481 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.17 137.84 50.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.951 0.405 . . . . 74.0 110.854 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.416 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 12.3 p -78.15 129.29 34.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 63.140000000000001 110.887 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 71.340000000000003 110.94 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.842 0.353 . . . . 74.019999999999996 110.937 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.6 mm 64.1 130.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 63.539999999999999 111.113 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.73 158.07 33.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 74.329999999999998 111.093 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -53.12 120.79 6.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 72.129999999999995 110.848 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 55.69 35.27 24.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 73.329999999999998 110.955 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.1 150.5 18.97 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.75 -0.738 . . . . 64.409999999999997 112.5 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.69 152.48 2.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.812 0.339 . . . . 75.519999999999996 110.895 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.7 m -116.87 165.19 13.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 74.519999999999996 110.858 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -59.67 -16.39 26.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 71.340000000000003 110.868 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.14 -90.93 0.73 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 71.209999999999994 112.516 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.39 -19.14 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.874 0.369 . . . . 74.0 111.199 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 49.1 mt -102.04 103.3 14.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 72.430000000000007 111.114 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.58 31.27 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 75.209999999999994 110.916 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -81.26 69.76 7.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 75.430000000000007 110.893 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 t -109.99 103.99 12.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 70.230000000000004 110.848 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.1 m -47.62 -70.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 75.450000000000003 110.886 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.483 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -117.85 161.03 36.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 74.540000000000006 110.902 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.77 -48.66 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.698 -1.793 . . . . 74.120000000000005 112.317 0.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -128.75 -92.6 0.46 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 72.430000000000007 110.923 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -124.5 161.93 25.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 73.430000000000007 110.926 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.0 t -93.19 104.74 16.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 70.209999999999994 110.876 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.509 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.9 m -139.35 131.9 15.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.559 0.695 . . . . 73.409999999999997 111.12 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.7 171.15 54.74 Favored 'Cis proline' 0 C--N 1.341 0.159 0 C-N-CA 122.706 -1.789 . . . . 74.109999999999999 112.336 -0.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.44 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.7 Cg_endo -69.76 -83.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.686 2.257 . . . . 74.230000000000004 112.359 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.44 ' H ' ' HG2' ' A' ' 24' ' ' PRO . 6.5 mt -60.67 107.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 64.420000000000002 111.123 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.6 mm 67.14 83.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 65.129999999999995 111.178 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.97 -177.87 40.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 72.129999999999995 112.49 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -130.21 137.41 50.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.402 . . . . 74.349999999999994 110.906 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.0 p -77.98 129.4 35.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 72.129999999999995 110.916 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 73.200000000000003 110.903 179.995 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.825 0.345 . . . . 72.299999999999997 110.866 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.8 mm 64.35 130.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 73.319999999999993 111.112 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.26 160.04 32.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 74.299999999999997 111.099 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.03 120.3 5.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 70.430000000000007 110.862 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 53.58 33.99 17.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 55.030000000000001 110.892 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.33 152.61 19.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.712 -0.756 . . . . 75.409999999999997 112.476 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.66 152.62 3.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.353 . . . . 75.019999999999996 110.894 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.6 m -116.36 164.13 14.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 72.150000000000006 110.892 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -16.42 28.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.409999999999997 110.867 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.35 -90.93 0.64 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.728 . . . . 64.219999999999999 112.444 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.22 -19.87 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 75.540000000000006 111.172 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 52.8 mt -99.56 103.16 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 64.209999999999994 111.105 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.92 31.05 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 63.420000000000002 110.886 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -81.5 70.25 8.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 74.340000000000003 110.961 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.9 t -110.02 104.45 13.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 72.140000000000001 110.878 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.1 m -45.97 -74.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 75.329999999999998 110.867 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -114.84 161.02 31.22 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.555 0.693 . . . . 64.329999999999998 110.925 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.78 -48.7 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.155 0 C-N-CA 122.671 -1.804 . . . . 74.230000000000004 112.326 0.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -129.05 -92.52 0.45 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 110.967 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.91 162.3 23.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 75.120000000000005 110.917 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 7.9 t -93.41 104.75 16.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 72.439999999999998 110.907 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.512 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.0 132.37 15.92 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.602 0.715 . . . . 72.450000000000003 111.118 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.512 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.81 171.19 55.07 Favored 'Cis proline' 0 C--N 1.342 0.191 0 C-N-CA 122.701 -1.791 . . . . 72.319999999999993 112.287 0.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.7 Cg_endo -69.76 -84.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.655 2.237 . . . . 75.099999999999994 112.375 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.422 ' H ' ' HG2' ' A' ' 24' ' ' PRO . 5.1 mt -59.45 106.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 71.230000000000004 111.149 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.0 mm 68.08 85.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 72.030000000000001 111.094 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.71 -178.12 41.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 54.32 112.469 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -130.18 137.64 50.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.36 . . . . 74.519999999999996 110.926 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.9 p -77.93 128.98 34.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.818 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 73.420000000000002 110.962 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.3 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.774 0.321 . . . . 74.340000000000003 110.882 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.8 mm 64.3 130.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 64.540000000000006 111.159 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.9 160.37 32.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 73.109999999999999 111.117 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -50.84 120.44 4.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.43 . . . . 70.209999999999994 110.856 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 55.16 35.04 23.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 73.510000000000005 110.959 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.82 151.22 19.48 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.747 -0.74 . . . . 73.230000000000004 112.466 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.04 148.79 29.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 73.219999999999999 110.902 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.2 p -120.35 171.84 8.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 64.430000000000007 110.869 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -57.5 -19.22 23.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 74.239999999999995 110.852 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.9 -92.09 0.6 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.731 -0.747 . . . . 72.040000000000006 112.463 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.71 -18.76 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 74.349999999999994 111.165 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.6 mt -90.31 103.65 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 73.329999999999998 111.13 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.454 ' N ' HD21 ' A' ' 13' ' ' ASN . 1.1 m-80 -86.62 30.51 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 70.329999999999998 110.927 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.38 66.91 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.483 . . . . 75.120000000000005 110.921 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.4 t -111.83 104.68 13.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 74.209999999999994 110.864 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 m -43.51 -63.62 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 72.140000000000001 110.868 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 2.0 m-20 -130.13 161.71 58.43 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.581 0.705 . . . . 71.310000000000002 110.886 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.8 -47.6 0.3 Allowed 'Cis proline' 0 C--O 1.231 0.167 0 C-N-CA 122.722 -1.783 . . . . 72.340000000000003 112.343 0.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -127.77 -92.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 75.409999999999997 110.925 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.98 162.18 27.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 72.319999999999993 110.897 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.431 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -84.79 104.48 14.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 73.420000000000002 110.883 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.508 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 98.4 m -137.64 132.35 17.47 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.558 0.694 . . . . 70.400000000000006 111.127 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.508 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.8 172.49 48.88 Favored 'Cis proline' 0 C--N 1.341 0.141 0 C-N-CA 122.646 -1.814 . . . . 74.239999999999995 112.333 -0.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 23' ' ' PRO . 53.3 Cg_endo -69.79 -88.66 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.643 2.229 . . . . 61.039999999999999 112.342 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -52.5 102.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.200000000000003 111.092 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.6 mm 65.17 85.79 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 73.019999999999996 111.097 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.02 175.49 42.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 74.340000000000003 112.478 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -121.14 138.65 54.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.916 0.388 . . . . 75.340000000000003 110.842 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.431 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 19.9 p -77.04 128.8 35.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 73.430000000000007 110.876 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 74.540000000000006 110.981 179.94 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.786 0.326 . . . . 74.140000000000001 110.855 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.4 mm 64.25 130.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 71.409999999999997 111.139 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.78 160.04 33.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 72.430000000000007 111.085 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -51.04 120.43 4.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 75.230000000000004 110.905 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 55.21 35.08 24.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 74.430000000000007 110.919 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.09 150.14 19.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.739 -0.743 . . . . 62.399999999999999 112.504 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.18 149.18 24.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.854 0.359 . . . . 75.439999999999998 110.831 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.2 p -120.01 171.8 8.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 54.329999999999998 110.919 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -57.73 -19.01 24.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 63.310000000000002 110.821 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.49 -92.23 0.61 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 72.319999999999993 112.471 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.54 -18.63 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 72.230000000000004 111.124 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 64.5 mt -91.04 103.59 14.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 71.439999999999998 111.107 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.457 ' N ' HD21 ' A' ' 13' ' ' ASN . 1.1 m-80 -86.23 30.66 0.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 65.109999999999999 110.914 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.38 66.93 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 65.319999999999993 110.887 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.5 t -111.77 104.78 13.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 74.340000000000003 110.885 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.1 m -43.55 -63.66 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 75.310000000000002 110.87 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 5.6 m-20 -130.01 161.72 58.15 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.612 0.72 . . . . 73.230000000000004 110.853 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.79 -48.53 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.17 0 C-N-CA 122.68 -1.8 . . . . 72.120000000000005 112.363 0.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -126.8 -92.99 0.48 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 74.150000000000006 110.925 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.57 162.28 26.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 73.129999999999995 110.921 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -85.01 104.36 14.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 73.409999999999997 110.892 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.509 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 98.5 m -137.52 132.41 17.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.584 0.707 . . . . 64.150000000000006 111.193 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.81 172.39 49.42 Favored 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.713 -1.786 . . . . 74.510000000000005 112.325 0.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HD2' ' HB2' ' A' ' 23' ' ' PRO . 53.9 Cg_endo -69.72 -88.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.693 2.262 . . . . 74.430000000000007 112.327 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.0 mt -52.94 102.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 111.142 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 31.8 mm 65.92 85.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 74.319999999999993 111.11 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.38 174.13 42.52 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 72.120000000000005 112.477 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -119.38 138.69 52.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.893 0.378 . . . . 64.299999999999997 110.934 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 18.1 p -77.02 128.69 34.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 63.329999999999998 110.889 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 64.129999999999995 110.957 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.801 0.334 . . . . 72.129999999999995 110.844 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.9 mm 64.39 130.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 75.340000000000003 111.153 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.91 160.04 32.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 70.150000000000006 111.116 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -53.0 120.52 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 73.510000000000005 110.828 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 55.24 32.51 18.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 73.450000000000003 110.924 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.27 150.38 18.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.755 -0.736 . . . . 72.209999999999994 112.475 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.14 152.35 2.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.363 . . . . 73.310000000000002 110.89 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.3 m -116.5 163.81 15.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.886 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -59.51 -16.37 24.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 71.340000000000003 110.893 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.8 -90.99 0.63 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 74.239999999999995 112.484 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -59.5 -19.94 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.756 0.312 . . . . 74.310000000000002 111.078 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 31.9 mt -98.99 103.25 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 75.439999999999998 111.16 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -90.34 31.1 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.926 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -81.31 69.88 8.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 74.329999999999998 110.898 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.4 t -110.02 104.19 13.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 73.019999999999996 110.896 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.4 m -46.66 -72.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 71.209999999999994 110.899 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -115.84 161.13 32.24 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.633 0.73 . . . . 75.310000000000002 110.867 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.71 -48.76 0.26 Allowed 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.664 -1.807 . . . . 75.120000000000005 112.369 -0.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -128.64 -92.46 0.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 75.200000000000003 110.886 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -124.45 161.88 25.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 73.340000000000003 110.912 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.8 t -92.88 104.8 17.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 73.340000000000003 110.872 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.51 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.42 132.26 15.41 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.55 0.69 . . . . 71.540000000000006 111.164 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.51 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.77 171.18 54.94 Favored 'Cis proline' 0 C--O 1.231 0.151 0 C-N-CA 122.68 -1.8 . . . . 73.319999999999993 112.329 -0.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.446 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.9 Cg_endo -69.73 -82.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.689 2.259 . . . . 74.439999999999998 112.39 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.446 ' H ' ' HG2' ' A' ' 24' ' ' PRO . 5.4 mt -61.34 106.64 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 72.140000000000001 111.115 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 23.3 mm 67.33 82.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 73.219999999999999 111.124 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.69 -178.0 39.47 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 62.329999999999998 112.452 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -130.21 137.43 50.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 71.219999999999999 110.87 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.0 p -77.89 129.31 35.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 72.329999999999998 110.915 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 74.430000000000007 110.887 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 8' ' ' CYS . 34.5 mm . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.805 0.336 . . . . 72.319999999999993 111.159 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.96 160.15 26.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 72.120000000000005 111.099 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.29 120.54 7.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 73.530000000000001 110.872 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 56.14 29.79 15.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 64.030000000000001 110.913 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.34 150.64 18.93 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 52.539999999999999 112.524 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.09 153.61 2.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.778 0.323 . . . . 70.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.419 ' HA ' HD12 ' A' ' 2' ' ' ILE . 10.2 m -114.96 164.57 13.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 61.240000000000002 110.871 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.79 -18.11 29.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 70.120000000000005 110.808 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.87 -92.64 0.6 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.767 -0.73 . . . . 62.539999999999999 112.49 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.81 -17.09 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 74.349999999999994 111.151 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 14' ' ' GLN . 19.9 mt -99.22 102.65 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 72.430000000000007 111.179 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.88 31.85 1.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 73.019999999999996 110.901 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.447 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.3 tp60 -80.11 69.59 6.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 75.120000000000005 110.941 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.7 t -110.3 103.55 12.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 62.350000000000001 110.879 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.9 m -46.7 -72.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 61.420000000000002 110.838 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.491 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -116.35 162.43 26.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.563 0.697 . . . . 64.400000000000006 110.883 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.77 -49.01 0.25 Allowed 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.701 -1.791 . . . . 65.349999999999994 112.308 0.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -127.76 -93.0 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 74.239999999999995 110.923 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.482 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.8 pt? -124.09 162.4 23.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 52.200000000000003 110.887 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 15.3 t -93.38 104.28 16.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 44.310000000000002 110.846 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.6 m -139.52 130.54 14.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.589 0.709 . . . . 71.239999999999995 111.14 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.67 170.84 56.11 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.7 -1.792 . . . . 74.120000000000005 112.383 -0.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 -53.63 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.698 2.265 . . . . 72.239999999999995 112.358 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.469 HG22 HG12 ' A' ' 26' ' ' ILE . 2.7 mt -96.17 119.27 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 74.109999999999999 111.13 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 25' ' ' ILE . 25.4 mm 65.96 65.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 73.019999999999996 111.173 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.02 179.38 38.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.741 . . . . 42.32 112.502 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.516 ' O ' HD12 ' A' ' 30' ' ' LEU . 3.4 m-85 -130.3 140.44 50.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 65.329999999999998 110.877 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.5 p -74.54 128.73 36.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 74.329999999999998 110.921 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 28' ' ' PHE . 2.1 mp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 75.239999999999995 110.898 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.9 mm . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.821 0.344 . . . . 74.439999999999998 111.093 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.97 158.63 30.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 71.030000000000001 111.13 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -54.35 120.53 6.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 73.439999999999998 110.884 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 55.4 35.18 24.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 70.299999999999997 110.923 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.95 150.59 19.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.78 -0.724 . . . . 55.439999999999998 112.508 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.55 153.43 5.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.822 0.344 . . . . 72.019999999999996 110.888 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.3 m -115.45 166.11 12.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 70.219999999999999 110.881 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.1 -17.98 31.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 72.519999999999996 110.937 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.41 -92.64 0.63 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 74.099999999999994 112.477 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -61.94 -16.74 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.335 . . . . 75.299999999999997 111.154 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 14' ' ' GLN . 48.4 mt -99.61 102.64 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 71.239999999999995 111.114 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.97 31.84 1.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 60.240000000000002 110.91 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.42 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -80.26 70.81 6.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 72.319999999999993 110.879 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.6 t -109.66 103.6 12.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 71.209999999999994 110.851 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 m -47.58 -65.41 0.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 70.409999999999997 110.895 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.493 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -123.85 161.63 45.51 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.58 0.705 . . . . 51.130000000000003 110.886 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.73 -49.1 0.24 Allowed 'Cis proline' 0 C--O 1.231 0.158 0 C-N-CA 122.723 -1.782 . . . . 74.430000000000007 112.33 0.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.769 ' HB3' HD23 ' A' ' 20' ' ' LEU . 84.6 m95 -128.06 -92.86 0.47 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 72.540000000000006 110.93 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.769 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -124.05 162.23 23.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 64.420000000000002 110.935 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 9.0 t -93.3 104.57 16.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 110.874 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.495 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.2 m -138.62 130.15 15.52 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.587 0.708 . . . . 74.310000000000002 111.093 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.4 Cg_endo -69.76 170.73 57.07 Favored 'Cis proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 -1.8 . . . . 64.540000000000006 112.314 -0.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -55.02 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.706 2.271 . . . . 70.430000000000007 112.348 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.503 HG22 HG12 ' A' ' 26' ' ' ILE . 3.1 mt -94.07 118.53 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 64.549999999999997 111.16 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.503 HG12 HG22 ' A' ' 25' ' ' ILE . 26.1 mm 65.99 63.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 63.409999999999997 111.125 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.3 178.92 35.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 73.109999999999999 112.496 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -130.35 139.74 50.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 74.120000000000005 110.871 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.4 p -75.01 128.35 35.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 53.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 74.219999999999999 110.887 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.8 mm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.867 0.365 . . . . 72.239999999999995 111.127 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.64 159.81 26.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 53.420000000000002 111.073 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -55.54 120.54 7.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 61.210000000000001 110.878 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 55.92 34.99 24.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 75.310000000000002 110.907 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.6 149.93 19.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.751 . . . . 45.100000000000001 112.46 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.38 153.24 5.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 74.340000000000003 110.865 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 m -115.41 165.95 12.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 110.906 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -59.16 -17.67 29.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 71.129999999999995 110.886 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.24 -92.62 0.63 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 32.520000000000003 112.497 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -61.91 -16.75 16.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.788 0.328 . . . . 73.040000000000006 111.169 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 43.9 mt -99.55 102.59 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 73.329999999999998 111.116 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.94 31.79 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 61.32 110.879 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.1 70.85 6.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 73.040000000000006 110.883 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.3 t -110.04 103.35 12.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 63.399999999999999 110.852 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.3 m -47.94 -64.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 71.400000000000006 110.904 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -124.01 161.87 44.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.589 0.709 . . . . 64.109999999999999 110.889 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.74 -49.19 0.24 Allowed 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.74 -1.775 . . . . 71.310000000000002 112.354 0.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -127.55 -92.93 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 75.430000000000007 110.95 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.7 pt? -124.49 162.01 24.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 53.009999999999998 110.969 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 8.0 t -93.13 104.69 16.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 70.010000000000005 110.896 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.496 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.1 m -138.99 130.14 15.08 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.559 0.695 . . . . 64.200000000000003 111.153 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.73 170.75 56.82 Favored 'Cis proline' 0 C--O 1.231 0.149 0 C-N-CA 122.692 -1.795 . . . . 73.340000000000003 112.348 -0.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -55.37 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.664 2.243 . . . . 73.340000000000003 112.346 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.518 HG22 HG12 ' A' ' 26' ' ' ILE . 3.3 mt -93.32 117.7 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 73.140000000000001 111.17 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.518 HG12 HG22 ' A' ' 25' ' ' ILE . 23.0 mm 66.17 65.9 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 61.240000000000002 111.143 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.37 179.42 36.8 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 64.219999999999999 112.463 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.34 139.64 50.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.881 0.372 . . . . 73.120000000000005 110.874 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.7 p -75.04 128.96 36.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 33.399999999999999 110.898 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 72.219999999999999 110.89 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.7 mm . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.802 0.334 . . . . 63.530000000000001 111.118 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.28 160.11 31.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 51.329999999999998 111.094 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -54.42 120.47 6.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 71.409999999999997 110.896 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 55.9 31.62 18.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 74.519999999999996 110.945 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.39 150.29 18.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 74.319999999999993 112.49 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.34 153.19 3.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 71.030000000000001 110.914 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.0 m -115.3 163.51 15.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 110.857 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -58.73 -17.91 26.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 64.349999999999994 110.887 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.84 -92.26 0.6 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.72 . . . . 44.130000000000003 112.494 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -61.7 -16.82 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.89 0.376 . . . . 51.450000000000003 111.158 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.434 HG22 ' HB2' ' A' ' 14' ' ' GLN . 27.7 mt -100.33 102.77 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 74.219999999999999 111.132 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.35 31.83 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 61.5 110.859 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.434 ' HB2' HG22 ' A' ' 12' ' ' ILE . 1.2 mp0 -79.34 69.56 5.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 74.230000000000004 110.893 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.2 t -110.44 103.86 12.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 54.109999999999999 110.912 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.3 m -47.27 -72.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 62.009999999999998 110.895 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.492 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.81 162.31 27.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.595 0.712 . . . . 74.030000000000001 110.875 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.74 -49.05 0.24 Allowed 'Cis proline' 0 C--N 1.341 0.138 0 C-N-CA 122.681 -1.799 . . . . 72.349999999999994 112.321 0.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.769 ' HB3' HD23 ' A' ' 20' ' ' LEU . 49.3 m95 -128.04 -92.9 0.46 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 62.420000000000002 110.936 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.769 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -123.9 162.35 23.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.428 . . . . 73.340000000000003 110.923 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 9.0 t -93.33 104.36 16.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 64.230000000000004 110.842 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.498 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.9 m -138.75 130.55 15.53 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.606 0.717 . . . . 65.420000000000002 111.104 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.77 170.82 56.64 Favored 'Cis proline' 0 C--N 1.342 0.202 0 C-N-CA 122.706 -1.789 . . . . 50.219999999999999 112.331 -0.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -54.41 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.244 . . . . 73.409999999999997 112.33 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.513 HG22 HG12 ' A' ' 26' ' ' ILE . 3.3 mt -94.54 118.32 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 74.140000000000001 111.165 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.513 HG12 HG22 ' A' ' 25' ' ' ILE . 25.5 mm 65.95 66.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 45.409999999999997 111.157 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.05 179.21 38.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.749 -0.739 . . . . 60.100000000000001 112.466 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -130.46 140.21 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 75.239999999999995 110.861 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.3 p -74.55 128.6 35.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 72.540000000000006 110.906 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 71.129999999999995 110.937 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 8' ' ' CYS . 34.0 mm . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.822 0.344 . . . . 53.509999999999998 111.124 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.41 160.16 30.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 73.040000000000006 111.087 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -55.74 120.55 7.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 44.340000000000003 110.886 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 55.58 30.55 15.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 73.219999999999999 110.912 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.52 150.5 18.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.76 -0.733 . . . . 61.310000000000002 112.478 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.91 153.62 2.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.835 0.35 . . . . 73.010000000000005 110.914 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.417 ' HA ' HD12 ' A' ' 2' ' ' ILE . 13.8 m -114.89 164.84 13.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 73.030000000000001 110.9 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -58.65 -18.46 30.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 70.219999999999999 110.847 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.55 -92.57 0.6 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.731 -0.747 . . . . 52.439999999999998 112.481 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -62.13 -16.47 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.74 0.305 . . . . 72.310000000000002 111.091 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.454 HG22 ' H ' ' A' ' 14' ' ' GLN . 64.3 mt -100.25 102.81 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 64.200000000000003 111.11 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.7 31.82 1.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 42.43 110.905 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.454 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.6 tp60 -80.13 69.76 6.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 74.310000000000002 110.919 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.5 t -110.1 103.94 12.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 74.329999999999998 110.91 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.4 m -46.16 -73.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.099999999999994 110.941 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.491 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -115.57 162.39 25.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.601 0.715 . . . . 64.409999999999997 110.912 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.77 -49.35 0.23 Allowed 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.663 -1.807 . . . . 72.409999999999997 112.322 0.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -128.11 -93.06 0.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 74.140000000000001 110.955 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.55 162.71 21.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 52.240000000000002 110.917 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 18.4 t -94.45 104.1 16.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 65.530000000000001 110.897 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.3 m -138.69 131.09 15.81 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.585 0.707 . . . . 61.049999999999997 111.162 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.7 170.72 56.86 Favored 'Cis proline' 0 C--O 1.231 0.172 0 C-N-CA 122.711 -1.787 . . . . 71.129999999999995 112.357 -0.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -54.18 0.23 Allowed 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.69 2.26 . . . . 63.509999999999998 112.373 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.495 HG22 HG12 ' A' ' 26' ' ' ILE . 3.0 mt -95.44 118.35 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 61.229999999999997 111.17 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.495 HG12 HG22 ' A' ' 25' ' ' ILE . 22.0 mm 66.4 63.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 71.299999999999997 111.152 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.36 178.82 35.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 74.310000000000002 112.48 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -130.45 140.24 50.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.875 0.369 . . . . 70.519999999999996 110.89 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.0 p -74.61 128.56 35.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 73.109999999999999 110.905 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.498 ' O ' HD12 ' A' ' 30' ' ' LEU . 1.4 pp . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 62.340000000000003 110.917 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.82 0.343 . . . . 74.230000000000004 111.149 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.46 160.11 33.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 64.530000000000001 111.101 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -52.1 120.55 5.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 61.340000000000003 110.877 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 54.86 34.02 21.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.040000000000006 110.944 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.19 150.76 19.0 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 74.109999999999999 112.513 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.89 151.89 3.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.837 0.351 . . . . 64.439999999999998 110.92 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.7 m -117.21 163.09 16.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 61.43 110.888 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -59.26 -16.59 22.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 74.329999999999998 110.853 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.01 -90.66 0.64 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.75 . . . . 64.140000000000001 112.512 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.06 -19.51 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.796 0.331 . . . . 75.430000000000007 111.127 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' A' ' 14' ' ' GLN . 33.2 mt -98.7 103.42 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 74.109999999999999 111.122 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.34 31.09 0.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 62.100000000000001 110.873 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.501 ' HB2' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -81.61 69.87 8.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 73.420000000000002 110.927 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.1 t -110.05 104.41 13.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 72.310000000000002 110.906 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.6 m -46.68 -68.97 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 54.119999999999997 110.885 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -121.06 160.91 43.18 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.565 0.698 . . . . 74.340000000000003 110.884 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.75 -48.69 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.144 0 C-N-CA 122.705 -1.79 . . . . 61.149999999999999 112.352 0.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.75 ' HB3' HD23 ' A' ' 20' ' ' LEU . 95.3 m95 -128.98 -92.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 75.140000000000001 110.94 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.75 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -124.33 161.98 24.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 110.947 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 4.8 t -92.92 104.5 16.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 52.210000000000001 110.921 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.522 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -138.93 132.46 16.04 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.587 0.708 . . . . 74.099999999999994 111.145 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.78 170.78 56.91 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 -1.8 . . . . 60.149999999999999 112.366 -0.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.405 ' HG2' HD12 ' A' ' 25' ' ' ILE . 53.7 Cg_endo -69.81 -87.26 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.67 2.247 . . . . 70.040000000000006 112.326 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.508 HG22 HG12 ' A' ' 26' ' ' ILE . 1.8 mp -54.7 105.75 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 75.230000000000004 111.146 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 25' ' ' ILE . 25.9 mm 65.84 84.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.430000000000007 111.14 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.71 -178.16 39.05 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 73.019999999999996 112.502 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -130.14 136.97 49.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 64.400000000000006 110.837 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 13.7 p -78.29 129.12 34.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 64.129999999999995 110.911 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 74.430000000000007 110.935 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.4 mm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.877 0.37 . . . . 75.340000000000003 111.109 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.61 158.56 31.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 74.409999999999997 111.083 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -53.0 120.47 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 74.030000000000001 110.858 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 54.9 35.3 24.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 71.540000000000006 110.877 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.67 149.94 19.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 73.030000000000001 112.501 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 152.15 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.323 . . . . 74.409999999999997 110.907 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.9 m -117.04 165.75 13.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 65.219999999999999 110.893 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.43 -16.09 32.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 72.129999999999995 110.843 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.36 -90.97 0.7 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.718 -0.753 . . . . 53.149999999999999 112.489 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -58.87 -20.91 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 74.230000000000004 111.127 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 14' ' ' GLN . 56.4 mt -98.94 103.01 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 111.14 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -90.29 30.82 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 35.439999999999998 110.865 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.452 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -81.73 70.49 8.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 64.150000000000006 110.864 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.4 t -108.85 104.13 13.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 60.329999999999998 110.87 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.0 m -46.86 -68.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 75.209999999999994 110.909 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -120.89 160.38 45.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.599 0.714 . . . . 55.310000000000002 110.861 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.8 -48.6 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.677 -1.801 . . . . 71.209999999999994 112.332 0.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.758 ' HB3' HD23 ' A' ' 20' ' ' LEU . 76.9 m95 -128.41 -92.47 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.929 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.758 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -126.09 161.92 26.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.276 -0.42 . . . . 63.439999999999998 110.942 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 6.0 t -92.03 104.64 17.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 70.310000000000002 110.866 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.519 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.7 m -139.24 131.53 15.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.59 0.71 . . . . 71.209999999999994 111.131 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.76 170.79 56.76 Favored 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.72 -1.783 . . . . 51.32 112.369 -0.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -87.48 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.667 2.245 . . . . 74.120000000000005 112.344 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.534 HG22 HG12 ' A' ' 26' ' ' ILE . 1.8 mp -55.32 106.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 62.340000000000003 111.101 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 25' ' ' ILE . 25.1 mm 66.09 84.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 111.147 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.59 -179.05 40.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 74.319999999999993 112.484 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.531 ' O ' HD12 ' A' ' 30' ' ' LEU . 1.6 m-85 -129.14 137.06 50.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 71.120000000000005 110.858 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.408 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 18.5 p -78.36 129.16 34.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 64.0 110.926 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 28' ' ' PHE . 4.6 mp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 64.540000000000006 110.907 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.876 0.37 . . . . 71.25 111.154 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.87 158.52 34.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 53.039999999999999 111.118 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -52.15 120.5 5.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 75.099999999999994 110.87 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 55.28 35.28 24.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 74.219999999999999 110.93 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.93 150.25 19.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.741 -0.742 . . . . 73.519999999999996 112.531 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 152.42 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 72.329999999999998 110.892 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 m -116.92 165.24 13.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 74.310000000000002 110.908 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.02 -16.45 31.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 72.129999999999995 110.879 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.68 -91.08 0.7 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 72.209999999999994 112.459 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -59.43 -19.41 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.34 . . . . 74.25 111.191 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.448 HG22 ' H ' ' A' ' 14' ' ' GLN . 54.4 mt -100.24 103.13 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 72.129999999999995 111.138 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -90.34 30.98 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 74.040000000000006 110.867 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.448 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.1 tp60 -81.52 70.86 8.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 74.400000000000006 110.91 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -109.21 104.09 13.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 72.439999999999998 110.899 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.0 m -47.39 -65.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 73.510000000000005 110.873 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -123.96 161.41 46.98 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.573 0.701 . . . . 65.510000000000005 110.912 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.0 Cg_endo -69.79 -48.66 0.26 Allowed 'Cis proline' 0 C--O 1.231 0.159 0 C-N-CA 122.675 -1.802 . . . . 64.010000000000005 112.337 0.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.801 ' HB3' HD23 ' A' ' 20' ' ' LEU . 20.7 m95 -127.82 -92.55 0.48 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 74.010000000000005 110.912 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.801 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -125.86 161.94 26.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 64.030000000000001 110.913 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.8 t -92.41 104.74 17.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 65.400000000000006 110.859 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.515 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.4 m -138.87 131.45 15.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.607 0.717 . . . . 74.150000000000006 111.154 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.1 Cg_endo -69.74 171.12 55.07 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.727 -1.781 . . . . 70.129999999999995 112.359 -0.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.9 Cg_endo -69.8 -83.5 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.692 2.261 . . . . 63.229999999999997 112.335 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.602 HG22 HG12 ' A' ' 26' ' ' ILE . 5.8 mt -60.41 106.76 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 71.109999999999999 111.154 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.602 HG12 HG22 ' A' ' 25' ' ' ILE . 22.5 mm 67.63 84.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 70.109999999999999 111.103 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.63 -178.58 41.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 65.430000000000007 112.476 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -129.3 137.18 50.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.367 . . . . 65.099999999999994 110.892 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.9 p -78.16 128.91 34.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.299999999999997 110.893 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 30' ' ' LEU . 1.4 pt? . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 64.329999999999998 110.922 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.0 mm . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.833 0.349 . . . . 65.409999999999997 111.172 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.37 158.67 33.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 52.200000000000003 111.091 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -53.01 120.64 6.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 70.25 110.862 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 55.58 35.34 24.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 72.519999999999996 110.966 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.81 150.65 19.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 72.25 112.491 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.18 152.53 3.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.836 0.351 . . . . 74.209999999999994 110.903 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.6 m -117.0 165.32 13.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 35.450000000000003 110.855 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -59.89 -16.54 30.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 53.240000000000002 110.853 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.8 -90.93 0.71 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.716 -0.754 . . . . 52.219999999999999 112.526 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.52 -19.47 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 75.310000000000002 111.116 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 14' ' ' GLN . 52.4 mt -101.26 103.14 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 54.149999999999999 111.117 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.65 31.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 61.219999999999999 110.856 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.447 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.2 tp60 -81.34 69.84 8.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 110.918 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.7 t -109.77 104.03 12.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 71.010000000000005 110.873 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.4 m -47.22 -70.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 73.239999999999995 110.909 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -117.36 160.7 36.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.566 0.698 . . . . 70.420000000000002 110.849 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.76 -48.69 0.26 Allowed 'Cis proline' 0 C--O 1.231 0.167 0 C-N-CA 122.743 -1.774 . . . . 75.439999999999998 112.29 0.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.765 ' HB3' HD23 ' A' ' 20' ' ' LEU . 69.9 m95 -128.94 -92.47 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 73.540000000000006 110.901 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.765 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -124.56 162.01 24.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 75.319999999999993 110.945 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 8.2 t -93.06 104.58 16.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 72.209999999999994 110.862 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.52 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.9 m -139.18 131.92 15.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.569 0.7 . . . . 72.530000000000001 111.135 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.75 171.15 54.97 Favored 'Cis proline' 0 C--N 1.342 0.186 0 C-N-CA 122.64 -1.817 . . . . 70.299999999999997 112.384 -0.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -85.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.69 2.26 . . . . 71.019999999999996 112.364 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.593 HG22 HG12 ' A' ' 26' ' ' ILE . 6.1 mt -59.11 107.38 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 73.340000000000003 111.115 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.593 HG12 HG22 ' A' ' 25' ' ' ILE . 25.8 mm 66.9 83.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 75.25 111.114 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.89 -178.14 40.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 75.040000000000006 112.48 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -130.01 137.39 50.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 75.019999999999996 110.865 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.0 p -78.24 128.93 34.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 72.010000000000005 110.888 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 72.200000000000003 110.912 179.982 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.4 mm . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.835 0.35 . . . . 73.540000000000006 111.134 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.44 160.04 28.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 65.450000000000003 111.138 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -55.06 120.68 7.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 72.140000000000001 110.856 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 55.86 35.36 25.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 64.099999999999994 110.918 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.03 152.54 19.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.797 -0.716 . . . . 71.200000000000003 112.501 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.7 152.5 5.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.888 0.375 . . . . 64.340000000000003 110.861 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.0 m -116.94 165.07 13.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 70.439999999999998 110.882 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.69 -16.67 28.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 75.329999999999998 110.903 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.23 -91.15 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 71.510000000000005 112.529 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.59 -19.25 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.791 0.329 . . . . 63.520000000000003 111.124 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.47 HG22 ' H ' ' A' ' 14' ' ' GLN . 2.7 mp -100.96 103.08 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 73.219999999999999 111.161 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -90.1 30.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 63.32 110.894 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.47 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -81.22 69.58 7.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 72.400000000000006 110.897 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.3 t -108.96 103.97 13.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 72.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.1 m -47.57 -68.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 62.25 110.868 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -120.12 161.49 38.41 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.577 0.704 . . . . 73.200000000000003 110.903 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.8 -48.43 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.147 0 C-N-CA 122.635 -1.819 . . . . 71.430000000000007 112.359 0.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -128.08 -92.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 74.540000000000006 110.902 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.481 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.8 pt? -125.9 161.8 26.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 65.530000000000001 110.945 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 7.5 t -92.35 104.42 16.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 75.439999999999998 110.911 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.5 m -139.55 131.61 15.02 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.545 0.688 . . . . 64.310000000000002 111.143 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.79 171.1 55.38 Favored 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.645 -1.814 . . . . 42.399999999999999 112.354 -0.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -85.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.708 2.272 . . . . 71.430000000000007 112.349 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.61 HG22 HG12 ' A' ' 26' ' ' ILE . 6.3 mt -58.45 107.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 71.239999999999995 111.134 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.61 HG12 HG22 ' A' ' 25' ' ' ILE . 23.8 mm 67.41 84.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 72.319999999999993 111.139 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.74 -178.07 41.15 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.719 -0.753 . . . . 64.120000000000005 112.456 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -130.02 137.32 50.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.381 . . . . 75.319999999999993 110.89 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 18.4 p -78.17 129.46 35.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 60.130000000000003 110.902 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 65.439999999999998 110.939 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.854 0.359 . . . . 72.030000000000001 111.118 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.16 157.92 34.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 64.540000000000006 111.12 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -52.58 120.6 5.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 75.140000000000001 110.884 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 55.81 35.38 25.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 74.109999999999999 110.926 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.83 150.48 19.05 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 63.329999999999998 112.479 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.29 152.53 3.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 71.129999999999995 110.927 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.1 m -116.75 164.94 13.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 71.239999999999995 110.874 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.48 -17.22 29.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 53.439999999999998 110.852 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.84 -91.34 0.68 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 63.340000000000003 112.489 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -60.08 -18.9 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 74.400000000000006 111.138 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 14' ' ' GLN . 53.3 mt -100.38 103.15 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 71.549999999999997 111.123 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -90.39 30.95 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 71.430000000000007 110.845 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.444 ' H ' HG22 ' A' ' 12' ' ' ILE . 10.5 tp-100 -81.31 69.89 8.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 72.150000000000006 110.926 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.1 t -109.06 103.91 13.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 73.030000000000001 110.907 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.6 m -47.5 -68.26 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 71.129999999999995 110.929 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.496 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -120.31 160.84 41.94 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.568 0.699 . . . . 74.450000000000003 110.841 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.0 Cg_endo -69.74 -48.73 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.167 0 C-N-CA 122.698 -1.793 . . . . 65.329999999999998 112.347 -0.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.779 ' HB3' HD23 ' A' ' 20' ' ' LEU . 54.9 m95 -128.05 -92.53 0.47 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 110.924 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.779 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -125.88 161.82 26.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 73.329999999999998 110.923 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 7.6 t -91.92 104.43 16.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 53.350000000000001 110.885 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.6 m -139.1 131.31 15.42 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.569 0.699 . . . . 62.229999999999997 111.163 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.79 171.06 55.6 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.672 -1.803 . . . . 74.329999999999998 112.351 0.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.9 Cg_endo -69.77 -85.09 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.698 2.265 . . . . 62.119999999999997 112.339 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.601 HG22 HG12 ' A' ' 26' ' ' ILE . 5.2 mt -59.24 107.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 75.349999999999994 111.105 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.601 HG12 HG22 ' A' ' 25' ' ' ILE . 22.8 mm 67.42 83.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 73.239999999999995 111.095 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.61 -178.46 40.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.758 -0.734 . . . . 41.350000000000001 112.49 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -129.87 137.25 50.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 74.439999999999998 110.818 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 18.2 p -77.98 128.92 34.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 74.109999999999999 110.889 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 75.150000000000006 110.879 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.7 mm . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.842 0.353 . . . . 54.32 111.142 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.5 159.92 9.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 72.120000000000005 111.123 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -55.4 120.02 6.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 72.209999999999994 110.851 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 51.84 34.28 13.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 74.530000000000001 110.923 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.25 153.03 19.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 71.140000000000001 112.496 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 153.13 8.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.84 0.352 . . . . 64.409999999999997 110.893 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.8 m -113.71 170.7 8.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 74.129999999999995 110.861 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.21 -16.88 23.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.478 . . . . 74.319999999999993 110.903 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.2 -89.91 0.61 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 74.140000000000001 112.451 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -58.61 -19.88 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.333 . . . . 55.229999999999997 111.135 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.49 HG22 ' HB2' ' A' ' 14' ' ' GLN . 34.9 mt -101.25 103.17 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 64.25 111.106 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.15 30.81 0.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 75.209999999999994 110.875 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HB2' HG22 ' A' ' 12' ' ' ILE . 1.2 mp0 -81.56 69.41 8.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 64.450000000000003 110.936 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.7 t -110.06 104.24 13.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 73.319999999999993 110.879 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.5 m -47.14 -72.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 55.219999999999999 110.863 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -115.1 161.02 31.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.55 0.691 . . . . 70.209999999999994 110.882 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.3 Cg_endo -69.74 -48.43 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.661 -1.808 . . . . 51.450000000000003 112.35 -0.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.773 ' HB3' HD23 ' A' ' 20' ' ' LEU . 75.9 m95 -129.23 -92.54 0.45 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 72.109999999999999 110.934 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.773 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -123.41 162.0 23.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 73.030000000000001 110.972 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.0 t -93.35 104.43 16.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 73.349999999999994 110.827 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.522 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.71 132.49 15.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.599 0.714 . . . . 74.239999999999995 111.12 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.76 171.07 55.4 Favored 'Cis proline' 0 C--O 1.232 0.178 0 C-N-CA 122.702 -1.791 . . . . 75.430000000000007 112.299 -0.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 -85.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.704 2.269 . . . . 72.409999999999997 112.373 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.618 HG22 HG12 ' A' ' 26' ' ' ILE . 8.1 mt -59.08 108.41 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 74.540000000000006 111.13 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.618 HG12 HG22 ' A' ' 25' ' ' ILE . 27.1 mm 66.04 78.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 72.530000000000001 111.187 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.11 -179.02 37.37 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.745 -0.74 . . . . 53.240000000000002 112.475 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.13 137.39 50.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.37 . . . . 75.209999999999994 110.878 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.8 p -78.01 128.82 34.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 52.229999999999997 110.875 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 71.319999999999993 110.912 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.7 mm . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.796 0.332 . . . . 65.040000000000006 111.147 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.4 160.09 9.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 44.409999999999997 111.062 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.84 120.14 7.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 110.844 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 54.31 35.17 22.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 64.540000000000006 110.947 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.3 156.81 19.52 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.737 -0.744 . . . . 73.409999999999997 112.433 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.21 152.79 27.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.836 0.351 . . . . 74.519999999999996 110.867 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.2 m -113.77 170.34 8.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 74.439999999999998 110.898 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -59.72 -16.41 26.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 75.310000000000002 110.849 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.22 -89.67 0.6 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.719 -0.753 . . . . 65.120000000000005 112.49 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -58.34 -20.55 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 72.540000000000006 111.138 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.453 HG22 ' H ' ' A' ' 14' ' ' GLN . 53.3 mt -100.34 103.13 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 70.420000000000002 111.136 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.55 30.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 75.329999999999998 110.91 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.453 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -81.78 69.39 8.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 63.409999999999997 110.893 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 t -110.19 104.2 13.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 53.350000000000001 110.87 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.9 m -48.05 -70.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 74.310000000000002 110.926 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.498 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.16 160.83 34.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.591 0.71 . . . . 52.149999999999999 110.903 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 52.9 Cg_endo -69.82 -48.35 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.154 0 C-N-CA 122.658 -1.809 . . . . 52.549999999999997 112.307 0.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -128.58 -92.65 0.46 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 72.530000000000001 110.915 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.497 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.9 pt? -124.62 161.89 25.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 64.310000000000002 110.914 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 4.6 t -93.06 104.8 16.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 75.329999999999998 110.879 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.525 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.6 m -141.4 132.69 13.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.522 0.677 . . . . 60.0 111.2 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.75 170.83 56.54 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 122.712 -1.787 . . . . 74.540000000000006 112.361 -0.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -87.43 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.686 2.257 . . . . 75.099999999999994 112.359 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.549 HG22 HG12 ' A' ' 26' ' ' ILE . 1.9 mp -55.85 107.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 70.010000000000005 111.109 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.549 HG12 HG22 ' A' ' 25' ' ' ILE . 25.4 mm 65.3 82.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 64.409999999999997 111.123 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.84 -178.73 39.52 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.732 . . . . 72.129999999999995 112.483 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -129.99 137.34 50.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.936 0.398 . . . . 72.310000000000002 110.884 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.416 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.7 p -77.91 129.5 35.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 64.120000000000005 110.926 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.459 . . . . 75.340000000000003 110.91 179.975 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.1 mm . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.828 0.347 . . . . 64.409999999999997 111.106 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.7 160.17 32.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 55.219999999999999 111.091 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -53.93 120.76 6.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 70.310000000000002 110.869 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 55.72 32.4 19.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 73.5 110.878 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.21 152.0 19.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.796 -0.716 . . . . 73.049999999999997 112.501 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.4 151.67 2.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 62.43 110.876 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.3 m -117.19 165.31 13.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 72.450000000000003 110.844 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.73 -16.25 25.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 74.430000000000007 110.907 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.61 -91.33 0.66 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.701 -0.761 . . . . 62.149999999999999 112.482 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -61.61 -17.34 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 74.219999999999999 111.093 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 14' ' ' GLN . 34.2 mt -99.42 103.4 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 71.150000000000006 111.095 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -88.17 31.77 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 61.229999999999997 110.853 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.422 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.1 tp60 -80.75 69.23 7.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.239999999999995 110.943 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.3 t -110.45 104.35 13.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 31.120000000000001 110.862 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.4 m -45.57 -64.86 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 64.129999999999995 110.857 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 2.0 m-20 -125.82 162.07 47.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.618 0.723 . . . . 71.239999999999995 110.856 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.78 -48.91 0.25 Allowed 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.639 -1.817 . . . . 65.329999999999998 112.345 0.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.788 ' HB3' HD23 ' A' ' 20' ' ' LEU . 66.9 m95 -130.1 -92.73 0.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.229 -0.442 . . . . 73.409999999999997 110.927 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.788 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -119.59 162.57 18.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 70.430000000000007 110.915 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.9 t -94.86 104.56 16.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 50.530000000000001 110.899 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.526 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.3 m -138.12 133.76 17.52 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.635 0.731 . . . . 54.549999999999997 111.12 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.526 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.77 171.62 52.84 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.715 -1.786 . . . . 74.329999999999998 112.331 -0.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -86.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.688 2.259 . . . . 75.5 112.347 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.591 HG22 HG12 ' A' ' 26' ' ' ILE . 5.4 mt -58.69 106.57 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 74.430000000000007 111.114 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.591 HG12 HG22 ' A' ' 25' ' ' ILE . 23.2 mm 67.43 83.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 71.25 111.082 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.88 -177.37 39.14 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 61.200000000000003 112.493 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -130.14 137.5 50.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.852 0.358 . . . . 75.109999999999999 110.929 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 13.4 p -77.87 128.53 34.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 73.099999999999994 110.846 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.411 ' HA ' ' HG3' ' A' ' 18' ' ' PRO . 1.6 pt? . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 62.539999999999999 110.886 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 8' ' ' CYS . 35.6 mm . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.848 0.356 . . . . 73.129999999999995 111.094 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.11 160.4 26.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 64.310000000000002 111.125 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -56.34 120.79 8.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 64.310000000000002 110.854 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 55.94 30.01 15.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 75.310000000000002 110.942 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.39 149.97 18.76 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 40.229999999999997 112.439 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 152.32 7.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 52.439999999999998 110.892 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.417 ' HA ' HD12 ' A' ' 2' ' ' ILE . 6.4 m -114.27 170.36 8.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 72.230000000000004 110.889 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -59.65 -16.33 25.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.852 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.52 -89.49 0.58 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.733 . . . . 72.129999999999995 112.474 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -58.84 -19.36 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.794 0.33 . . . . 73.129999999999995 111.125 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.435 HG22 ' H ' ' A' ' 14' ' ' GLN . 42.4 mt -100.63 103.5 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 75.230000000000004 111.082 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -88.87 30.98 0.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 72.129999999999995 110.915 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.435 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.1 tp60 -81.57 69.29 8.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 41.420000000000002 110.907 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.9 t -110.46 104.73 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 55.329999999999998 110.871 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.9 m -47.28 -72.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 74.120000000000005 110.845 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.42 161.34 32.15 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 75.299999999999997 110.855 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.81 -48.52 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.669 -1.804 . . . . 73.430000000000007 112.301 0.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.799 ' HB3' HD23 ' A' ' 20' ' ' LEU . 57.9 m95 -128.91 -92.63 0.45 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 71.420000000000002 110.868 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.799 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -123.99 162.07 24.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 70.109999999999999 110.898 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 3.8 t -93.12 104.19 16.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 74.109999999999999 110.922 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.525 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.54 132.78 15.48 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.588 0.709 . . . . 73.200000000000003 111.141 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.5 Cg_endo -69.73 170.77 56.74 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.713 -1.786 . . . . 54.0 112.343 -0.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -87.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.697 2.265 . . . . 71.340000000000003 112.385 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.543 HG22 HG12 ' A' ' 26' ' ' ILE . 1.9 mp -55.13 107.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 64.439999999999998 111.103 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.543 HG12 HG22 ' A' ' 25' ' ' ILE . 26.0 mm 65.4 83.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 63.409999999999997 111.173 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.7 -178.99 39.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.688 -0.768 . . . . 75.510000000000005 112.481 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.17 137.84 50.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.951 0.405 . . . . 72.140000000000001 110.854 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 12.3 p -78.15 129.29 34.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 63.140000000000001 110.887 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 53.049999999999997 110.94 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.6 mm . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.87 0.367 . . . . 53.340000000000003 111.113 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.73 158.07 33.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 64.120000000000005 111.093 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -53.12 120.79 6.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 72.129999999999995 110.848 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 55.69 35.27 24.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 71.120000000000005 110.955 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.1 150.5 18.97 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.75 -0.738 . . . . 64.409999999999997 112.5 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.69 152.48 2.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.812 0.339 . . . . 74.530000000000001 110.895 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.7 m -116.87 165.19 13.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 73.120000000000005 110.858 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -59.67 -16.39 26.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 71.340000000000003 110.868 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.14 -90.93 0.73 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 43.43 112.516 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.39 -19.14 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.874 0.369 . . . . 53.450000000000003 111.199 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 14' ' ' GLN . 49.1 mt -102.04 103.3 14.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 63.409999999999997 111.114 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.58 31.27 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.030000000000001 110.916 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.447 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.4 tp60 -81.26 69.76 7.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 75.430000000000007 110.893 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 t -109.99 103.99 12.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 70.230000000000004 110.848 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.1 m -47.62 -70.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 75.450000000000003 110.886 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.494 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -117.85 161.03 36.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 74.540000000000006 110.902 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.77 -48.66 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.698 -1.793 . . . . 63.219999999999999 112.317 0.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -128.75 -92.6 0.46 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 64.209999999999994 110.923 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.485 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.8 pt? -124.5 161.93 25.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 73.430000000000007 110.926 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 11.0 t -93.19 104.74 16.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 70.209999999999994 110.876 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.9 m -139.35 131.9 15.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.559 0.695 . . . . 73.409999999999997 111.12 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.7 171.15 54.74 Favored 'Cis proline' 0 C--N 1.341 0.159 0 C-N-CA 122.706 -1.789 . . . . 74.109999999999999 112.336 -0.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.7 Cg_endo -69.76 -83.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.686 2.257 . . . . 74.230000000000004 112.359 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.609 HG22 HG12 ' A' ' 26' ' ' ILE . 6.5 mt -60.67 107.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 63.219999999999999 111.123 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.609 HG12 HG22 ' A' ' 25' ' ' ILE . 23.6 mm 67.14 83.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 65.129999999999995 111.178 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.97 -177.87 40.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 72.129999999999995 112.49 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -130.21 137.41 50.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.402 . . . . 74.349999999999994 110.906 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.0 p -77.98 129.4 35.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 72.129999999999995 110.916 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.557 ' O ' HD12 ' A' ' 30' ' ' LEU . 3.2 pp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 73.200000000000003 110.903 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.8 mm . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.85 0.357 . . . . 73.319999999999993 111.112 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.26 160.04 32.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 74.299999999999997 111.099 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.03 120.3 5.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 62.32 110.862 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 53.58 33.99 17.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 55.030000000000001 110.892 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.33 152.61 19.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.712 -0.756 . . . . 75.409999999999997 112.476 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.66 152.62 3.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.353 . . . . 75.019999999999996 110.894 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.6 m -116.36 164.13 14.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 43.140000000000001 110.892 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -16.42 28.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.409999999999997 110.867 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.35 -90.93 0.64 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.728 . . . . 64.219999999999999 112.444 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.22 -19.87 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 75.540000000000006 111.172 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.459 HG22 ' HB2' ' A' ' 14' ' ' GLN . 52.8 mt -99.56 103.16 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 62.020000000000003 111.105 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.92 31.05 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 63.210000000000001 110.886 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.459 ' HB2' HG22 ' A' ' 12' ' ' ILE . 1.6 mp0 -81.5 70.25 8.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 74.340000000000003 110.961 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.9 t -110.02 104.45 13.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 62.25 110.878 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.1 m -45.97 -74.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 75.329999999999998 110.867 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -114.84 161.02 31.22 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.555 0.693 . . . . 64.329999999999998 110.925 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.78 -48.7 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.155 0 C-N-CA 122.671 -1.804 . . . . 64.010000000000005 112.326 0.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.766 ' HB3' HD23 ' A' ' 20' ' ' LEU . 78.1 m95 -129.05 -92.52 0.45 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 110.967 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.766 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -123.91 162.3 23.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 75.120000000000005 110.917 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 7.9 t -93.41 104.75 16.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 72.439999999999998 110.907 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.52 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.0 132.37 15.92 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.602 0.715 . . . . 72.450000000000003 111.118 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.81 171.19 55.07 Favored 'Cis proline' 0 C--N 1.342 0.191 0 C-N-CA 122.701 -1.791 . . . . 72.319999999999993 112.287 0.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.7 Cg_endo -69.76 -84.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.655 2.237 . . . . 75.099999999999994 112.375 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.597 HG22 HG12 ' A' ' 26' ' ' ILE . 5.1 mt -59.45 106.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 71.230000000000004 111.149 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.597 HG12 HG22 ' A' ' 25' ' ' ILE . 20.0 mm 68.08 85.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 64.049999999999997 111.094 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.71 -178.12 41.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 54.32 112.469 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -130.18 137.64 50.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.36 . . . . 74.519999999999996 110.926 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.9 p -77.93 128.98 34.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.818 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.488 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 73.420000000000002 110.962 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.8 mm . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.843 0.354 . . . . 61.039999999999999 111.159 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.9 160.37 32.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 70.319999999999993 111.117 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -50.84 120.44 4.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.43 . . . . 63.119999999999997 110.856 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 55.16 35.04 23.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 63.130000000000003 110.959 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.82 151.22 19.48 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.747 -0.74 . . . . 52.340000000000003 112.466 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.04 148.79 29.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 73.219999999999999 110.902 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.2 p -120.35 171.84 8.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 62.329999999999998 110.869 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -57.5 -19.22 23.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 63.340000000000003 110.852 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.9 -92.09 0.6 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.731 -0.747 . . . . 72.040000000000006 112.463 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.71 -18.76 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 70.25 111.165 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.495 HG22 ' H ' ' A' ' 14' ' ' GLN . 63.6 mt -90.31 103.65 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 65.340000000000003 111.13 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -86.62 30.51 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 63.340000000000003 110.927 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.495 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -81.38 66.91 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.483 . . . . 75.120000000000005 110.921 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.4 t -111.83 104.68 13.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 74.209999999999994 110.864 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 m -43.51 -63.62 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 72.140000000000001 110.868 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 2.0 m-20 -130.13 161.71 58.43 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.581 0.705 . . . . 71.310000000000002 110.886 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.8 -47.6 0.3 Allowed 'Cis proline' 0 C--O 1.231 0.167 0 C-N-CA 122.722 -1.783 . . . . 72.340000000000003 112.343 0.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.794 ' HB3' HD23 ' A' ' 20' ' ' LEU . 67.8 m95 -127.77 -92.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 75.409999999999997 110.925 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.794 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -127.98 162.18 27.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 72.319999999999993 110.897 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -84.79 104.48 14.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 73.420000000000002 110.883 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.514 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 98.4 m -137.64 132.35 17.47 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.558 0.694 . . . . 70.400000000000006 111.127 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.514 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.8 172.49 48.88 Favored 'Cis proline' 0 C--N 1.341 0.141 0 C-N-CA 122.646 -1.814 . . . . 71.25 112.333 -0.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 23' ' ' PRO . 53.3 Cg_endo -69.79 -88.66 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.643 2.229 . . . . 61.039999999999999 112.342 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -52.5 102.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.200000000000003 111.092 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.6 mm 65.17 85.79 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 61.439999999999998 111.097 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.02 175.49 42.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 52.409999999999997 112.478 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -121.14 138.65 54.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.916 0.388 . . . . 75.340000000000003 110.842 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 19.9 p -77.04 128.8 35.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 64.140000000000001 110.876 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 73.239999999999995 110.981 179.94 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.4 mm . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.849 0.357 . . . . 51.149999999999999 111.139 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.78 160.04 33.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 34.109999999999999 111.085 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -51.04 120.43 4.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 75.230000000000004 110.905 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 55.21 35.08 24.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 64.400000000000006 110.919 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.09 150.14 19.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.739 -0.743 . . . . 31.039999999999999 112.504 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.18 149.18 24.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.854 0.359 . . . . 75.439999999999998 110.831 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.2 p -120.01 171.8 8.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 30.399999999999999 110.919 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -57.73 -19.01 24.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 63.310000000000002 110.821 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.49 -92.23 0.61 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 72.319999999999993 112.471 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.54 -18.63 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 72.230000000000004 111.124 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.5 HG22 ' H ' ' A' ' 14' ' ' GLN . 64.5 mt -91.04 103.59 14.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 71.239999999999995 111.107 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -86.23 30.66 0.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 65.109999999999999 110.914 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.5 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -81.38 66.93 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 60.140000000000001 110.887 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.5 t -111.77 104.78 13.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 73.019999999999996 110.885 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.1 m -43.55 -63.66 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 75.310000000000002 110.87 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.502 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 5.6 m-20 -130.01 161.72 58.15 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.612 0.72 . . . . 73.230000000000004 110.853 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.79 -48.53 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.17 0 C-N-CA 122.68 -1.8 . . . . 62.229999999999997 112.363 0.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TRP . . . . . 0.773 ' HB3' HD23 ' A' ' 20' ' ' LEU . 95.2 m95 -126.8 -92.99 0.48 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 74.150000000000006 110.925 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.773 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -127.57 162.28 26.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 73.129999999999995 110.921 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -85.01 104.36 14.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 73.409999999999997 110.892 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.515 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 98.5 m -137.52 132.41 17.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.584 0.707 . . . . 63.530000000000001 111.193 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.81 172.39 49.42 Favored 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.713 -1.786 . . . . 74.510000000000005 112.325 0.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 23' ' ' PRO . 53.9 Cg_endo -69.72 -88.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.693 2.262 . . . . 34.329999999999998 112.327 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.408 HG22 HG12 ' A' ' 26' ' ' ILE . 14.0 mt -52.94 102.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 62.049999999999997 111.142 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.408 HG12 HG22 ' A' ' 25' ' ' ILE . 31.8 mm 65.92 85.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 72.150000000000006 111.11 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.38 174.13 42.52 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 72.120000000000005 112.477 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -119.38 138.69 52.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.893 0.378 . . . . 64.299999999999997 110.934 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.451 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 18.1 p -77.02 128.69 34.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 60.229999999999997 110.889 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 64.129999999999995 110.957 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.9 mm . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.808 0.337 . . . . 64.409999999999997 111.153 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.91 160.04 32.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 64.239999999999995 111.116 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -53.0 120.52 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 62.210000000000001 110.828 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 55.24 32.51 18.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 71.129999999999995 110.924 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.27 150.38 18.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.755 -0.736 . . . . 63.450000000000003 112.475 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.14 152.35 2.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.363 . . . . 73.310000000000002 110.89 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.3 m -116.5 163.81 15.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.886 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -59.51 -16.37 24.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 71.209999999999994 110.893 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.8 -90.99 0.63 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 74.239999999999995 112.484 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -59.5 -19.94 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.756 0.312 . . . . 74.310000000000002 111.078 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.464 HG22 ' HB2' ' A' ' 14' ' ' GLN . 31.9 mt -98.99 103.25 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 75.439999999999998 111.16 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -90.34 31.1 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.926 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.464 ' HB2' HG22 ' A' ' 12' ' ' ILE . 1.2 mp0 -81.31 69.88 8.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 63.119999999999997 110.898 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.4 t -110.02 104.19 13.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 73.019999999999996 110.896 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.4 m -46.66 -72.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 71.209999999999994 110.899 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -115.84 161.13 32.24 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.633 0.73 . . . . 75.310000000000002 110.867 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.71 -48.76 0.26 Allowed 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.664 -1.807 . . . . 74.109999999999999 112.369 -0.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -128.64 -92.46 0.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 75.200000000000003 110.886 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.7 pt? -124.45 161.88 25.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 73.340000000000003 110.912 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.8 t -92.88 104.8 17.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 64.400000000000006 110.872 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.518 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.42 132.26 15.41 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.55 0.69 . . . . 71.540000000000006 111.164 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.77 171.18 54.94 Favored 'Cis proline' 0 C--O 1.231 0.151 0 C-N-CA 122.68 -1.8 . . . . 73.319999999999993 112.329 -0.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.9 Cg_endo -69.73 -82.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.689 2.259 . . . . 74.439999999999998 112.39 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.586 HG22 HG12 ' A' ' 26' ' ' ILE . 5.4 mt -61.34 106.64 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 55.25 111.115 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.586 HG12 HG22 ' A' ' 25' ' ' ILE . 23.3 mm 67.33 82.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 73.219999999999999 111.124 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.69 -178.0 39.47 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 62.329999999999998 112.452 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -130.21 137.43 50.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 43.329999999999998 110.87 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.0 p -77.89 129.31 35.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 72.329999999999998 110.915 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 74.319999999999993 110.887 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.778 0.323 . . . . 62.409999999999997 110.869 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 8' ' ' CYS . 34.5 mm 64.19 130.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 111.159 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.96 160.15 26.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 72.120000000000005 111.099 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.29 120.54 7.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 73.530000000000001 110.872 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 56.14 29.79 15.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 64.030000000000001 110.913 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.34 150.64 18.93 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 52.539999999999999 112.524 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.09 153.61 2.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.778 0.323 . . . . 70.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.419 ' HA ' HD12 ' A' ' 2' ' ' ILE . 10.2 m -114.96 164.57 13.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 61.240000000000002 110.871 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.79 -18.11 29.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 70.120000000000005 110.808 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.87 -92.64 0.6 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.767 -0.73 . . . . 62.539999999999999 112.49 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.81 -17.09 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 74.349999999999994 111.151 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 14' ' ' GLN . 19.9 mt -99.22 102.65 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 72.430000000000007 111.179 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.88 31.85 1.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 73.019999999999996 110.901 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.447 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.3 tp60 -80.11 69.59 6.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 75.120000000000005 110.941 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.7 t -110.3 103.55 12.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 62.350000000000001 110.879 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.9 m -46.7 -72.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 61.420000000000002 110.838 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.491 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -116.35 162.43 26.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.563 0.697 . . . . 64.400000000000006 110.883 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.77 -49.01 0.25 Allowed 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.701 -1.791 . . . . 65.349999999999994 112.308 0.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -127.76 -93.0 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 74.239999999999995 110.923 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.482 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.8 pt? -124.09 162.4 23.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 52.200000000000003 110.887 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 15.3 t -93.38 104.28 16.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 44.310000000000002 110.846 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.6 m -139.52 130.54 14.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.589 0.709 . . . . 71.239999999999995 111.14 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.67 170.84 56.11 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.7 -1.792 . . . . 74.120000000000005 112.383 -0.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 -53.63 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.698 2.265 . . . . 72.239999999999995 112.358 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.469 HG22 HG12 ' A' ' 26' ' ' ILE . 2.7 mt -96.17 119.27 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 74.109999999999999 111.13 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 25' ' ' ILE . 25.4 mm 65.96 65.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 73.019999999999996 111.173 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.02 179.38 38.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.741 . . . . 42.32 112.502 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.516 ' O ' HD12 ' A' ' 30' ' ' LEU . 3.4 m-85 -130.3 140.44 50.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 65.329999999999998 110.877 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.5 p -74.54 128.73 36.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 74.329999999999998 110.921 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 28' ' ' PHE . 2.1 mp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 75.239999999999995 110.898 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.862 0.363 . . . . 54.0 110.897 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.9 mm 64.38 130.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 74.439999999999998 111.093 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.97 158.63 30.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 71.030000000000001 111.13 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -54.35 120.53 6.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 73.439999999999998 110.884 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 55.4 35.18 24.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 70.299999999999997 110.923 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.95 150.59 19.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.78 -0.724 . . . . 55.439999999999998 112.508 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.55 153.43 5.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.822 0.344 . . . . 72.019999999999996 110.888 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.3 m -115.45 166.11 12.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 70.219999999999999 110.881 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.1 -17.98 31.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 72.519999999999996 110.937 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.41 -92.64 0.63 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 74.099999999999994 112.477 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -61.94 -16.74 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.335 . . . . 75.299999999999997 111.154 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 14' ' ' GLN . 48.4 mt -99.61 102.64 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 71.239999999999995 111.114 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.97 31.84 1.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 60.240000000000002 110.91 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.42 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -80.26 70.81 6.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 72.319999999999993 110.879 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.6 t -109.66 103.6 12.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 71.209999999999994 110.851 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 m -47.58 -65.41 0.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 70.409999999999997 110.895 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.493 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -123.85 161.63 45.51 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.58 0.705 . . . . 51.130000000000003 110.886 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.73 -49.1 0.24 Allowed 'Cis proline' 0 C--O 1.231 0.158 0 C-N-CA 122.723 -1.782 . . . . 74.430000000000007 112.33 0.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.769 ' HB3' HD23 ' A' ' 20' ' ' LEU . 84.6 m95 -128.06 -92.86 0.47 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 72.540000000000006 110.93 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.769 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -124.05 162.23 23.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 64.420000000000002 110.935 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 9.0 t -93.3 104.57 16.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 110.874 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.495 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.2 m -138.62 130.15 15.52 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.587 0.708 . . . . 74.310000000000002 111.093 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.4 Cg_endo -69.76 170.73 57.07 Favored 'Cis proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 -1.8 . . . . 64.540000000000006 112.314 -0.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -55.02 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.706 2.271 . . . . 70.430000000000007 112.348 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.503 HG22 HG12 ' A' ' 26' ' ' ILE . 3.1 mt -94.07 118.53 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 64.549999999999997 111.16 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.503 HG12 HG22 ' A' ' 25' ' ' ILE . 26.1 mm 65.99 63.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 63.409999999999997 111.125 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.3 178.92 35.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 73.109999999999999 112.496 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -130.35 139.74 50.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 74.120000000000005 110.871 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.4 p -75.01 128.35 35.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 53.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 74.219999999999999 110.887 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.815 0.341 . . . . 60.109999999999999 110.859 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.8 mm 64.31 130.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 72.239999999999995 111.127 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.64 159.81 26.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 53.420000000000002 111.073 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -55.54 120.54 7.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 61.210000000000001 110.878 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 55.92 34.99 24.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 75.310000000000002 110.907 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.6 149.93 19.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.751 . . . . 45.100000000000001 112.46 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.38 153.24 5.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 74.340000000000003 110.865 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 m -115.41 165.95 12.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 110.906 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -59.16 -17.67 29.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 71.129999999999995 110.886 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.24 -92.62 0.63 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 32.520000000000003 112.497 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -61.91 -16.75 16.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.788 0.328 . . . . 73.040000000000006 111.169 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 43.9 mt -99.55 102.59 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 73.329999999999998 111.116 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.94 31.79 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 61.32 110.879 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.1 70.85 6.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 73.040000000000006 110.883 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.3 t -110.04 103.35 12.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 63.399999999999999 110.852 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.3 m -47.94 -64.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 71.400000000000006 110.904 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -124.01 161.87 44.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.589 0.709 . . . . 64.109999999999999 110.889 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.74 -49.19 0.24 Allowed 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.74 -1.775 . . . . 71.310000000000002 112.354 0.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -127.55 -92.93 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 75.430000000000007 110.95 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.7 pt? -124.49 162.01 24.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 53.009999999999998 110.969 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 8.0 t -93.13 104.69 16.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 70.010000000000005 110.896 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.496 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.1 m -138.99 130.14 15.08 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.559 0.695 . . . . 64.200000000000003 111.153 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.73 170.75 56.82 Favored 'Cis proline' 0 C--O 1.231 0.149 0 C-N-CA 122.692 -1.795 . . . . 73.340000000000003 112.348 -0.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -55.37 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.664 2.243 . . . . 73.340000000000003 112.346 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.518 HG22 HG12 ' A' ' 26' ' ' ILE . 3.3 mt -93.32 117.7 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 73.140000000000001 111.17 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.518 HG12 HG22 ' A' ' 25' ' ' ILE . 23.0 mm 66.17 65.9 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 61.240000000000002 111.143 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.37 179.42 36.8 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 64.219999999999999 112.463 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.34 139.64 50.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.881 0.372 . . . . 73.120000000000005 110.874 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.7 p -75.04 128.96 36.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 33.399999999999999 110.898 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 72.219999999999999 110.89 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.773 0.321 . . . . 74.549999999999997 110.886 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.7 mm 64.45 130.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 63.530000000000001 111.118 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.28 160.11 31.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 51.329999999999998 111.094 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -54.42 120.47 6.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 71.409999999999997 110.896 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 55.9 31.62 18.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 74.519999999999996 110.945 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.39 150.29 18.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 74.319999999999993 112.49 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.34 153.19 3.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 71.030000000000001 110.914 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.0 m -115.3 163.51 15.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 74.420000000000002 110.857 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -58.73 -17.91 26.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 64.349999999999994 110.887 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.84 -92.26 0.6 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.72 . . . . 44.130000000000003 112.494 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -61.7 -16.82 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.89 0.376 . . . . 51.450000000000003 111.158 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.434 HG22 ' HB2' ' A' ' 14' ' ' GLN . 27.7 mt -100.33 102.77 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 74.219999999999999 111.132 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.35 31.83 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 61.5 110.859 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.434 ' HB2' HG22 ' A' ' 12' ' ' ILE . 1.2 mp0 -79.34 69.56 5.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 74.230000000000004 110.893 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.2 t -110.44 103.86 12.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 54.109999999999999 110.912 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.3 m -47.27 -72.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 62.009999999999998 110.895 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.492 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.81 162.31 27.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.595 0.712 . . . . 74.030000000000001 110.875 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.74 -49.05 0.24 Allowed 'Cis proline' 0 C--N 1.341 0.138 0 C-N-CA 122.681 -1.799 . . . . 72.349999999999994 112.321 0.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.769 ' HB3' HD23 ' A' ' 20' ' ' LEU . 49.3 m95 -128.04 -92.9 0.46 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 62.420000000000002 110.936 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.769 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -123.9 162.35 23.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.428 . . . . 73.340000000000003 110.923 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 9.0 t -93.33 104.36 16.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 64.230000000000004 110.842 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.498 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.9 m -138.75 130.55 15.53 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.606 0.717 . . . . 65.420000000000002 111.104 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.77 170.82 56.64 Favored 'Cis proline' 0 C--N 1.342 0.202 0 C-N-CA 122.706 -1.789 . . . . 50.219999999999999 112.331 -0.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -54.41 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.244 . . . . 73.409999999999997 112.33 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.513 HG22 HG12 ' A' ' 26' ' ' ILE . 3.3 mt -94.54 118.32 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 74.140000000000001 111.165 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.513 HG12 HG22 ' A' ' 25' ' ' ILE . 25.5 mm 65.95 66.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 45.409999999999997 111.157 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.05 179.21 38.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.749 -0.739 . . . . 60.100000000000001 112.466 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -130.46 140.21 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 75.239999999999995 110.861 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.3 p -74.55 128.6 35.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 72.540000000000006 110.906 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 71.129999999999995 110.937 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.808 0.337 . . . . 62.520000000000003 110.882 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 8' ' ' CYS . 34.0 mm 64.32 130.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 53.509999999999998 111.124 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.41 160.16 30.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 73.040000000000006 111.087 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -55.74 120.55 7.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 44.340000000000003 110.886 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 55.58 30.55 15.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 73.219999999999999 110.912 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.52 150.5 18.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.76 -0.733 . . . . 61.310000000000002 112.478 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.91 153.62 2.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.835 0.35 . . . . 73.010000000000005 110.914 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.417 ' HA ' HD12 ' A' ' 2' ' ' ILE . 13.8 m -114.89 164.84 13.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 73.030000000000001 110.9 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -58.65 -18.46 30.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 70.219999999999999 110.847 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.55 -92.57 0.6 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.731 -0.747 . . . . 52.439999999999998 112.481 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -62.13 -16.47 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.74 0.305 . . . . 72.310000000000002 111.091 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.454 HG22 ' H ' ' A' ' 14' ' ' GLN . 64.3 mt -100.25 102.81 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 64.200000000000003 111.11 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.7 31.82 1.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 42.43 110.905 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.454 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.6 tp60 -80.13 69.76 6.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 74.310000000000002 110.919 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.5 t -110.1 103.94 12.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 74.329999999999998 110.91 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.4 m -46.16 -73.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.099999999999994 110.941 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.491 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -115.57 162.39 25.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.601 0.715 . . . . 64.409999999999997 110.912 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.77 -49.35 0.23 Allowed 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.663 -1.807 . . . . 72.409999999999997 112.322 0.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -128.11 -93.06 0.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 74.140000000000001 110.955 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.55 162.71 21.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 52.240000000000002 110.917 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 18.4 t -94.45 104.1 16.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 65.530000000000001 110.897 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.3 m -138.69 131.09 15.81 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.585 0.707 . . . . 61.049999999999997 111.162 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.7 170.72 56.86 Favored 'Cis proline' 0 C--O 1.231 0.172 0 C-N-CA 122.711 -1.787 . . . . 71.129999999999995 112.357 -0.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -54.18 0.23 Allowed 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.69 2.26 . . . . 63.509999999999998 112.373 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.495 HG22 HG12 ' A' ' 26' ' ' ILE . 3.0 mt -95.44 118.35 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 61.229999999999997 111.17 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.495 HG12 HG22 ' A' ' 25' ' ' ILE . 22.0 mm 66.4 63.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 71.299999999999997 111.152 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.36 178.82 35.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 74.310000000000002 112.48 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -130.45 140.24 50.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.875 0.369 . . . . 70.519999999999996 110.89 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.0 p -74.61 128.56 35.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 73.109999999999999 110.905 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.498 ' O ' HD12 ' A' ' 30' ' ' LEU . 1.4 pp . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 62.340000000000003 110.917 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.834 0.349 . . . . 72.129999999999995 110.885 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm 64.34 130.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 74.230000000000004 111.149 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.46 160.11 33.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 64.530000000000001 111.101 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -52.1 120.55 5.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 61.340000000000003 110.877 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 54.86 34.02 21.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.040000000000006 110.944 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.19 150.76 19.0 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 74.109999999999999 112.513 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.89 151.89 3.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.837 0.351 . . . . 64.439999999999998 110.92 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.7 m -117.21 163.09 16.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 61.43 110.888 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -59.26 -16.59 22.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 74.329999999999998 110.853 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.01 -90.66 0.64 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.75 . . . . 64.140000000000001 112.512 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.06 -19.51 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.796 0.331 . . . . 75.430000000000007 111.127 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' A' ' 14' ' ' GLN . 33.2 mt -98.7 103.42 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 74.109999999999999 111.122 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.34 31.09 0.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 62.100000000000001 110.873 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.501 ' HB2' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -81.61 69.87 8.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 73.420000000000002 110.927 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.1 t -110.05 104.41 13.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 72.310000000000002 110.906 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.6 m -46.68 -68.97 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 54.119999999999997 110.885 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -121.06 160.91 43.18 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.565 0.698 . . . . 74.340000000000003 110.884 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.75 -48.69 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.144 0 C-N-CA 122.705 -1.79 . . . . 61.149999999999999 112.352 0.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.75 ' HB3' HD23 ' A' ' 20' ' ' LEU . 95.3 m95 -128.98 -92.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 75.140000000000001 110.94 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.75 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -124.33 161.98 24.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 110.947 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 4.8 t -92.92 104.5 16.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 52.210000000000001 110.921 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.522 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -138.93 132.46 16.04 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.587 0.708 . . . . 74.099999999999994 111.145 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.78 170.78 56.91 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 -1.8 . . . . 60.149999999999999 112.366 -0.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.405 ' HG2' HD12 ' A' ' 25' ' ' ILE . 53.7 Cg_endo -69.81 -87.26 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.67 2.247 . . . . 70.040000000000006 112.326 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.508 HG22 HG12 ' A' ' 26' ' ' ILE . 1.8 mp -54.7 105.75 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 75.230000000000004 111.146 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 25' ' ' ILE . 25.9 mm 65.84 84.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.430000000000007 111.14 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.71 -178.16 39.05 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 73.019999999999996 112.502 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -130.14 136.97 49.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 64.400000000000006 110.837 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 13.7 p -78.29 129.12 34.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 64.129999999999995 110.911 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 74.430000000000007 110.935 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.837 0.351 . . . . 75.439999999999998 110.914 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.4 mm 64.26 130.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 75.340000000000003 111.109 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.61 158.56 31.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 74.409999999999997 111.083 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -53.0 120.47 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 74.030000000000001 110.858 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 54.9 35.3 24.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 71.540000000000006 110.877 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.67 149.94 19.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 73.030000000000001 112.501 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 152.15 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.323 . . . . 74.409999999999997 110.907 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.9 m -117.04 165.75 13.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 65.219999999999999 110.893 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.43 -16.09 32.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 72.129999999999995 110.843 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.36 -90.97 0.7 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.718 -0.753 . . . . 53.149999999999999 112.489 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -58.87 -20.91 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 74.230000000000004 111.127 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 14' ' ' GLN . 56.4 mt -98.94 103.01 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 111.14 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -90.29 30.82 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 35.439999999999998 110.865 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.452 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -81.73 70.49 8.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 64.150000000000006 110.864 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.4 t -108.85 104.13 13.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 60.329999999999998 110.87 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.0 m -46.86 -68.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 75.209999999999994 110.909 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -120.89 160.38 45.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.599 0.714 . . . . 55.310000000000002 110.861 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.8 -48.6 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.677 -1.801 . . . . 71.209999999999994 112.332 0.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.758 ' HB3' HD23 ' A' ' 20' ' ' LEU . 76.9 m95 -128.41 -92.47 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.929 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.758 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -126.09 161.92 26.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.276 -0.42 . . . . 63.439999999999998 110.942 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 6.0 t -92.03 104.64 17.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 70.310000000000002 110.866 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.519 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.7 m -139.24 131.53 15.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.59 0.71 . . . . 71.209999999999994 111.131 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.76 170.79 56.76 Favored 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.72 -1.783 . . . . 51.32 112.369 -0.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -87.48 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.667 2.245 . . . . 74.120000000000005 112.344 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.534 HG22 HG12 ' A' ' 26' ' ' ILE . 1.8 mp -55.32 106.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 62.340000000000003 111.101 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 25' ' ' ILE . 25.1 mm 66.09 84.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 72.340000000000003 111.147 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.59 -179.05 40.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 74.319999999999993 112.484 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.531 ' O ' HD12 ' A' ' 30' ' ' LEU . 1.6 m-85 -129.14 137.06 50.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 71.120000000000005 110.858 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.408 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 18.5 p -78.36 129.16 34.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 64.0 110.926 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 28' ' ' PHE . 4.6 mp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 64.540000000000006 110.907 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.853 0.358 . . . . 64.310000000000002 110.887 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.2 mm 64.06 130.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 71.25 111.154 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.87 158.52 34.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 53.039999999999999 111.118 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -52.15 120.5 5.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 75.099999999999994 110.87 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 55.28 35.28 24.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 74.219999999999999 110.93 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.93 150.25 19.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.741 -0.742 . . . . 73.519999999999996 112.531 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 152.42 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 72.329999999999998 110.892 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 m -116.92 165.24 13.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 74.310000000000002 110.908 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.02 -16.45 31.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 72.129999999999995 110.879 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.68 -91.08 0.7 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 72.209999999999994 112.459 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -59.43 -19.41 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.34 . . . . 74.25 111.191 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.448 HG22 ' H ' ' A' ' 14' ' ' GLN . 54.4 mt -100.24 103.13 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 72.129999999999995 111.138 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -90.34 30.98 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 74.040000000000006 110.867 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.448 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.1 tp60 -81.52 70.86 8.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 74.400000000000006 110.91 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -109.21 104.09 13.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 72.439999999999998 110.899 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.0 m -47.39 -65.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 73.510000000000005 110.873 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -123.96 161.41 46.98 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.573 0.701 . . . . 65.510000000000005 110.912 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.0 Cg_endo -69.79 -48.66 0.26 Allowed 'Cis proline' 0 C--O 1.231 0.159 0 C-N-CA 122.675 -1.802 . . . . 64.010000000000005 112.337 0.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.801 ' HB3' HD23 ' A' ' 20' ' ' LEU . 20.7 m95 -127.82 -92.55 0.48 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 74.010000000000005 110.912 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.801 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -125.86 161.94 26.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 64.030000000000001 110.913 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.8 t -92.41 104.74 17.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 65.400000000000006 110.859 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.515 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.4 m -138.87 131.45 15.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.607 0.717 . . . . 74.150000000000006 111.154 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.1 Cg_endo -69.74 171.12 55.07 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.727 -1.781 . . . . 70.129999999999995 112.359 -0.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.9 Cg_endo -69.8 -83.5 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.692 2.261 . . . . 63.229999999999997 112.335 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.602 HG22 HG12 ' A' ' 26' ' ' ILE . 5.8 mt -60.41 106.76 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 71.109999999999999 111.154 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.602 HG12 HG22 ' A' ' 25' ' ' ILE . 22.5 mm 67.63 84.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 70.109999999999999 111.103 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.63 -178.58 41.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 65.430000000000007 112.476 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -129.3 137.18 50.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.367 . . . . 65.099999999999994 110.892 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.9 p -78.16 128.91 34.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.299999999999997 110.893 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 30' ' ' LEU . 1.4 pt? . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 64.329999999999998 110.922 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.76 0.314 . . . . 74.340000000000003 110.87 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.0 mm 64.11 130.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 65.409999999999997 111.172 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.37 158.67 33.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 52.200000000000003 111.091 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -53.01 120.64 6.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 70.25 110.862 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 55.58 35.34 24.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 72.519999999999996 110.966 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.81 150.65 19.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 72.25 112.491 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.18 152.53 3.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.836 0.351 . . . . 74.209999999999994 110.903 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.6 m -117.0 165.32 13.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 35.450000000000003 110.855 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -59.89 -16.54 30.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 53.240000000000002 110.853 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.8 -90.93 0.71 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.716 -0.754 . . . . 52.219999999999999 112.526 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.52 -19.47 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 75.310000000000002 111.116 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 14' ' ' GLN . 52.4 mt -101.26 103.14 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 54.149999999999999 111.117 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.65 31.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 61.219999999999999 110.856 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.447 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.2 tp60 -81.34 69.84 8.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 110.918 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.7 t -109.77 104.03 12.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 71.010000000000005 110.873 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.4 m -47.22 -70.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 73.239999999999995 110.909 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -117.36 160.7 36.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.566 0.698 . . . . 70.420000000000002 110.849 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.76 -48.69 0.26 Allowed 'Cis proline' 0 C--O 1.231 0.167 0 C-N-CA 122.743 -1.774 . . . . 75.439999999999998 112.29 0.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.765 ' HB3' HD23 ' A' ' 20' ' ' LEU . 69.9 m95 -128.94 -92.47 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 73.540000000000006 110.901 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.765 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -124.56 162.01 24.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 75.319999999999993 110.945 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 8.2 t -93.06 104.58 16.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 72.209999999999994 110.862 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.52 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.9 m -139.18 131.92 15.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.569 0.7 . . . . 72.530000000000001 111.135 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.75 171.15 54.97 Favored 'Cis proline' 0 C--N 1.342 0.186 0 C-N-CA 122.64 -1.817 . . . . 70.299999999999997 112.384 -0.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -85.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.69 2.26 . . . . 71.019999999999996 112.364 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.593 HG22 HG12 ' A' ' 26' ' ' ILE . 6.1 mt -59.11 107.38 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 73.340000000000003 111.115 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.593 HG12 HG22 ' A' ' 25' ' ' ILE . 25.8 mm 66.9 83.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 75.25 111.114 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.89 -178.14 40.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 75.040000000000006 112.48 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -130.01 137.39 50.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 75.019999999999996 110.865 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.0 p -78.24 128.93 34.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 72.010000000000005 110.888 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 72.200000000000003 110.912 179.982 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.804 0.335 . . . . 74.510000000000005 110.872 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.4 mm 64.21 130.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 73.540000000000006 111.134 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.44 160.04 28.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 65.450000000000003 111.138 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -55.06 120.68 7.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 72.140000000000001 110.856 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 55.86 35.36 25.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 64.099999999999994 110.918 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.03 152.54 19.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.797 -0.716 . . . . 71.200000000000003 112.501 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.7 152.5 5.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.888 0.375 . . . . 64.340000000000003 110.861 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.0 m -116.94 165.07 13.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 70.439999999999998 110.882 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.69 -16.67 28.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 75.329999999999998 110.903 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.23 -91.15 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 71.510000000000005 112.529 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.59 -19.25 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.791 0.329 . . . . 63.520000000000003 111.124 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.47 HG22 ' H ' ' A' ' 14' ' ' GLN . 2.7 mp -100.96 103.08 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 73.219999999999999 111.161 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -90.1 30.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 63.32 110.894 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.47 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -81.22 69.58 7.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 72.400000000000006 110.897 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.3 t -108.96 103.97 13.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 72.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.1 m -47.57 -68.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 62.25 110.868 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -120.12 161.49 38.41 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.577 0.704 . . . . 73.200000000000003 110.903 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.8 -48.43 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.147 0 C-N-CA 122.635 -1.819 . . . . 71.430000000000007 112.359 0.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -128.08 -92.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 74.540000000000006 110.902 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.481 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.8 pt? -125.9 161.8 26.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 65.530000000000001 110.945 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 7.5 t -92.35 104.42 16.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 75.439999999999998 110.911 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.5 m -139.55 131.61 15.02 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.545 0.688 . . . . 64.310000000000002 111.143 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.79 171.1 55.38 Favored 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.645 -1.814 . . . . 42.399999999999999 112.354 -0.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -85.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.708 2.272 . . . . 71.430000000000007 112.349 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.61 HG22 HG12 ' A' ' 26' ' ' ILE . 6.3 mt -58.45 107.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 71.239999999999995 111.134 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.61 HG12 HG22 ' A' ' 25' ' ' ILE . 23.8 mm 67.41 84.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 72.319999999999993 111.139 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.74 -178.07 41.15 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.719 -0.753 . . . . 64.120000000000005 112.456 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -130.02 137.32 50.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.381 . . . . 75.319999999999993 110.89 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 18.4 p -78.17 129.46 35.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 60.130000000000003 110.902 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 65.439999999999998 110.939 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.803 0.335 . . . . 55.299999999999997 110.914 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.2 mm 64.22 130.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 72.030000000000001 111.118 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.16 157.92 34.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 64.540000000000006 111.12 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -52.58 120.6 5.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 75.140000000000001 110.884 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 55.81 35.38 25.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 74.109999999999999 110.926 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.83 150.48 19.05 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 63.329999999999998 112.479 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.29 152.53 3.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 71.129999999999995 110.927 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.1 m -116.75 164.94 13.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 71.239999999999995 110.874 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.48 -17.22 29.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 53.439999999999998 110.852 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.84 -91.34 0.68 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 63.340000000000003 112.489 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -60.08 -18.9 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 74.400000000000006 111.138 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 14' ' ' GLN . 53.3 mt -100.38 103.15 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 71.549999999999997 111.123 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -90.39 30.95 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 71.430000000000007 110.845 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.444 ' H ' HG22 ' A' ' 12' ' ' ILE . 10.5 tp-100 -81.31 69.89 8.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 72.150000000000006 110.926 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.1 t -109.06 103.91 13.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 73.030000000000001 110.907 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.6 m -47.5 -68.26 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 71.129999999999995 110.929 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.496 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -120.31 160.84 41.94 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.568 0.699 . . . . 74.450000000000003 110.841 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.0 Cg_endo -69.74 -48.73 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.167 0 C-N-CA 122.698 -1.793 . . . . 65.329999999999998 112.347 -0.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.779 ' HB3' HD23 ' A' ' 20' ' ' LEU . 54.9 m95 -128.05 -92.53 0.47 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 75.409999999999997 110.924 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.779 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -125.88 161.82 26.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 73.329999999999998 110.923 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 7.6 t -91.92 104.43 16.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 53.350000000000001 110.885 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.6 m -139.1 131.31 15.42 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.569 0.699 . . . . 62.229999999999997 111.163 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.79 171.06 55.6 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.672 -1.803 . . . . 74.329999999999998 112.351 0.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.9 Cg_endo -69.77 -85.09 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.698 2.265 . . . . 62.119999999999997 112.339 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.601 HG22 HG12 ' A' ' 26' ' ' ILE . 5.2 mt -59.24 107.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 75.349999999999994 111.105 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.601 HG12 HG22 ' A' ' 25' ' ' ILE . 22.8 mm 67.42 83.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 73.239999999999995 111.095 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.61 -178.46 40.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.758 -0.734 . . . . 41.350000000000001 112.49 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -129.87 137.25 50.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 74.439999999999998 110.818 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 18.2 p -77.98 128.92 34.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 74.109999999999999 110.889 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 75.150000000000006 110.879 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.785 0.326 . . . . 61.539999999999999 110.87 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.7 mm 64.29 129.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 54.32 111.142 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.5 159.92 9.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 72.120000000000005 111.123 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -55.4 120.02 6.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 72.209999999999994 110.851 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 51.84 34.28 13.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 74.530000000000001 110.923 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.25 153.03 19.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 71.140000000000001 112.496 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 153.13 8.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.84 0.352 . . . . 64.409999999999997 110.893 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.8 m -113.71 170.7 8.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 74.129999999999995 110.861 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.21 -16.88 23.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.478 . . . . 74.319999999999993 110.903 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.2 -89.91 0.61 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 74.140000000000001 112.451 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -58.61 -19.88 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.333 . . . . 55.229999999999997 111.135 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.49 HG22 ' HB2' ' A' ' 14' ' ' GLN . 34.9 mt -101.25 103.17 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 64.25 111.106 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.15 30.81 0.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 75.209999999999994 110.875 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HB2' HG22 ' A' ' 12' ' ' ILE . 1.2 mp0 -81.56 69.41 8.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 64.450000000000003 110.936 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.7 t -110.06 104.24 13.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 73.319999999999993 110.879 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.5 m -47.14 -72.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 55.219999999999999 110.863 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -115.1 161.02 31.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.55 0.691 . . . . 70.209999999999994 110.882 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.3 Cg_endo -69.74 -48.43 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.661 -1.808 . . . . 51.450000000000003 112.35 -0.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.773 ' HB3' HD23 ' A' ' 20' ' ' LEU . 75.9 m95 -129.23 -92.54 0.45 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 72.109999999999999 110.934 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.773 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -123.41 162.0 23.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 73.030000000000001 110.972 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.0 t -93.35 104.43 16.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 73.349999999999994 110.827 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.522 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.71 132.49 15.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.599 0.714 . . . . 74.239999999999995 111.12 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.76 171.07 55.4 Favored 'Cis proline' 0 C--O 1.232 0.178 0 C-N-CA 122.702 -1.791 . . . . 75.430000000000007 112.299 -0.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 -85.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.704 2.269 . . . . 72.409999999999997 112.373 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.618 HG22 HG12 ' A' ' 26' ' ' ILE . 8.1 mt -59.08 108.41 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 74.540000000000006 111.13 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.618 HG12 HG22 ' A' ' 25' ' ' ILE . 27.1 mm 66.04 78.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 72.530000000000001 111.187 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.11 -179.02 37.37 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.745 -0.74 . . . . 53.240000000000002 112.475 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.13 137.39 50.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.37 . . . . 75.209999999999994 110.878 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.8 p -78.01 128.82 34.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 52.229999999999997 110.875 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 71.319999999999993 110.912 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.794 0.33 . . . . 73.319999999999993 110.874 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.7 mm 64.26 130.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 65.040000000000006 111.147 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.4 160.09 9.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 44.409999999999997 111.062 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.84 120.14 7.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 110.844 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 54.31 35.17 22.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 64.540000000000006 110.947 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.3 156.81 19.52 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.737 -0.744 . . . . 73.409999999999997 112.433 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.21 152.79 27.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.836 0.351 . . . . 74.519999999999996 110.867 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.2 m -113.77 170.34 8.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 74.439999999999998 110.898 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -59.72 -16.41 26.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 75.310000000000002 110.849 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.22 -89.67 0.6 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.719 -0.753 . . . . 65.120000000000005 112.49 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -58.34 -20.55 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 72.540000000000006 111.138 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.453 HG22 ' H ' ' A' ' 14' ' ' GLN . 53.3 mt -100.34 103.13 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 70.420000000000002 111.136 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.55 30.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 75.329999999999998 110.91 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.453 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -81.78 69.39 8.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 63.409999999999997 110.893 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 t -110.19 104.2 13.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 53.350000000000001 110.87 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.9 m -48.05 -70.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 74.310000000000002 110.926 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.498 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.16 160.83 34.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.591 0.71 . . . . 52.149999999999999 110.903 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 52.9 Cg_endo -69.82 -48.35 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.154 0 C-N-CA 122.658 -1.809 . . . . 52.549999999999997 112.307 0.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -128.58 -92.65 0.46 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 72.530000000000001 110.915 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.497 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.9 pt? -124.62 161.89 25.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 64.310000000000002 110.914 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 4.6 t -93.06 104.8 16.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 75.329999999999998 110.879 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.525 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.6 m -141.4 132.69 13.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.522 0.677 . . . . 60.0 111.2 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.75 170.83 56.54 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 122.712 -1.787 . . . . 74.540000000000006 112.361 -0.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -87.43 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.686 2.257 . . . . 75.099999999999994 112.359 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.549 HG22 HG12 ' A' ' 26' ' ' ILE . 1.9 mp -55.85 107.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 70.010000000000005 111.109 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.549 HG12 HG22 ' A' ' 25' ' ' ILE . 25.4 mm 65.3 82.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 64.409999999999997 111.123 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.84 -178.73 39.52 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.732 . . . . 72.129999999999995 112.483 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -129.99 137.34 50.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.936 0.398 . . . . 72.310000000000002 110.884 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.416 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.7 p -77.91 129.5 35.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 64.120000000000005 110.926 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.459 . . . . 75.340000000000003 110.91 179.975 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.767 0.317 . . . . 72.400000000000006 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.1 mm 64.5 130.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 64.409999999999997 111.106 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.7 160.17 32.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 55.219999999999999 111.091 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -53.93 120.76 6.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 70.310000000000002 110.869 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 55.72 32.4 19.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 73.5 110.878 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.21 152.0 19.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.796 -0.716 . . . . 73.049999999999997 112.501 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.4 151.67 2.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 62.43 110.876 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.3 m -117.19 165.31 13.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 72.450000000000003 110.844 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.73 -16.25 25.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 74.430000000000007 110.907 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.61 -91.33 0.66 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.701 -0.761 . . . . 62.149999999999999 112.482 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -61.61 -17.34 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 74.219999999999999 111.093 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 14' ' ' GLN . 34.2 mt -99.42 103.4 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 71.150000000000006 111.095 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -88.17 31.77 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 61.229999999999997 110.853 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.422 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.1 tp60 -80.75 69.23 7.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.239999999999995 110.943 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.3 t -110.45 104.35 13.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 31.120000000000001 110.862 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.4 m -45.57 -64.86 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 64.129999999999995 110.857 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 2.0 m-20 -125.82 162.07 47.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.618 0.723 . . . . 71.239999999999995 110.856 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.78 -48.91 0.25 Allowed 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.639 -1.817 . . . . 65.329999999999998 112.345 0.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.788 ' HB3' HD23 ' A' ' 20' ' ' LEU . 66.9 m95 -130.1 -92.73 0.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.229 -0.442 . . . . 73.409999999999997 110.927 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.788 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -119.59 162.57 18.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 70.430000000000007 110.915 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.9 t -94.86 104.56 16.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 50.530000000000001 110.899 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.526 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.3 m -138.12 133.76 17.52 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.635 0.731 . . . . 54.549999999999997 111.12 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.526 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.77 171.62 52.84 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.715 -1.786 . . . . 74.329999999999998 112.331 -0.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -86.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.688 2.259 . . . . 75.5 112.347 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.591 HG22 HG12 ' A' ' 26' ' ' ILE . 5.4 mt -58.69 106.57 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 74.430000000000007 111.114 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.591 HG12 HG22 ' A' ' 25' ' ' ILE . 23.2 mm 67.43 83.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 71.25 111.082 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.88 -177.37 39.14 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 61.200000000000003 112.493 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -130.14 137.5 50.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.852 0.358 . . . . 75.109999999999999 110.929 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 13.4 p -77.87 128.53 34.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 73.099999999999994 110.846 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.411 ' HA ' ' HG3' ' A' ' 18' ' ' PRO . 1.6 pt? . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 62.539999999999999 110.886 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.847 0.356 . . . . 73.510000000000005 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 8' ' ' CYS . 35.6 mm 64.56 130.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 73.129999999999995 111.094 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.11 160.4 26.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 64.310000000000002 111.125 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -56.34 120.79 8.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 64.310000000000002 110.854 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 55.94 30.01 15.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 75.310000000000002 110.942 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.39 149.97 18.76 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 40.229999999999997 112.439 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 152.32 7.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 52.439999999999998 110.892 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.417 ' HA ' HD12 ' A' ' 2' ' ' ILE . 6.4 m -114.27 170.36 8.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 72.230000000000004 110.889 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -59.65 -16.33 25.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.852 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.52 -89.49 0.58 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.733 . . . . 72.129999999999995 112.474 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -58.84 -19.36 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.794 0.33 . . . . 73.129999999999995 111.125 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.435 HG22 ' H ' ' A' ' 14' ' ' GLN . 42.4 mt -100.63 103.5 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 75.230000000000004 111.082 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -88.87 30.98 0.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 72.129999999999995 110.915 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.435 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.1 tp60 -81.57 69.29 8.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 41.420000000000002 110.907 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.9 t -110.46 104.73 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 55.329999999999998 110.871 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.9 m -47.28 -72.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 74.120000000000005 110.845 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.42 161.34 32.15 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 75.299999999999997 110.855 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.81 -48.52 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.669 -1.804 . . . . 73.430000000000007 112.301 0.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.799 ' HB3' HD23 ' A' ' 20' ' ' LEU . 57.9 m95 -128.91 -92.63 0.45 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 71.420000000000002 110.868 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.799 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -123.99 162.07 24.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 70.109999999999999 110.898 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 3.8 t -93.12 104.19 16.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 74.109999999999999 110.922 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.525 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.54 132.78 15.48 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.588 0.709 . . . . 73.200000000000003 111.141 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.5 Cg_endo -69.73 170.77 56.74 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.713 -1.786 . . . . 54.0 112.343 -0.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -87.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.697 2.265 . . . . 71.340000000000003 112.385 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.543 HG22 HG12 ' A' ' 26' ' ' ILE . 1.9 mp -55.13 107.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 64.439999999999998 111.103 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.543 HG12 HG22 ' A' ' 25' ' ' ILE . 26.0 mm 65.4 83.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 63.409999999999997 111.173 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.7 -178.99 39.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.688 -0.768 . . . . 75.510000000000005 112.481 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.17 137.84 50.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.951 0.405 . . . . 72.140000000000001 110.854 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 12.3 p -78.15 129.29 34.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 63.140000000000001 110.887 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 53.049999999999997 110.94 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.842 0.353 . . . . 63.409999999999997 110.937 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.6 mm 64.1 130.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 53.340000000000003 111.113 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.73 158.07 33.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 64.120000000000005 111.093 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -53.12 120.79 6.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 72.129999999999995 110.848 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 55.69 35.27 24.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 71.120000000000005 110.955 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.1 150.5 18.97 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.75 -0.738 . . . . 64.409999999999997 112.5 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.69 152.48 2.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.812 0.339 . . . . 74.530000000000001 110.895 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.7 m -116.87 165.19 13.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 73.120000000000005 110.858 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -59.67 -16.39 26.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 71.340000000000003 110.868 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.14 -90.93 0.73 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 43.43 112.516 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.39 -19.14 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.874 0.369 . . . . 53.450000000000003 111.199 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 14' ' ' GLN . 49.1 mt -102.04 103.3 14.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 63.409999999999997 111.114 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.58 31.27 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.030000000000001 110.916 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.447 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.4 tp60 -81.26 69.76 7.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 75.430000000000007 110.893 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 t -109.99 103.99 12.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 70.230000000000004 110.848 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.1 m -47.62 -70.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 75.450000000000003 110.886 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.494 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -117.85 161.03 36.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 74.540000000000006 110.902 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.77 -48.66 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.698 -1.793 . . . . 63.219999999999999 112.317 0.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -128.75 -92.6 0.46 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 64.209999999999994 110.923 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.485 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.8 pt? -124.5 161.93 25.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 73.430000000000007 110.926 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 11.0 t -93.19 104.74 16.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 70.209999999999994 110.876 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.9 m -139.35 131.9 15.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.559 0.695 . . . . 73.409999999999997 111.12 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.7 171.15 54.74 Favored 'Cis proline' 0 C--N 1.341 0.159 0 C-N-CA 122.706 -1.789 . . . . 74.109999999999999 112.336 -0.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.7 Cg_endo -69.76 -83.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.686 2.257 . . . . 74.230000000000004 112.359 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.609 HG22 HG12 ' A' ' 26' ' ' ILE . 6.5 mt -60.67 107.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 63.219999999999999 111.123 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.609 HG12 HG22 ' A' ' 25' ' ' ILE . 23.6 mm 67.14 83.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 65.129999999999995 111.178 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.97 -177.87 40.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 72.129999999999995 112.49 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -130.21 137.41 50.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.402 . . . . 74.349999999999994 110.906 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.0 p -77.98 129.4 35.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 72.129999999999995 110.916 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.557 ' O ' HD12 ' A' ' 30' ' ' LEU . 3.2 pp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 73.200000000000003 110.903 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.825 0.345 . . . . 62.020000000000003 110.866 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.8 mm 64.35 130.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 73.319999999999993 111.112 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.26 160.04 32.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 74.299999999999997 111.099 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.03 120.3 5.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 62.32 110.862 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 53.58 33.99 17.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 55.030000000000001 110.892 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.33 152.61 19.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.712 -0.756 . . . . 75.409999999999997 112.476 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.66 152.62 3.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.353 . . . . 75.019999999999996 110.894 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.6 m -116.36 164.13 14.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 43.140000000000001 110.892 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -16.42 28.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.409999999999997 110.867 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.35 -90.93 0.64 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.728 . . . . 64.219999999999999 112.444 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.22 -19.87 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 75.540000000000006 111.172 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.459 HG22 ' HB2' ' A' ' 14' ' ' GLN . 52.8 mt -99.56 103.16 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 62.020000000000003 111.105 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.92 31.05 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 63.210000000000001 110.886 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.459 ' HB2' HG22 ' A' ' 12' ' ' ILE . 1.6 mp0 -81.5 70.25 8.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 74.340000000000003 110.961 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.9 t -110.02 104.45 13.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 62.25 110.878 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.1 m -45.97 -74.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 75.329999999999998 110.867 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -114.84 161.02 31.22 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.555 0.693 . . . . 64.329999999999998 110.925 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.78 -48.7 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.155 0 C-N-CA 122.671 -1.804 . . . . 64.010000000000005 112.326 0.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.766 ' HB3' HD23 ' A' ' 20' ' ' LEU . 78.1 m95 -129.05 -92.52 0.45 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 75.209999999999994 110.967 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.766 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -123.91 162.3 23.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 75.120000000000005 110.917 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 7.9 t -93.41 104.75 16.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 72.439999999999998 110.907 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.52 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.0 132.37 15.92 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.602 0.715 . . . . 72.450000000000003 111.118 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.81 171.19 55.07 Favored 'Cis proline' 0 C--N 1.342 0.191 0 C-N-CA 122.701 -1.791 . . . . 72.319999999999993 112.287 0.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.7 Cg_endo -69.76 -84.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.655 2.237 . . . . 75.099999999999994 112.375 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.597 HG22 HG12 ' A' ' 26' ' ' ILE . 5.1 mt -59.45 106.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 71.230000000000004 111.149 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.597 HG12 HG22 ' A' ' 25' ' ' ILE . 20.0 mm 68.08 85.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 64.049999999999997 111.094 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.71 -178.12 41.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 54.32 112.469 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -130.18 137.64 50.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.36 . . . . 74.519999999999996 110.926 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.9 p -77.93 128.98 34.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 75.409999999999997 110.818 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.488 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 73.420000000000002 110.962 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.3 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.774 0.321 . . . . 74.109999999999999 110.882 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.8 mm 64.3 130.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 61.039999999999999 111.159 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.9 160.37 32.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 70.319999999999993 111.117 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -50.84 120.44 4.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.43 . . . . 63.119999999999997 110.856 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 55.16 35.04 23.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 63.130000000000003 110.959 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.82 151.22 19.48 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.747 -0.74 . . . . 52.340000000000003 112.466 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.04 148.79 29.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 73.219999999999999 110.902 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.2 p -120.35 171.84 8.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 62.329999999999998 110.869 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -57.5 -19.22 23.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 63.340000000000003 110.852 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.9 -92.09 0.6 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.731 -0.747 . . . . 72.040000000000006 112.463 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.71 -18.76 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 70.25 111.165 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.495 HG22 ' H ' ' A' ' 14' ' ' GLN . 63.6 mt -90.31 103.65 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 65.340000000000003 111.13 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -86.62 30.51 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 63.340000000000003 110.927 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.495 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -81.38 66.91 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.483 . . . . 75.120000000000005 110.921 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.4 t -111.83 104.68 13.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 74.209999999999994 110.864 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 m -43.51 -63.62 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 72.140000000000001 110.868 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 2.0 m-20 -130.13 161.71 58.43 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.581 0.705 . . . . 71.310000000000002 110.886 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.8 -47.6 0.3 Allowed 'Cis proline' 0 C--O 1.231 0.167 0 C-N-CA 122.722 -1.783 . . . . 72.340000000000003 112.343 0.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.794 ' HB3' HD23 ' A' ' 20' ' ' LEU . 67.8 m95 -127.77 -92.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 75.409999999999997 110.925 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.794 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -127.98 162.18 27.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 72.319999999999993 110.897 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -84.79 104.48 14.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 73.420000000000002 110.883 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.514 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 98.4 m -137.64 132.35 17.47 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.558 0.694 . . . . 70.400000000000006 111.127 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.514 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.8 172.49 48.88 Favored 'Cis proline' 0 C--N 1.341 0.141 0 C-N-CA 122.646 -1.814 . . . . 71.25 112.333 -0.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 23' ' ' PRO . 53.3 Cg_endo -69.79 -88.66 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.643 2.229 . . . . 61.039999999999999 112.342 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -52.5 102.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.200000000000003 111.092 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.6 mm 65.17 85.79 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 61.439999999999998 111.097 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.02 175.49 42.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 52.409999999999997 112.478 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -121.14 138.65 54.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.916 0.388 . . . . 75.340000000000003 110.842 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 19.9 p -77.04 128.8 35.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 64.140000000000001 110.876 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 73.239999999999995 110.981 179.94 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.786 0.326 . . . . 71.310000000000002 110.855 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.4 mm 64.25 130.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 51.149999999999999 111.139 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.78 160.04 33.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 34.109999999999999 111.085 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -51.04 120.43 4.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 75.230000000000004 110.905 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 55.21 35.08 24.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 64.400000000000006 110.919 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.09 150.14 19.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.739 -0.743 . . . . 31.039999999999999 112.504 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.18 149.18 24.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.854 0.359 . . . . 75.439999999999998 110.831 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.2 p -120.01 171.8 8.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 30.399999999999999 110.919 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -57.73 -19.01 24.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 63.310000000000002 110.821 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.49 -92.23 0.61 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 72.319999999999993 112.471 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.54 -18.63 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 72.230000000000004 111.124 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.5 HG22 ' H ' ' A' ' 14' ' ' GLN . 64.5 mt -91.04 103.59 14.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 71.239999999999995 111.107 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -86.23 30.66 0.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 65.109999999999999 110.914 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.5 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -81.38 66.93 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 60.140000000000001 110.887 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.5 t -111.77 104.78 13.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 73.019999999999996 110.885 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.1 m -43.55 -63.66 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 75.310000000000002 110.87 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.502 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 5.6 m-20 -130.01 161.72 58.15 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.612 0.72 . . . . 73.230000000000004 110.853 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.79 -48.53 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.17 0 C-N-CA 122.68 -1.8 . . . . 62.229999999999997 112.363 0.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TRP . . . . . 0.773 ' HB3' HD23 ' A' ' 20' ' ' LEU . 95.2 m95 -126.8 -92.99 0.48 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 74.150000000000006 110.925 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.773 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -127.57 162.28 26.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 73.129999999999995 110.921 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -85.01 104.36 14.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 73.409999999999997 110.892 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.515 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 98.5 m -137.52 132.41 17.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.584 0.707 . . . . 63.530000000000001 111.193 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.81 172.39 49.42 Favored 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.713 -1.786 . . . . 74.510000000000005 112.325 0.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 23' ' ' PRO . 53.9 Cg_endo -69.72 -88.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.693 2.262 . . . . 34.329999999999998 112.327 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.408 HG22 HG12 ' A' ' 26' ' ' ILE . 14.0 mt -52.94 102.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 62.049999999999997 111.142 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.408 HG12 HG22 ' A' ' 25' ' ' ILE . 31.8 mm 65.92 85.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 72.150000000000006 111.11 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.38 174.13 42.52 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 72.120000000000005 112.477 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -119.38 138.69 52.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.893 0.378 . . . . 64.299999999999997 110.934 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.451 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 18.1 p -77.02 128.69 34.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 60.229999999999997 110.889 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 64.129999999999995 110.957 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.801 0.334 . . . . 65.219999999999999 110.844 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.9 mm 64.39 130.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 64.409999999999997 111.153 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.91 160.04 32.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 64.239999999999995 111.116 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -53.0 120.52 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 62.210000000000001 110.828 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 55.24 32.51 18.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 71.129999999999995 110.924 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.27 150.38 18.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.755 -0.736 . . . . 63.450000000000003 112.475 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.14 152.35 2.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.363 . . . . 73.310000000000002 110.89 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.3 m -116.5 163.81 15.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 74.109999999999999 110.886 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -59.51 -16.37 24.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 71.209999999999994 110.893 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.8 -90.99 0.63 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 74.239999999999995 112.484 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -59.5 -19.94 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.756 0.312 . . . . 74.310000000000002 111.078 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.464 HG22 ' HB2' ' A' ' 14' ' ' GLN . 31.9 mt -98.99 103.25 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 75.439999999999998 111.16 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -90.34 31.1 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.926 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.464 ' HB2' HG22 ' A' ' 12' ' ' ILE . 1.2 mp0 -81.31 69.88 8.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 63.119999999999997 110.898 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.4 t -110.02 104.19 13.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 73.019999999999996 110.896 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.4 m -46.66 -72.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 71.209999999999994 110.899 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -115.84 161.13 32.24 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.633 0.73 . . . . 75.310000000000002 110.867 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.71 -48.76 0.26 Allowed 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.664 -1.807 . . . . 74.109999999999999 112.369 -0.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -128.64 -92.46 0.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 75.200000000000003 110.886 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.7 pt? -124.45 161.88 25.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 73.340000000000003 110.912 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.8 t -92.88 104.8 17.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 64.400000000000006 110.872 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.518 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.42 132.26 15.41 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.55 0.69 . . . . 71.540000000000006 111.164 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.77 171.18 54.94 Favored 'Cis proline' 0 C--O 1.231 0.151 0 C-N-CA 122.68 -1.8 . . . . 73.319999999999993 112.329 -0.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.9 Cg_endo -69.73 -82.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.689 2.259 . . . . 74.439999999999998 112.39 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.586 HG22 HG12 ' A' ' 26' ' ' ILE . 5.4 mt -61.34 106.64 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 55.25 111.115 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.586 HG12 HG22 ' A' ' 25' ' ' ILE . 23.3 mm 67.33 82.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 73.219999999999999 111.124 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.69 -178.0 39.47 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 62.329999999999998 112.452 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -130.21 137.43 50.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 43.329999999999998 110.87 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.0 p -77.89 129.31 35.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 72.329999999999998 110.915 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 74.319999999999993 110.887 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 8' ' ' CYS . 34.5 mm . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.805 0.336 . . . . 72.32 111.159 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.96 160.15 26.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 72.12 111.099 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.29 120.54 7.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 73.53 110.872 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 56.14 29.79 15.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 64.03 110.913 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.34 150.64 18.93 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 52.54 112.524 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.09 153.61 2.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.778 0.323 . . . . 70.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.419 ' HA ' HD12 ' A' ' 2' ' ' ILE . 10.2 m -114.96 164.57 13.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 61.24 110.871 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.79 -18.11 29.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 70.12 110.808 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.87 -92.64 0.6 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.767 -0.73 . . . . 62.54 112.49 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.81 -17.09 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 74.35 111.151 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 14' ' ' GLN . 19.9 mt -99.22 102.65 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 72.43 111.179 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.88 31.85 1.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 73.02 110.901 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.447 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.3 tp60 -80.11 69.59 6.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 75.12 110.941 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.7 t -110.3 103.55 12.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 62.35 110.879 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.9 m -46.7 -72.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 61.42 110.838 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.491 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -116.35 162.43 26.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.563 0.697 . . . . 64.4 110.883 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.77 -49.01 0.25 Allowed 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.701 -1.791 . . . . 65.35 112.308 0.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -127.76 -93.0 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 74.24 110.923 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.482 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.8 pt? -124.09 162.4 23.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 52.2 110.887 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 15.3 t -93.38 104.28 16.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 44.31 110.846 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.6 m -139.52 130.54 14.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.589 0.709 . . . . 71.24 111.14 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.67 170.84 56.11 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.7 -1.792 . . . . 74.12 112.383 -0.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 -53.63 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.698 2.265 . . . . 72.24 112.358 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.469 HG22 HG12 ' A' ' 26' ' ' ILE . 2.7 mt -96.17 119.27 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 74.11 111.13 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 25' ' ' ILE . 25.4 mm 65.96 65.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 73.02 111.173 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.02 179.38 38.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.741 . . . . 42.32 112.502 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.516 ' O ' HD12 ' A' ' 30' ' ' LEU . 3.4 m-85 -130.3 140.44 50.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 65.33 110.877 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.5 p -74.54 128.73 36.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 74.33 110.921 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 28' ' ' PHE . 2.1 mp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 75.24 110.898 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.9 mm . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.821 0.344 . . . . 74.44 111.093 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.97 158.63 30.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 71.03 111.13 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -54.35 120.53 6.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 73.44 110.884 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 55.4 35.18 24.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 70.3 110.923 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.95 150.59 19.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.78 -0.724 . . . . 55.44 112.508 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.55 153.43 5.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.822 0.344 . . . . 72.02 110.888 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.3 m -115.45 166.11 12.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 70.22 110.881 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.1 -17.98 31.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 72.52 110.937 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.41 -92.64 0.63 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 74.1 112.477 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -61.94 -16.74 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.335 . . . . 75.3 111.154 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 14' ' ' GLN . 48.4 mt -99.61 102.64 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 71.24 111.114 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.97 31.84 1.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 60.24 110.91 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.42 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -80.26 70.81 6.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 72.32 110.879 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.6 t -109.66 103.6 12.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 71.21 110.851 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 m -47.58 -65.41 0.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 70.41 110.895 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.493 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -123.85 161.63 45.51 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.58 0.705 . . . . 51.13 110.886 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.73 -49.1 0.24 Allowed 'Cis proline' 0 C--O 1.231 0.158 0 C-N-CA 122.723 -1.782 . . . . 74.43 112.33 0.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.769 ' HB3' HD23 ' A' ' 20' ' ' LEU . 84.6 m95 -128.06 -92.86 0.47 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 72.54 110.93 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.769 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -124.05 162.23 23.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 64.42 110.935 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 9.0 t -93.3 104.57 16.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 74.22 110.874 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.495 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.2 m -138.62 130.15 15.52 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.587 0.708 . . . . 74.31 111.093 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.4 Cg_endo -69.76 170.73 57.07 Favored 'Cis proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 -1.8 . . . . 64.54 112.314 -0.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -55.02 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.706 2.271 . . . . 70.43 112.348 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.503 HG22 HG12 ' A' ' 26' ' ' ILE . 3.1 mt -94.07 118.53 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 64.55 111.16 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.503 HG12 HG22 ' A' ' 25' ' ' ILE . 26.1 mm 65.99 63.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 63.41 111.125 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.3 178.92 35.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 73.11 112.496 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -130.35 139.74 50.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 74.12 110.871 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.4 p -75.01 128.35 35.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 53.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 74.22 110.887 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.8 mm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.867 0.365 . . . . 72.24 111.127 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.64 159.81 26.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 53.42 111.073 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -55.54 120.54 7.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 61.21 110.878 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 55.92 34.99 24.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 75.31 110.907 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.6 149.93 19.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.751 . . . . 45.1 112.46 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.38 153.24 5.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 74.34 110.865 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 m -115.41 165.95 12.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 74.33 110.906 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -59.16 -17.67 29.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 71.13 110.886 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.24 -92.62 0.63 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 32.52 112.497 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -61.91 -16.75 16.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.788 0.328 . . . . 73.04 111.169 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 43.9 mt -99.55 102.59 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 73.33 111.116 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.94 31.79 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 61.32 110.879 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.1 70.85 6.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 73.04 110.883 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.3 t -110.04 103.35 12.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 63.4 110.852 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.3 m -47.94 -64.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 71.4 110.904 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -124.01 161.87 44.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.589 0.709 . . . . 64.11 110.889 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.74 -49.19 0.24 Allowed 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.74 -1.775 . . . . 71.31 112.354 0.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -127.55 -92.93 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 75.43 110.95 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.7 pt? -124.49 162.01 24.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 53.01 110.969 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 8.0 t -93.13 104.69 16.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 70.01 110.896 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.496 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.1 m -138.99 130.14 15.08 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.559 0.695 . . . . 64.2 111.153 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.73 170.75 56.82 Favored 'Cis proline' 0 C--O 1.231 0.149 0 C-N-CA 122.692 -1.795 . . . . 73.34 112.348 -0.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -55.37 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.664 2.243 . . . . 73.34 112.346 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.518 HG22 HG12 ' A' ' 26' ' ' ILE . 3.3 mt -93.32 117.7 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 73.14 111.17 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.518 HG12 HG22 ' A' ' 25' ' ' ILE . 23.0 mm 66.17 65.9 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 61.24 111.143 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.37 179.42 36.8 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 64.22 112.463 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.34 139.64 50.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.881 0.372 . . . . 73.12 110.874 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.7 p -75.04 128.96 36.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 33.4 110.898 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 72.22 110.89 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.7 mm . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.802 0.334 . . . . 63.53 111.118 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.28 160.11 31.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 51.33 111.094 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -54.42 120.47 6.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 71.41 110.896 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 55.9 31.62 18.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 74.52 110.945 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.39 150.29 18.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 74.32 112.49 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.34 153.19 3.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 71.03 110.914 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.0 m -115.3 163.51 15.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 74.42 110.857 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -58.73 -17.91 26.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 64.35 110.887 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.84 -92.26 0.6 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.72 . . . . 44.13 112.494 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -61.7 -16.82 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.89 0.376 . . . . 51.45 111.158 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.434 HG22 ' HB2' ' A' ' 14' ' ' GLN . 27.7 mt -100.33 102.77 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 74.22 111.132 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.35 31.83 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 61.5 110.859 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.434 ' HB2' HG22 ' A' ' 12' ' ' ILE . 1.2 mp0 -79.34 69.56 5.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 74.23 110.893 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.2 t -110.44 103.86 12.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 54.11 110.912 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.3 m -47.27 -72.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 62.01 110.895 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.492 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.81 162.31 27.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.595 0.712 . . . . 74.03 110.875 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.74 -49.05 0.24 Allowed 'Cis proline' 0 C--N 1.341 0.138 0 C-N-CA 122.681 -1.799 . . . . 72.35 112.321 0.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.769 ' HB3' HD23 ' A' ' 20' ' ' LEU . 49.3 m95 -128.04 -92.9 0.46 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 62.42 110.936 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.769 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -123.9 162.35 23.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.428 . . . . 73.34 110.923 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 9.0 t -93.33 104.36 16.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 64.23 110.842 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.498 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.9 m -138.75 130.55 15.53 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.606 0.717 . . . . 65.42 111.104 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.77 170.82 56.64 Favored 'Cis proline' 0 C--N 1.342 0.202 0 C-N-CA 122.706 -1.789 . . . . 50.22 112.331 -0.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -54.41 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.244 . . . . 73.41 112.33 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.513 HG22 HG12 ' A' ' 26' ' ' ILE . 3.3 mt -94.54 118.32 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 74.14 111.165 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.513 HG12 HG22 ' A' ' 25' ' ' ILE . 25.5 mm 65.95 66.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 45.41 111.157 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.05 179.21 38.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.749 -0.739 . . . . 60.1 112.466 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -130.46 140.21 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 75.24 110.861 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.3 p -74.55 128.6 35.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 72.54 110.906 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 71.13 110.937 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 8' ' ' CYS . 34.0 mm . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.822 0.344 . . . . 53.51 111.124 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.41 160.16 30.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 73.04 111.087 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -55.74 120.55 7.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 44.34 110.886 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 55.58 30.55 15.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 73.22 110.912 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.52 150.5 18.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.76 -0.733 . . . . 61.31 112.478 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.91 153.62 2.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.835 0.35 . . . . 73.01 110.914 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.417 ' HA ' HD12 ' A' ' 2' ' ' ILE . 13.8 m -114.89 164.84 13.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 73.03 110.9 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -58.65 -18.46 30.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 70.22 110.847 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.55 -92.57 0.6 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.731 -0.747 . . . . 52.44 112.481 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -62.13 -16.47 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.74 0.305 . . . . 72.31 111.091 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.454 HG22 ' H ' ' A' ' 14' ' ' GLN . 64.3 mt -100.25 102.81 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 64.2 111.11 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.7 31.82 1.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 42.43 110.905 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.454 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.6 tp60 -80.13 69.76 6.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.919 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.5 t -110.1 103.94 12.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 74.33 110.91 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.4 m -46.16 -73.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.1 110.941 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.491 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -115.57 162.39 25.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.601 0.715 . . . . 64.41 110.912 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.77 -49.35 0.23 Allowed 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.663 -1.807 . . . . 72.41 112.322 0.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -128.11 -93.06 0.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 74.14 110.955 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.55 162.71 21.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 52.24 110.917 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 18.4 t -94.45 104.1 16.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 65.53 110.897 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.3 m -138.69 131.09 15.81 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.585 0.707 . . . . 61.05 111.162 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.7 170.72 56.86 Favored 'Cis proline' 0 C--O 1.231 0.172 0 C-N-CA 122.711 -1.787 . . . . 71.13 112.357 -0.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -54.18 0.23 Allowed 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.69 2.26 . . . . 63.51 112.373 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.495 HG22 HG12 ' A' ' 26' ' ' ILE . 3.0 mt -95.44 118.35 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 61.23 111.17 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.495 HG12 HG22 ' A' ' 25' ' ' ILE . 22.0 mm 66.4 63.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 71.3 111.152 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.36 178.82 35.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 74.31 112.48 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -130.45 140.24 50.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.875 0.369 . . . . 70.52 110.89 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.0 p -74.61 128.56 35.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 73.11 110.905 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.498 ' O ' HD12 ' A' ' 30' ' ' LEU . 1.4 pp . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 62.34 110.917 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.82 0.343 . . . . 74.23 111.149 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.46 160.11 33.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 64.53 111.101 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -52.1 120.55 5.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 61.34 110.877 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 54.86 34.02 21.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.04 110.944 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.19 150.76 19.0 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 74.11 112.513 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.89 151.89 3.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.837 0.351 . . . . 64.44 110.92 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.7 m -117.21 163.09 16.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 61.43 110.888 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -59.26 -16.59 22.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 74.33 110.853 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.01 -90.66 0.64 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.75 . . . . 64.14 112.512 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.06 -19.51 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.796 0.331 . . . . 75.43 111.127 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' A' ' 14' ' ' GLN . 33.2 mt -98.7 103.42 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 74.11 111.122 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.34 31.09 0.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 62.1 110.873 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.501 ' HB2' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -81.61 69.87 8.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 73.42 110.927 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.1 t -110.05 104.41 13.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 72.31 110.906 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.6 m -46.68 -68.97 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 54.12 110.885 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -121.06 160.91 43.18 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.565 0.698 . . . . 74.34 110.884 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.75 -48.69 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.144 0 C-N-CA 122.705 -1.79 . . . . 61.15 112.352 0.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.75 ' HB3' HD23 ' A' ' 20' ' ' LEU . 95.3 m95 -128.98 -92.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 75.14 110.94 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.75 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -124.33 161.98 24.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 73.31 110.947 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 4.8 t -92.92 104.5 16.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 52.21 110.921 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.522 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -138.93 132.46 16.04 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.587 0.708 . . . . 74.1 111.145 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.78 170.78 56.91 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 -1.8 . . . . 60.15 112.366 -0.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.405 ' HG2' HD12 ' A' ' 25' ' ' ILE . 53.7 Cg_endo -69.81 -87.26 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.67 2.247 . . . . 70.04 112.326 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.508 HG22 HG12 ' A' ' 26' ' ' ILE . 1.8 mp -54.7 105.75 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 75.23 111.146 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 25' ' ' ILE . 25.9 mm 65.84 84.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.43 111.14 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.71 -178.16 39.05 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 73.02 112.502 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -130.14 136.97 49.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 64.4 110.837 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 13.7 p -78.29 129.12 34.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 64.13 110.911 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 74.43 110.935 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.4 mm . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.877 0.37 . . . . 75.34 111.109 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.61 158.56 31.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 74.41 111.083 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -53.0 120.47 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 74.03 110.858 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 54.9 35.3 24.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 71.54 110.877 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.67 149.94 19.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 73.03 112.501 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 152.15 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.323 . . . . 74.41 110.907 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.9 m -117.04 165.75 13.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 65.22 110.893 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.43 -16.09 32.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 72.13 110.843 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.36 -90.97 0.7 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.718 -0.753 . . . . 53.15 112.489 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -58.87 -20.91 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 74.23 111.127 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 14' ' ' GLN . 56.4 mt -98.94 103.01 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 72.23 111.14 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -90.29 30.82 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 35.44 110.865 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.452 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -81.73 70.49 8.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 64.15 110.864 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.4 t -108.85 104.13 13.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 60.33 110.87 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.0 m -46.86 -68.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 75.21 110.909 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -120.89 160.38 45.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.599 0.714 . . . . 55.31 110.861 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.8 -48.6 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.677 -1.801 . . . . 71.21 112.332 0.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.758 ' HB3' HD23 ' A' ' 20' ' ' LEU . 76.9 m95 -128.41 -92.47 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 74.33 110.929 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.758 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -126.09 161.92 26.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.276 -0.42 . . . . 63.44 110.942 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 6.0 t -92.03 104.64 17.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 70.31 110.866 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.519 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.7 m -139.24 131.53 15.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.59 0.71 . . . . 71.21 111.131 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.76 170.79 56.76 Favored 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.72 -1.783 . . . . 51.32 112.369 -0.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -87.48 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.667 2.245 . . . . 74.12 112.344 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.534 HG22 HG12 ' A' ' 26' ' ' ILE . 1.8 mp -55.32 106.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 62.34 111.101 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 25' ' ' ILE . 25.1 mm 66.09 84.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 72.34 111.147 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.59 -179.05 40.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 74.32 112.484 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.531 ' O ' HD12 ' A' ' 30' ' ' LEU . 1.6 m-85 -129.14 137.06 50.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 71.12 110.858 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.408 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 18.5 p -78.36 129.16 34.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 64.0 110.926 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 28' ' ' PHE . 4.6 mp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 64.54 110.907 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.876 0.37 . . . . 71.25 111.154 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.87 158.52 34.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 53.04 111.118 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -52.15 120.5 5.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 75.1 110.87 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 55.28 35.28 24.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 74.22 110.93 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.93 150.25 19.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.741 -0.742 . . . . 73.52 112.531 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 152.42 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 72.33 110.892 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 m -116.92 165.24 13.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 74.31 110.908 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.02 -16.45 31.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 72.13 110.879 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.68 -91.08 0.7 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 72.21 112.459 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -59.43 -19.41 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.34 . . . . 74.25 111.191 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.448 HG22 ' H ' ' A' ' 14' ' ' GLN . 54.4 mt -100.24 103.13 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 72.13 111.138 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -90.34 30.98 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 74.04 110.867 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.448 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.1 tp60 -81.52 70.86 8.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 74.4 110.91 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -109.21 104.09 13.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 72.44 110.899 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.0 m -47.39 -65.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 73.51 110.873 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -123.96 161.41 46.98 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.573 0.701 . . . . 65.51 110.912 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.0 Cg_endo -69.79 -48.66 0.26 Allowed 'Cis proline' 0 C--O 1.231 0.159 0 C-N-CA 122.675 -1.802 . . . . 64.01 112.337 0.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.801 ' HB3' HD23 ' A' ' 20' ' ' LEU . 20.7 m95 -127.82 -92.55 0.48 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 74.01 110.912 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.801 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -125.86 161.94 26.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 64.03 110.913 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.8 t -92.41 104.74 17.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 65.4 110.859 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.515 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.4 m -138.87 131.45 15.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.607 0.717 . . . . 74.15 111.154 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.1 Cg_endo -69.74 171.12 55.07 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.727 -1.781 . . . . 70.13 112.359 -0.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.9 Cg_endo -69.8 -83.5 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.692 2.261 . . . . 63.23 112.335 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.602 HG22 HG12 ' A' ' 26' ' ' ILE . 5.8 mt -60.41 106.76 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 71.11 111.154 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.602 HG12 HG22 ' A' ' 25' ' ' ILE . 22.5 mm 67.63 84.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 70.11 111.103 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.63 -178.58 41.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 65.43 112.476 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -129.3 137.18 50.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.367 . . . . 65.1 110.892 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.9 p -78.16 128.91 34.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.3 110.893 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 30' ' ' LEU . 1.4 pt? . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 64.33 110.922 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.0 mm . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.833 0.349 . . . . 65.41 111.172 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.37 158.67 33.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 52.2 111.091 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -53.01 120.64 6.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 70.25 110.862 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 55.58 35.34 24.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 72.52 110.966 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.81 150.65 19.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 72.25 112.491 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.18 152.53 3.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.836 0.351 . . . . 74.21 110.903 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.6 m -117.0 165.32 13.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 35.45 110.855 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -59.89 -16.54 30.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 53.24 110.853 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.8 -90.93 0.71 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.716 -0.754 . . . . 52.22 112.526 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.52 -19.47 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 75.31 111.116 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 14' ' ' GLN . 52.4 mt -101.26 103.14 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 54.15 111.117 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.65 31.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 61.22 110.856 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.447 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.2 tp60 -81.34 69.84 8.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 73.34 110.918 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.7 t -109.77 104.03 12.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 71.01 110.873 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.4 m -47.22 -70.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 73.24 110.909 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -117.36 160.7 36.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.566 0.698 . . . . 70.42 110.849 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.76 -48.69 0.26 Allowed 'Cis proline' 0 C--O 1.231 0.167 0 C-N-CA 122.743 -1.774 . . . . 75.44 112.29 0.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.765 ' HB3' HD23 ' A' ' 20' ' ' LEU . 69.9 m95 -128.94 -92.47 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 73.54 110.901 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.765 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -124.56 162.01 24.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 75.32 110.945 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 8.2 t -93.06 104.58 16.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 72.21 110.862 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.52 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.9 m -139.18 131.92 15.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.569 0.7 . . . . 72.53 111.135 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.75 171.15 54.97 Favored 'Cis proline' 0 C--N 1.342 0.186 0 C-N-CA 122.64 -1.817 . . . . 70.3 112.384 -0.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -85.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.69 2.26 . . . . 71.02 112.364 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.593 HG22 HG12 ' A' ' 26' ' ' ILE . 6.1 mt -59.11 107.38 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 73.34 111.115 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.593 HG12 HG22 ' A' ' 25' ' ' ILE . 25.8 mm 66.9 83.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 75.25 111.114 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.89 -178.14 40.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 75.04 112.48 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -130.01 137.39 50.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 75.02 110.865 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.0 p -78.24 128.93 34.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 72.01 110.888 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 72.2 110.912 179.982 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.4 mm . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.835 0.35 . . . . 73.54 111.134 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.44 160.04 28.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 65.45 111.138 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -55.06 120.68 7.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 72.14 110.856 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 55.86 35.36 25.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 64.1 110.918 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.03 152.54 19.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.797 -0.716 . . . . 71.2 112.501 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.7 152.5 5.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.888 0.375 . . . . 64.34 110.861 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.0 m -116.94 165.07 13.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 70.44 110.882 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.69 -16.67 28.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 75.33 110.903 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.23 -91.15 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 71.51 112.529 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.59 -19.25 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.791 0.329 . . . . 63.52 111.124 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.47 HG22 ' H ' ' A' ' 14' ' ' GLN . 2.7 mp -100.96 103.08 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 73.22 111.161 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -90.1 30.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 63.32 110.894 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.47 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -81.22 69.58 7.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 72.4 110.897 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.3 t -108.96 103.97 13.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 72.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.1 m -47.57 -68.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 62.25 110.868 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -120.12 161.49 38.41 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.577 0.704 . . . . 73.2 110.903 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.8 -48.43 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.147 0 C-N-CA 122.635 -1.819 . . . . 71.43 112.359 0.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -128.08 -92.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 74.54 110.902 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.481 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.8 pt? -125.9 161.8 26.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 65.53 110.945 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 7.5 t -92.35 104.42 16.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 75.44 110.911 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.5 m -139.55 131.61 15.02 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.545 0.688 . . . . 64.31 111.143 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.79 171.1 55.38 Favored 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.645 -1.814 . . . . 42.4 112.354 -0.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -85.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.708 2.272 . . . . 71.43 112.349 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.61 HG22 HG12 ' A' ' 26' ' ' ILE . 6.3 mt -58.45 107.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 71.24 111.134 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.61 HG12 HG22 ' A' ' 25' ' ' ILE . 23.8 mm 67.41 84.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 72.32 111.139 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.74 -178.07 41.15 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.719 -0.753 . . . . 64.12 112.456 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -130.02 137.32 50.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.381 . . . . 75.32 110.89 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 18.4 p -78.17 129.46 35.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 60.13 110.902 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 65.44 110.939 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.854 0.359 . . . . 72.03 111.118 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.16 157.92 34.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 64.54 111.12 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -52.58 120.6 5.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 75.14 110.884 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 55.81 35.38 25.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 74.11 110.926 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.83 150.48 19.05 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 63.33 112.479 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.29 152.53 3.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 71.13 110.927 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.1 m -116.75 164.94 13.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 71.24 110.874 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.48 -17.22 29.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 53.44 110.852 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.84 -91.34 0.68 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 63.34 112.489 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -60.08 -18.9 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 74.4 111.138 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 14' ' ' GLN . 53.3 mt -100.38 103.15 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 71.55 111.123 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -90.39 30.95 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 71.43 110.845 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.444 ' H ' HG22 ' A' ' 12' ' ' ILE . 10.5 tp-100 -81.31 69.89 8.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 72.15 110.926 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.1 t -109.06 103.91 13.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 73.03 110.907 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.6 m -47.5 -68.26 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 71.13 110.929 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.496 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -120.31 160.84 41.94 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.568 0.699 . . . . 74.45 110.841 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.0 Cg_endo -69.74 -48.73 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.167 0 C-N-CA 122.698 -1.793 . . . . 65.33 112.347 -0.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.779 ' HB3' HD23 ' A' ' 20' ' ' LEU . 54.9 m95 -128.05 -92.53 0.47 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 75.41 110.924 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.779 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -125.88 161.82 26.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 73.33 110.923 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 7.6 t -91.92 104.43 16.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 53.35 110.885 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.6 m -139.1 131.31 15.42 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.569 0.699 . . . . 62.23 111.163 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.79 171.06 55.6 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.672 -1.803 . . . . 74.33 112.351 0.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.9 Cg_endo -69.77 -85.09 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.698 2.265 . . . . 62.12 112.339 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.601 HG22 HG12 ' A' ' 26' ' ' ILE . 5.2 mt -59.24 107.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 75.35 111.105 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.601 HG12 HG22 ' A' ' 25' ' ' ILE . 22.8 mm 67.42 83.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 73.24 111.095 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.61 -178.46 40.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.758 -0.734 . . . . 41.35 112.49 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -129.87 137.25 50.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 74.44 110.818 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 18.2 p -77.98 128.92 34.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 74.11 110.889 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 75.15 110.879 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.7 mm . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.842 0.353 . . . . 54.32 111.142 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.5 159.92 9.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 72.12 111.123 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -55.4 120.02 6.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 72.21 110.851 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 51.84 34.28 13.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 74.53 110.923 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.25 153.03 19.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 71.14 112.496 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 153.13 8.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.84 0.352 . . . . 64.41 110.893 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.8 m -113.71 170.7 8.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 74.13 110.861 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.21 -16.88 23.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.478 . . . . 74.32 110.903 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.2 -89.91 0.61 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 74.14 112.451 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -58.61 -19.88 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.333 . . . . 55.23 111.135 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.49 HG22 ' HB2' ' A' ' 14' ' ' GLN . 34.9 mt -101.25 103.17 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 64.25 111.106 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.15 30.81 0.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 75.21 110.875 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HB2' HG22 ' A' ' 12' ' ' ILE . 1.2 mp0 -81.56 69.41 8.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 64.45 110.936 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.7 t -110.06 104.24 13.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 73.32 110.879 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.5 m -47.14 -72.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 55.22 110.863 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -115.1 161.02 31.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.55 0.691 . . . . 70.21 110.882 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.3 Cg_endo -69.74 -48.43 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.661 -1.808 . . . . 51.45 112.35 -0.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.773 ' HB3' HD23 ' A' ' 20' ' ' LEU . 75.9 m95 -129.23 -92.54 0.45 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 72.11 110.934 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.773 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -123.41 162.0 23.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 73.03 110.972 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.0 t -93.35 104.43 16.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 73.35 110.827 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.522 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.71 132.49 15.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.599 0.714 . . . . 74.24 111.12 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.76 171.07 55.4 Favored 'Cis proline' 0 C--O 1.232 0.178 0 C-N-CA 122.702 -1.791 . . . . 75.43 112.299 -0.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 -85.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.704 2.269 . . . . 72.41 112.373 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.618 HG22 HG12 ' A' ' 26' ' ' ILE . 8.1 mt -59.08 108.41 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 74.54 111.13 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.618 HG12 HG22 ' A' ' 25' ' ' ILE . 27.1 mm 66.04 78.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 72.53 111.187 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.11 -179.02 37.37 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.745 -0.74 . . . . 53.24 112.475 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.13 137.39 50.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.37 . . . . 75.21 110.878 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.8 p -78.01 128.82 34.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 52.23 110.875 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 71.32 110.912 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.7 mm . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.796 0.332 . . . . 65.04 111.147 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.4 160.09 9.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 44.41 111.062 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.84 120.14 7.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 72.22 110.844 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 54.31 35.17 22.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 64.54 110.947 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.3 156.81 19.52 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.737 -0.744 . . . . 73.41 112.433 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.21 152.79 27.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.836 0.351 . . . . 74.52 110.867 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.2 m -113.77 170.34 8.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.898 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -59.72 -16.41 26.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 75.31 110.849 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.22 -89.67 0.6 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.719 -0.753 . . . . 65.12 112.49 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -58.34 -20.55 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 72.54 111.138 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.453 HG22 ' H ' ' A' ' 14' ' ' GLN . 53.3 mt -100.34 103.13 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 70.42 111.136 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.55 30.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 75.33 110.91 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.453 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -81.78 69.39 8.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 63.41 110.893 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 t -110.19 104.2 13.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 53.35 110.87 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.9 m -48.05 -70.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 74.31 110.926 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.498 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.16 160.83 34.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.591 0.71 . . . . 52.15 110.903 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 52.9 Cg_endo -69.82 -48.35 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.154 0 C-N-CA 122.658 -1.809 . . . . 52.55 112.307 0.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -128.58 -92.65 0.46 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 72.53 110.915 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.497 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.9 pt? -124.62 161.89 25.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 64.31 110.914 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 4.6 t -93.06 104.8 16.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 75.33 110.879 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.525 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.6 m -141.4 132.69 13.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.522 0.677 . . . . 60.0 111.2 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.75 170.83 56.54 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 122.712 -1.787 . . . . 74.54 112.361 -0.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -87.43 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.686 2.257 . . . . 75.1 112.359 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.549 HG22 HG12 ' A' ' 26' ' ' ILE . 1.9 mp -55.85 107.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 70.01 111.109 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.549 HG12 HG22 ' A' ' 25' ' ' ILE . 25.4 mm 65.3 82.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 64.41 111.123 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.84 -178.73 39.52 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.732 . . . . 72.13 112.483 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -129.99 137.34 50.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.936 0.398 . . . . 72.31 110.884 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.416 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.7 p -77.91 129.5 35.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 64.12 110.926 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.459 . . . . 75.34 110.91 179.975 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.1 mm . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.828 0.347 . . . . 64.41 111.106 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.7 160.17 32.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 55.22 111.091 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -53.93 120.76 6.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 70.31 110.869 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 55.72 32.4 19.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 73.5 110.878 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.21 152.0 19.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.796 -0.716 . . . . 73.05 112.501 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.4 151.67 2.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 62.43 110.876 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.3 m -117.19 165.31 13.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 72.45 110.844 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.73 -16.25 25.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 74.43 110.907 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.61 -91.33 0.66 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.701 -0.761 . . . . 62.15 112.482 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -61.61 -17.34 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 74.22 111.093 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 14' ' ' GLN . 34.2 mt -99.42 103.4 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 71.15 111.095 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.552 HD22 ' N ' ' A' ' 13' ' ' ASN . 1.2 m-80 -88.17 31.77 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 61.23 110.853 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.422 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.1 tp60 -80.75 69.23 7.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.24 110.943 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.3 t -110.45 104.35 13.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 31.12 110.862 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.4 m -45.57 -64.86 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 64.13 110.857 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 2.0 m-20 -125.82 162.07 47.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.618 0.723 . . . . 71.24 110.856 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.78 -48.91 0.25 Allowed 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.639 -1.817 . . . . 65.33 112.345 0.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.788 ' HB3' HD23 ' A' ' 20' ' ' LEU . 66.9 m95 -130.1 -92.73 0.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.229 -0.442 . . . . 73.41 110.927 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.788 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -119.59 162.57 18.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 70.43 110.915 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.9 t -94.86 104.56 16.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 50.53 110.899 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.526 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.3 m -138.12 133.76 17.52 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.635 0.731 . . . . 54.55 111.12 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.526 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.77 171.62 52.84 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.715 -1.786 . . . . 74.33 112.331 -0.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -86.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.688 2.259 . . . . 75.5 112.347 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.591 HG22 HG12 ' A' ' 26' ' ' ILE . 5.4 mt -58.69 106.57 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 74.43 111.114 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.591 HG12 HG22 ' A' ' 25' ' ' ILE . 23.2 mm 67.43 83.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 71.25 111.082 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.88 -177.37 39.14 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 61.2 112.493 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -130.14 137.5 50.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.852 0.358 . . . . 75.11 110.929 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 13.4 p -77.87 128.53 34.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 73.1 110.846 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.411 ' HA ' ' HG3' ' A' ' 18' ' ' PRO . 1.6 pt? . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 62.54 110.886 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 8' ' ' CYS . 35.6 mm . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.848 0.356 . . . . 73.13 111.094 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.11 160.4 26.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 64.31 111.125 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -56.34 120.79 8.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 64.31 110.854 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 55.94 30.01 15.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 75.31 110.942 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.39 149.97 18.76 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 40.23 112.439 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 152.32 7.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 52.44 110.892 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.417 ' HA ' HD12 ' A' ' 2' ' ' ILE . 6.4 m -114.27 170.36 8.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 72.23 110.889 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -59.65 -16.33 25.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.852 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.52 -89.49 0.58 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.733 . . . . 72.13 112.474 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -58.84 -19.36 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.794 0.33 . . . . 73.13 111.125 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.435 HG22 ' H ' ' A' ' 14' ' ' GLN . 42.4 mt -100.63 103.5 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 75.23 111.082 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -88.87 30.98 0.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 72.13 110.915 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.435 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.1 tp60 -81.57 69.29 8.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 41.42 110.907 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.9 t -110.46 104.73 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 55.33 110.871 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.9 m -47.28 -72.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 74.12 110.845 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.42 161.34 32.15 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 75.3 110.855 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.81 -48.52 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.669 -1.804 . . . . 73.43 112.301 0.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.799 ' HB3' HD23 ' A' ' 20' ' ' LEU . 57.9 m95 -128.91 -92.63 0.45 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 71.42 110.868 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.799 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -123.99 162.07 24.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 70.11 110.898 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 3.8 t -93.12 104.19 16.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 74.11 110.922 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.525 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.54 132.78 15.48 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.588 0.709 . . . . 73.2 111.141 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.5 Cg_endo -69.73 170.77 56.74 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.713 -1.786 . . . . 54.0 112.343 -0.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -87.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.697 2.265 . . . . 71.34 112.385 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.543 HG22 HG12 ' A' ' 26' ' ' ILE . 1.9 mp -55.13 107.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 64.44 111.103 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.543 HG12 HG22 ' A' ' 25' ' ' ILE . 26.0 mm 65.4 83.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 63.41 111.173 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.7 -178.99 39.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.688 -0.768 . . . . 75.51 112.481 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.17 137.84 50.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.951 0.405 . . . . 72.14 110.854 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 12.3 p -78.15 129.29 34.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 63.14 110.887 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 53.05 110.94 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.6 mm . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.87 0.367 . . . . 53.34 111.113 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.73 158.07 33.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 64.12 111.093 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -53.12 120.79 6.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 72.13 110.848 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 55.69 35.27 24.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 71.12 110.955 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.1 150.5 18.97 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.75 -0.738 . . . . 64.41 112.5 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.69 152.48 2.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.812 0.339 . . . . 74.53 110.895 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.7 m -116.87 165.19 13.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 73.12 110.858 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -59.67 -16.39 26.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 71.34 110.868 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.14 -90.93 0.73 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 43.43 112.516 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.39 -19.14 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.874 0.369 . . . . 53.45 111.199 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 14' ' ' GLN . 49.1 mt -102.04 103.3 14.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 63.41 111.114 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.58 31.27 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.03 110.916 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.447 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.4 tp60 -81.26 69.76 7.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 75.43 110.893 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 t -109.99 103.99 12.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 70.23 110.848 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.1 m -47.62 -70.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 75.45 110.886 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.494 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -117.85 161.03 36.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 74.54 110.902 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.77 -48.66 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.698 -1.793 . . . . 63.22 112.317 0.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -128.75 -92.6 0.46 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 64.21 110.923 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.485 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.8 pt? -124.5 161.93 25.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 73.43 110.926 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 11.0 t -93.19 104.74 16.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 70.21 110.876 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.9 m -139.35 131.9 15.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.559 0.695 . . . . 73.41 111.12 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.7 171.15 54.74 Favored 'Cis proline' 0 C--N 1.341 0.159 0 C-N-CA 122.706 -1.789 . . . . 74.11 112.336 -0.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.7 Cg_endo -69.76 -83.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.686 2.257 . . . . 74.23 112.359 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.609 HG22 HG12 ' A' ' 26' ' ' ILE . 6.5 mt -60.67 107.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 63.22 111.123 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.609 HG12 HG22 ' A' ' 25' ' ' ILE . 23.6 mm 67.14 83.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 65.13 111.178 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.97 -177.87 40.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 72.13 112.49 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -130.21 137.41 50.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.402 . . . . 74.35 110.906 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.0 p -77.98 129.4 35.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 72.13 110.916 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.557 ' O ' HD12 ' A' ' 30' ' ' LEU . 3.2 pp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 73.2 110.903 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.8 mm . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.85 0.357 . . . . 73.32 111.112 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.26 160.04 32.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 74.3 111.099 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.03 120.3 5.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 62.32 110.862 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 53.58 33.99 17.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 55.03 110.892 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.33 152.61 19.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.712 -0.756 . . . . 75.41 112.476 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.66 152.62 3.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.353 . . . . 75.02 110.894 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.6 m -116.36 164.13 14.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 43.14 110.892 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -16.42 28.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.41 110.867 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.35 -90.93 0.64 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.728 . . . . 64.22 112.444 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.22 -19.87 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 75.54 111.172 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.459 HG22 ' HB2' ' A' ' 14' ' ' GLN . 52.8 mt -99.56 103.16 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 62.02 111.105 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.92 31.05 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 63.21 110.886 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.459 ' HB2' HG22 ' A' ' 12' ' ' ILE . 1.6 mp0 -81.5 70.25 8.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 74.34 110.961 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.9 t -110.02 104.45 13.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 62.25 110.878 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.1 m -45.97 -74.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 75.33 110.867 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -114.84 161.02 31.22 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.555 0.693 . . . . 64.33 110.925 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.78 -48.7 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.155 0 C-N-CA 122.671 -1.804 . . . . 64.01 112.326 0.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.766 ' HB3' HD23 ' A' ' 20' ' ' LEU . 78.1 m95 -129.05 -92.52 0.45 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 75.21 110.967 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.766 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -123.91 162.3 23.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 75.12 110.917 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 7.9 t -93.41 104.75 16.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 72.44 110.907 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.52 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.0 132.37 15.92 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.602 0.715 . . . . 72.45 111.118 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.81 171.19 55.07 Favored 'Cis proline' 0 C--N 1.342 0.191 0 C-N-CA 122.701 -1.791 . . . . 72.32 112.287 0.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.7 Cg_endo -69.76 -84.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.655 2.237 . . . . 75.1 112.375 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.597 HG22 HG12 ' A' ' 26' ' ' ILE . 5.1 mt -59.45 106.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 71.23 111.149 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.597 HG12 HG22 ' A' ' 25' ' ' ILE . 20.0 mm 68.08 85.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 64.05 111.094 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.71 -178.12 41.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 54.32 112.469 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -130.18 137.64 50.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.36 . . . . 74.52 110.926 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.9 p -77.93 128.98 34.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 75.41 110.818 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.488 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 73.42 110.962 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.8 mm . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.843 0.354 . . . . 61.04 111.159 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.9 160.37 32.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 70.32 111.117 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -50.84 120.44 4.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.43 . . . . 63.12 110.856 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 55.16 35.04 23.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 63.13 110.959 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.82 151.22 19.48 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.747 -0.74 . . . . 52.34 112.466 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.04 148.79 29.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 73.22 110.902 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.2 p -120.35 171.84 8.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 62.33 110.869 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -57.5 -19.22 23.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 63.34 110.852 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.9 -92.09 0.6 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.731 -0.747 . . . . 72.04 112.463 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.71 -18.76 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 70.25 111.165 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.495 HG22 ' H ' ' A' ' 14' ' ' GLN . 63.6 mt -90.31 103.65 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 65.34 111.13 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.458 HD22 ' N ' ' A' ' 13' ' ' ASN . 1.1 m-80 -86.62 30.51 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 63.34 110.927 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.495 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -81.38 66.91 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.483 . . . . 75.12 110.921 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.4 t -111.83 104.68 13.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 74.21 110.864 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 m -43.51 -63.62 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 72.14 110.868 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 2.0 m-20 -130.13 161.71 58.43 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.581 0.705 . . . . 71.31 110.886 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.8 -47.6 0.3 Allowed 'Cis proline' 0 C--O 1.231 0.167 0 C-N-CA 122.722 -1.783 . . . . 72.34 112.343 0.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.794 ' HB3' HD23 ' A' ' 20' ' ' LEU . 67.8 m95 -127.77 -92.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 75.41 110.925 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.794 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -127.98 162.18 27.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.897 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -84.79 104.48 14.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 73.42 110.883 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.514 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 98.4 m -137.64 132.35 17.47 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.558 0.694 . . . . 70.4 111.127 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.514 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.8 172.49 48.88 Favored 'Cis proline' 0 C--N 1.341 0.141 0 C-N-CA 122.646 -1.814 . . . . 71.25 112.333 -0.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 23' ' ' PRO . 53.3 Cg_endo -69.79 -88.66 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.643 2.229 . . . . 61.04 112.342 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -52.5 102.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.2 111.092 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.6 mm 65.17 85.79 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 61.44 111.097 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.02 175.49 42.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 52.41 112.478 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -121.14 138.65 54.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.916 0.388 . . . . 75.34 110.842 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 19.9 p -77.04 128.8 35.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 64.14 110.876 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 73.24 110.981 179.94 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.4 mm . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.849 0.357 . . . . 51.15 111.139 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.78 160.04 33.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 34.11 111.085 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -51.04 120.43 4.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 75.23 110.905 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 55.21 35.08 24.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 64.4 110.919 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.09 150.14 19.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.739 -0.743 . . . . 31.04 112.504 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.18 149.18 24.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.854 0.359 . . . . 75.44 110.831 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.2 p -120.01 171.8 8.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 30.4 110.919 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -57.73 -19.01 24.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 63.31 110.821 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.49 -92.23 0.61 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 72.32 112.471 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.54 -18.63 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 72.23 111.124 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.5 HG22 ' H ' ' A' ' 14' ' ' GLN . 64.5 mt -91.04 103.59 14.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 71.24 111.107 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.462 HD22 ' N ' ' A' ' 13' ' ' ASN . 1.1 m-80 -86.23 30.66 0.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 65.11 110.914 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.5 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -81.38 66.93 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 60.14 110.887 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.5 t -111.77 104.78 13.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 73.02 110.885 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.1 m -43.55 -63.66 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 75.31 110.87 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.502 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 5.6 m-20 -130.01 161.72 58.15 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.612 0.72 . . . . 73.23 110.853 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.79 -48.53 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.17 0 C-N-CA 122.68 -1.8 . . . . 62.23 112.363 0.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . 0.773 ' HB3' HD23 ' A' ' 20' ' ' LEU . 95.2 m95 -126.8 -92.99 0.48 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 74.15 110.925 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.773 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -127.57 162.28 26.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 73.13 110.921 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -85.01 104.36 14.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 73.41 110.892 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.515 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 98.5 m -137.52 132.41 17.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.584 0.707 . . . . 63.53 111.193 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.81 172.39 49.42 Favored 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.713 -1.786 . . . . 74.51 112.325 0.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 23' ' ' PRO . 53.9 Cg_endo -69.72 -88.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.693 2.262 . . . . 34.33 112.327 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.408 HG22 HG12 ' A' ' 26' ' ' ILE . 14.0 mt -52.94 102.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 62.05 111.142 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.408 HG12 HG22 ' A' ' 25' ' ' ILE . 31.8 mm 65.92 85.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 72.15 111.11 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.38 174.13 42.52 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 72.12 112.477 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -119.38 138.69 52.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.893 0.378 . . . . 64.3 110.934 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.451 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 18.1 p -77.02 128.69 34.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 60.23 110.889 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 64.13 110.957 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.9 mm . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.808 0.337 . . . . 64.41 111.153 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.91 160.04 32.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 64.24 111.116 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -53.0 120.52 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 62.21 110.828 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 55.24 32.51 18.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 71.13 110.924 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.27 150.38 18.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.755 -0.736 . . . . 63.45 112.475 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.14 152.35 2.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.363 . . . . 73.31 110.89 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.3 m -116.5 163.81 15.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.886 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -59.51 -16.37 24.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 71.21 110.893 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.8 -90.99 0.63 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 74.24 112.484 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -59.5 -19.94 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.756 0.312 . . . . 74.31 111.078 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.464 HG22 ' HB2' ' A' ' 14' ' ' GLN . 31.9 mt -98.99 103.25 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 75.44 111.16 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -90.34 31.1 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.926 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.464 ' HB2' HG22 ' A' ' 12' ' ' ILE . 1.2 mp0 -81.31 69.88 8.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 63.12 110.898 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.4 t -110.02 104.19 13.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 73.02 110.896 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.4 m -46.66 -72.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 71.21 110.899 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -115.84 161.13 32.24 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.633 0.73 . . . . 75.31 110.867 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.71 -48.76 0.26 Allowed 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.664 -1.807 . . . . 74.11 112.369 -0.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -128.64 -92.46 0.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 75.2 110.886 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.7 pt? -124.45 161.88 25.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 73.34 110.912 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.8 t -92.88 104.8 17.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 64.4 110.872 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.518 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.42 132.26 15.41 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.55 0.69 . . . . 71.54 111.164 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.77 171.18 54.94 Favored 'Cis proline' 0 C--O 1.231 0.151 0 C-N-CA 122.68 -1.8 . . . . 73.32 112.329 -0.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.9 Cg_endo -69.73 -82.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.689 2.259 . . . . 74.44 112.39 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.586 HG22 HG12 ' A' ' 26' ' ' ILE . 5.4 mt -61.34 106.64 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 55.25 111.115 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.586 HG12 HG22 ' A' ' 25' ' ' ILE . 23.3 mm 67.33 82.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 73.22 111.124 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.69 -178.0 39.47 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 62.33 112.452 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -130.21 137.43 50.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 43.33 110.87 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.0 p -77.89 129.31 35.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 72.33 110.915 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 74.32 110.887 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.4 p . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.778 0.323 . . . . 62.41 110.869 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 8' ' ' CYS . 34.5 mm 64.19 130.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 72.32 111.159 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.96 160.15 26.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.441 . . . . 72.12 111.099 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.29 120.54 7.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 73.53 110.872 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 56.14 29.79 15.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 64.03 110.913 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.34 150.64 18.93 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 52.54 112.524 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.09 153.61 2.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.778 0.323 . . . . 70.0 110.938 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.419 ' HA ' HD12 ' A' ' 2' ' ' ILE . 10.2 m -114.96 164.57 13.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 61.24 110.871 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -58.79 -18.11 29.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 70.12 110.808 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.87 -92.64 0.6 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.767 -0.73 . . . . 62.54 112.49 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.81 -17.09 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 74.35 111.151 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 14' ' ' GLN . 19.9 mt -99.22 102.65 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 72.43 111.179 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.88 31.85 1.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 73.02 110.901 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.447 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.3 tp60 -80.11 69.59 6.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 75.12 110.941 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.7 t -110.3 103.55 12.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 62.35 110.879 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.9 m -46.7 -72.59 0.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 61.42 110.838 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.491 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -116.35 162.43 26.46 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.563 0.697 . . . . 64.4 110.883 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.77 -49.01 0.25 Allowed 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.701 -1.791 . . . . 65.35 112.308 0.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 81.4 m95 -127.76 -93.0 0.47 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 74.24 110.923 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.482 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.8 pt? -124.09 162.4 23.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 52.2 110.887 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 15.3 t -93.38 104.28 16.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 44.31 110.846 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.6 m -139.52 130.54 14.63 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.589 0.709 . . . . 71.24 111.14 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.67 170.84 56.11 Favored 'Cis proline' 0 C--N 1.341 0.18 0 C-N-CA 122.7 -1.792 . . . . 74.12 112.383 -0.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 -53.63 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.698 2.265 . . . . 72.24 112.358 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.469 HG22 HG12 ' A' ' 26' ' ' ILE . 2.7 mt -96.17 119.27 44.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.243 -0.435 . . . . 74.11 111.13 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 25' ' ' ILE . 25.4 mm 65.96 65.57 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 73.02 111.173 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.02 179.38 38.29 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.741 . . . . 42.32 112.502 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.516 ' O ' HD12 ' A' ' 30' ' ' LEU . 3.4 m-85 -130.3 140.44 50.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 65.33 110.877 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.5 p -74.54 128.73 36.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 74.33 110.921 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.516 HD12 ' O ' ' A' ' 28' ' ' PHE . 2.1 mp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 75.24 110.898 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.862 0.363 . . . . 54.0 110.897 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.9 mm 64.38 130.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 74.44 111.093 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.97 158.63 30.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 71.03 111.13 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -54.35 120.53 6.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 73.44 110.884 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 55.4 35.18 24.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.449 . . . . 70.3 110.923 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.95 150.59 19.04 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.78 -0.724 . . . . 55.44 112.508 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.55 153.43 5.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.822 0.344 . . . . 72.02 110.888 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.3 m -115.45 166.11 12.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.452 . . . . 70.22 110.881 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.1 -17.98 31.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 72.52 110.937 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.41 -92.64 0.63 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 74.1 112.477 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -61.94 -16.74 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.802 0.335 . . . . 75.3 111.154 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 14' ' ' GLN . 48.4 mt -99.61 102.64 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 71.24 111.114 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.97 31.84 1.21 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 60.24 110.91 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.42 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -80.26 70.81 6.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 72.32 110.879 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.6 t -109.66 103.6 12.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 71.21 110.851 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.0 m -47.58 -65.41 0.57 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 70.41 110.895 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.493 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -123.85 161.63 45.51 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.58 0.705 . . . . 51.13 110.886 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.493 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.73 -49.1 0.24 Allowed 'Cis proline' 0 C--O 1.231 0.158 0 C-N-CA 122.723 -1.782 . . . . 74.43 112.33 0.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.769 ' HB3' HD23 ' A' ' 20' ' ' LEU . 84.6 m95 -128.06 -92.86 0.47 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 72.54 110.93 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.769 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -124.05 162.23 23.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 64.42 110.935 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 9.0 t -93.3 104.57 16.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 74.22 110.874 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.495 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.2 m -138.62 130.15 15.52 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.587 0.708 . . . . 74.31 111.093 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.495 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.4 Cg_endo -69.76 170.73 57.07 Favored 'Cis proline' 0 C--N 1.342 0.187 0 C-N-CA 122.68 -1.8 . . . . 64.54 112.314 -0.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -55.02 0.19 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.706 2.271 . . . . 70.43 112.348 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.503 HG22 HG12 ' A' ' 26' ' ' ILE . 3.1 mt -94.07 118.53 40.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 64.55 111.16 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.503 HG12 HG22 ' A' ' 25' ' ' ILE . 26.1 mm 65.99 63.39 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 63.41 111.125 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.3 178.92 35.25 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 73.11 112.496 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -130.35 139.74 50.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.867 0.365 . . . . 74.12 110.871 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.4 p -75.01 128.35 35.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 53.0 110.905 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 74.22 110.887 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.815 0.341 . . . . 60.11 110.859 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.8 mm 64.31 130.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 72.24 111.127 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.64 159.81 26.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 53.42 111.073 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -55.54 120.54 7.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 61.21 110.878 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 55.92 34.99 24.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 75.31 110.907 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.6 149.93 19.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.724 -0.751 . . . . 45.1 112.46 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.38 153.24 5.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.899 0.38 . . . . 74.34 110.865 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 m -115.41 165.95 12.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 74.33 110.906 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -59.16 -17.67 29.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.187 -0.461 . . . . 71.13 110.886 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.24 -92.62 0.63 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.73 -0.748 . . . . 32.52 112.497 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -61.91 -16.75 16.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.788 0.328 . . . . 73.04 111.169 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 43.9 mt -99.55 102.59 13.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 73.33 111.116 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.94 31.79 1.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 61.32 110.879 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -80.1 70.85 6.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 73.04 110.883 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.3 t -110.04 103.35 12.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 63.4 110.852 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 7.3 m -47.94 -64.97 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 71.4 110.904 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.488 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -124.01 161.87 44.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.589 0.709 . . . . 64.11 110.889 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.488 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.74 -49.19 0.24 Allowed 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.74 -1.775 . . . . 71.31 112.354 0.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -127.55 -92.93 0.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 75.43 110.95 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.7 pt? -124.49 162.01 24.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.252 -0.431 . . . . 53.01 110.969 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 8.0 t -93.13 104.69 16.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 70.01 110.896 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.496 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.1 m -138.99 130.14 15.08 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.559 0.695 . . . . 64.2 111.153 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.0 Cg_endo -69.73 170.75 56.82 Favored 'Cis proline' 0 C--O 1.231 0.149 0 C-N-CA 122.692 -1.795 . . . . 73.34 112.348 -0.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -55.37 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.664 2.243 . . . . 73.34 112.346 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.518 HG22 HG12 ' A' ' 26' ' ' ILE . 3.3 mt -93.32 117.7 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 73.14 111.17 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.518 HG12 HG22 ' A' ' 25' ' ' ILE . 23.0 mm 66.17 65.9 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 61.24 111.143 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.37 179.42 36.8 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 64.22 112.463 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.34 139.64 50.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.881 0.372 . . . . 73.12 110.874 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.7 p -75.04 128.96 36.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.126 -0.488 . . . . 33.4 110.898 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.481 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 72.22 110.89 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.773 0.321 . . . . 74.55 110.886 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.7 mm 64.45 130.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 63.53 111.118 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.28 160.11 31.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 51.33 111.094 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -54.42 120.47 6.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 71.41 110.896 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 55.9 31.62 18.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 74.52 110.945 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.39 150.29 18.84 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 74.32 112.49 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.34 153.19 3.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.825 0.345 . . . . 71.03 110.914 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.0 m -115.3 163.51 15.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 74.42 110.857 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -58.73 -17.91 26.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 64.35 110.887 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.84 -92.26 0.6 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.72 . . . . 44.13 112.494 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -61.7 -16.82 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.89 0.376 . . . . 51.45 111.158 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.434 HG22 ' HB2' ' A' ' 14' ' ' GLN . 27.7 mt -100.33 102.77 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 74.22 111.132 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.35 31.83 1.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 61.5 110.859 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.434 ' HB2' HG22 ' A' ' 12' ' ' ILE . 1.2 mp0 -79.34 69.56 5.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 74.23 110.893 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.2 t -110.44 103.86 12.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 54.11 110.912 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 66.3 m -47.27 -72.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 62.01 110.895 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.492 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.81 162.31 27.87 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.595 0.712 . . . . 74.03 110.875 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.492 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.74 -49.05 0.24 Allowed 'Cis proline' 0 C--N 1.341 0.138 0 C-N-CA 122.681 -1.799 . . . . 72.35 112.321 0.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.769 ' HB3' HD23 ' A' ' 20' ' ' LEU . 49.3 m95 -128.04 -92.9 0.46 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 62.42 110.936 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.769 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -123.9 162.35 23.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.428 . . . . 73.34 110.923 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 9.0 t -93.33 104.36 16.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 64.23 110.842 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.498 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.9 m -138.75 130.55 15.53 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.606 0.717 . . . . 65.42 111.104 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.77 170.82 56.64 Favored 'Cis proline' 0 C--N 1.342 0.202 0 C-N-CA 122.706 -1.789 . . . . 50.22 112.331 -0.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 -54.41 0.22 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.665 2.244 . . . . 73.41 112.33 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.513 HG22 HG12 ' A' ' 26' ' ' ILE . 3.3 mt -94.54 118.32 40.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 74.14 111.165 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.513 HG12 HG22 ' A' ' 25' ' ' ILE . 25.5 mm 65.95 66.61 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 45.41 111.157 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.05 179.21 38.41 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.749 -0.739 . . . . 60.1 112.466 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -130.46 140.21 50.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 75.24 110.861 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.445 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.3 p -74.55 128.6 35.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 72.54 110.906 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 71.13 110.937 179.984 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.808 0.337 . . . . 62.52 110.882 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 8' ' ' CYS . 34.0 mm 64.32 130.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 53.51 111.124 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.41 160.16 30.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 73.04 111.087 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -55.74 120.55 7.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.455 . . . . 44.34 110.886 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 55.58 30.55 15.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 73.22 110.912 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.52 150.5 18.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.76 -0.733 . . . . 61.31 112.478 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.91 153.62 2.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.835 0.35 . . . . 73.01 110.914 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.417 ' HA ' HD12 ' A' ' 2' ' ' ILE . 13.8 m -114.89 164.84 13.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 73.03 110.9 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -58.65 -18.46 30.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 70.22 110.847 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.55 -92.57 0.6 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.731 -0.747 . . . . 52.44 112.481 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -62.13 -16.47 16.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.74 0.305 . . . . 72.31 111.091 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.454 HG22 ' H ' ' A' ' 14' ' ' GLN . 64.3 mt -100.25 102.81 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 64.2 111.11 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -91.7 31.82 1.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 42.43 110.905 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.454 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.6 tp60 -80.13 69.76 6.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.919 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.5 t -110.1 103.94 12.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 74.33 110.91 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.4 m -46.16 -73.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 74.1 110.941 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.491 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -115.57 162.39 25.27 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.601 0.715 . . . . 64.41 110.912 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.491 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.2 Cg_endo -69.77 -49.35 0.23 Allowed 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.663 -1.807 . . . . 72.41 112.322 0.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -128.11 -93.06 0.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 74.14 110.955 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.55 162.71 21.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 52.24 110.917 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 18.4 t -94.45 104.1 16.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 65.53 110.897 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.502 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.3 m -138.69 131.09 15.81 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.585 0.707 . . . . 61.05 111.162 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.7 170.72 56.86 Favored 'Cis proline' 0 C--O 1.231 0.172 0 C-N-CA 122.711 -1.787 . . . . 71.13 112.357 -0.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -54.18 0.23 Allowed 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.69 2.26 . . . . 63.51 112.373 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.495 HG22 HG12 ' A' ' 26' ' ' ILE . 3.0 mt -95.44 118.35 41.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 61.23 111.17 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.495 HG12 HG22 ' A' ' 25' ' ' ILE . 22.0 mm 66.4 63.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.47 . . . . 71.3 111.152 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.36 178.82 35.34 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 74.31 112.48 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -130.45 140.24 50.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.875 0.369 . . . . 70.52 110.89 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.0 p -74.61 128.56 35.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 73.11 110.905 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.498 ' O ' HD12 ' A' ' 30' ' ' LEU . 1.4 pp . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 62.34 110.917 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.834 0.349 . . . . 72.13 110.885 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.3 mm 64.34 130.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 74.23 111.149 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.46 160.11 33.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 64.53 111.101 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -52.1 120.55 5.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 61.34 110.877 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 54.86 34.02 21.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.04 110.944 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.19 150.76 19.0 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.743 -0.741 . . . . 74.11 112.513 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.89 151.89 3.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.837 0.351 . . . . 64.44 110.92 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.7 m -117.21 163.09 16.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 61.43 110.888 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -59.26 -16.59 22.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 74.33 110.853 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.01 -90.66 0.64 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.75 . . . . 64.14 112.512 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.06 -19.51 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.796 0.331 . . . . 75.43 111.127 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.501 HG22 ' HB2' ' A' ' 14' ' ' GLN . 33.2 mt -98.7 103.42 14.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 74.11 111.122 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.34 31.09 0.92 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.446 . . . . 62.1 110.873 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.501 ' HB2' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -81.61 69.87 8.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 73.42 110.927 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.1 t -110.05 104.41 13.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 72.31 110.906 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 26.6 m -46.68 -68.97 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 54.12 110.885 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -121.06 160.91 43.18 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.565 0.698 . . . . 74.34 110.884 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.8 Cg_endo -69.75 -48.69 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.144 0 C-N-CA 122.705 -1.79 . . . . 61.15 112.352 0.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.75 ' HB3' HD23 ' A' ' 20' ' ' LEU . 95.3 m95 -128.98 -92.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 75.14 110.94 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.75 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -124.33 161.98 24.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 73.31 110.947 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 4.8 t -92.92 104.5 16.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 52.21 110.921 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.522 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -138.93 132.46 16.04 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.587 0.708 . . . . 74.1 111.145 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.78 170.78 56.91 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.681 -1.8 . . . . 60.15 112.366 -0.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.405 ' HG2' HD12 ' A' ' 25' ' ' ILE . 53.7 Cg_endo -69.81 -87.26 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.67 2.247 . . . . 70.04 112.326 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.508 HG22 HG12 ' A' ' 26' ' ' ILE . 1.8 mp -54.7 105.75 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 75.23 111.146 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 25' ' ' ILE . 25.9 mm 65.84 84.09 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 72.43 111.14 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.71 -178.16 39.05 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.761 -0.733 . . . . 73.02 112.502 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -130.14 136.97 49.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.927 0.394 . . . . 64.4 110.837 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 13.7 p -78.29 129.12 34.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 64.13 110.911 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 74.43 110.935 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.837 0.351 . . . . 75.44 110.914 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.4 mm 64.26 130.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.449 . . . . 75.34 111.109 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.61 158.56 31.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 74.41 111.083 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -53.0 120.47 5.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.218 -0.446 . . . . 74.03 110.858 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 54.9 35.3 24.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 71.54 110.877 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.67 149.94 19.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.751 -0.738 . . . . 73.03 112.501 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.53 152.15 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.323 . . . . 74.41 110.907 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.9 m -117.04 165.75 13.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 65.22 110.893 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -60.43 -16.09 32.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 72.13 110.843 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.36 -90.97 0.7 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.718 -0.753 . . . . 53.15 112.489 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -58.87 -20.91 18.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 74.23 111.127 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 14' ' ' GLN . 56.4 mt -98.94 103.01 14.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 72.23 111.14 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -90.29 30.82 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 35.44 110.865 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.452 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -81.73 70.49 8.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 64.15 110.864 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.4 t -108.85 104.13 13.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.209 -0.45 . . . . 60.33 110.87 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.0 m -46.86 -68.31 0.2 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 75.21 110.909 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.503 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -120.89 160.38 45.05 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.599 0.714 . . . . 55.31 110.861 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.8 -48.6 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.165 0 C-N-CA 122.677 -1.801 . . . . 71.21 112.332 0.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.758 ' HB3' HD23 ' A' ' 20' ' ' LEU . 76.9 m95 -128.41 -92.47 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 74.33 110.929 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.758 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -126.09 161.92 26.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.276 -0.42 . . . . 63.44 110.942 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.408 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 6.0 t -92.03 104.64 17.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 70.31 110.866 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.519 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.7 m -139.24 131.53 15.35 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.59 0.71 . . . . 71.21 111.131 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.76 170.79 56.76 Favored 'Cis proline' 0 C--N 1.341 0.152 0 C-N-CA 122.72 -1.783 . . . . 51.32 112.369 -0.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -87.48 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.667 2.245 . . . . 74.12 112.344 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.534 HG22 HG12 ' A' ' 26' ' ' ILE . 1.8 mp -55.32 106.89 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 62.34 111.101 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.534 HG12 HG22 ' A' ' 25' ' ' ILE . 25.1 mm 66.09 84.16 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 72.34 111.147 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.59 -179.05 40.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.714 -0.755 . . . . 74.32 112.484 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.531 ' O ' HD12 ' A' ' 30' ' ' LEU . 1.6 m-85 -129.14 137.06 50.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 71.12 110.858 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.408 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 18.5 p -78.36 129.16 34.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 64.0 110.926 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 28' ' ' PHE . 4.6 mp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 64.54 110.907 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.853 0.358 . . . . 64.31 110.887 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.2 mm 64.06 130.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 71.25 111.154 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.87 158.52 34.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 53.04 111.118 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -52.15 120.5 5.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 75.1 110.87 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 55.28 35.28 24.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 74.22 110.93 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.93 150.25 19.26 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.741 -0.742 . . . . 73.52 112.531 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 152.42 3.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.801 0.334 . . . . 72.33 110.892 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.7 m -116.92 165.24 13.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 74.31 110.908 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.02 -16.45 31.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 72.13 110.879 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.68 -91.08 0.7 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.75 -0.738 . . . . 72.21 112.459 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -59.43 -19.41 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.34 . . . . 74.25 111.191 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.448 HG22 ' H ' ' A' ' 14' ' ' GLN . 54.4 mt -100.24 103.13 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 72.13 111.138 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -90.34 30.98 1.05 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 74.04 110.867 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.448 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.1 tp60 -81.52 70.86 8.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 74.4 110.91 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -109.21 104.09 13.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 72.44 110.899 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.0 m -47.39 -65.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 73.51 110.873 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.5 OUTLIER -123.96 161.41 46.98 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.573 0.701 . . . . 65.51 110.912 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.0 Cg_endo -69.79 -48.66 0.26 Allowed 'Cis proline' 0 C--O 1.231 0.159 0 C-N-CA 122.675 -1.802 . . . . 64.01 112.337 0.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.801 ' HB3' HD23 ' A' ' 20' ' ' LEU . 20.7 m95 -127.82 -92.55 0.48 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.235 -0.439 . . . . 74.01 110.912 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.801 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -125.86 161.94 26.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 64.03 110.913 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.8 t -92.41 104.74 17.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 65.4 110.859 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.515 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.4 m -138.87 131.45 15.74 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.607 0.717 . . . . 74.15 111.154 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.1 Cg_endo -69.74 171.12 55.07 Favored 'Cis proline' 0 C--N 1.341 0.173 0 C-N-CA 122.727 -1.781 . . . . 70.13 112.359 -0.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.9 Cg_endo -69.8 -83.5 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.692 2.261 . . . . 63.23 112.335 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.602 HG22 HG12 ' A' ' 26' ' ' ILE . 5.8 mt -60.41 106.76 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.259 -0.428 . . . . 71.11 111.154 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.602 HG12 HG22 ' A' ' 25' ' ' ILE . 22.5 mm 67.63 84.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 70.11 111.103 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.63 -178.58 41.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 65.43 112.476 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -129.3 137.18 50.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.872 0.367 . . . . 65.1 110.892 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.9 p -78.16 128.91 34.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 75.3 110.893 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.408 HD23 ' N ' ' A' ' 30' ' ' LEU . 1.4 pt? . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 64.33 110.922 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.76 0.314 . . . . 74.34 110.87 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.0 mm 64.11 130.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 65.41 111.172 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.37 158.67 33.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 52.2 111.091 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -53.01 120.64 6.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 70.25 110.862 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 55.58 35.34 24.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 72.52 110.966 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.81 150.65 19.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.736 -0.745 . . . . 72.25 112.491 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.18 152.53 3.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.836 0.351 . . . . 74.21 110.903 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.6 m -117.0 165.32 13.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 35.45 110.855 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -59.89 -16.54 30.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 53.24 110.853 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.8 -90.93 0.71 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.716 -0.754 . . . . 52.22 112.526 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.52 -19.47 16.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 75.31 111.116 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 14' ' ' GLN . 52.4 mt -101.26 103.14 14.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 54.15 111.117 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.65 31.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 61.22 110.856 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.447 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.2 tp60 -81.34 69.84 8.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 73.34 110.918 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.7 t -109.77 104.03 12.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 71.01 110.873 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.4 m -47.22 -70.78 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 73.24 110.909 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -117.36 160.7 36.68 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.566 0.698 . . . . 70.42 110.849 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.76 -48.69 0.26 Allowed 'Cis proline' 0 C--O 1.231 0.167 0 C-N-CA 122.743 -1.774 . . . . 75.44 112.29 0.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.765 ' HB3' HD23 ' A' ' 20' ' ' LEU . 69.9 m95 -128.94 -92.47 0.46 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 73.54 110.901 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.765 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -124.56 162.01 24.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.252 -0.431 . . . . 75.32 110.945 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 8.2 t -93.06 104.58 16.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 72.21 110.862 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.52 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.9 m -139.18 131.92 15.56 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.569 0.7 . . . . 72.53 111.135 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.75 171.15 54.97 Favored 'Cis proline' 0 C--N 1.342 0.186 0 C-N-CA 122.64 -1.817 . . . . 70.3 112.384 -0.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -85.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.69 2.26 . . . . 71.02 112.364 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.593 HG22 HG12 ' A' ' 26' ' ' ILE . 6.1 mt -59.11 107.38 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 73.34 111.115 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.593 HG12 HG22 ' A' ' 25' ' ' ILE . 25.8 mm 66.9 83.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 75.25 111.114 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.89 -178.14 40.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.764 -0.732 . . . . 75.04 112.48 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -130.01 137.39 50.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 75.02 110.865 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 17.0 p -78.24 128.93 34.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 72.01 110.888 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.121 -0.49 . . . . 72.2 110.912 179.982 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.804 0.335 . . . . 74.51 110.872 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.4 mm 64.21 130.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 73.54 111.134 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.44 160.04 28.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 65.45 111.138 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -55.06 120.68 7.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.252 -0.431 . . . . 72.14 110.856 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 55.86 35.36 25.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 64.1 110.918 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.03 152.54 19.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.797 -0.716 . . . . 71.2 112.501 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.7 152.5 5.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.888 0.375 . . . . 64.34 110.861 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.0 m -116.94 165.07 13.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 70.44 110.882 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -59.69 -16.67 28.56 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 75.33 110.903 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.23 -91.15 0.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 71.51 112.529 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.59 -19.25 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.791 0.329 . . . . 63.52 111.124 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.47 HG22 ' H ' ' A' ' 14' ' ' GLN . 2.7 mp -100.96 103.08 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 73.22 111.161 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -90.1 30.96 1.02 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 63.32 110.894 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.47 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -81.22 69.58 7.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 72.4 110.897 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.3 t -108.96 103.97 13.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 72.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.1 m -47.57 -68.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 62.25 110.868 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.489 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -120.12 161.49 38.41 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.577 0.704 . . . . 73.2 110.903 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.489 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.8 -48.43 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.147 0 C-N-CA 122.635 -1.819 . . . . 71.43 112.359 0.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 17.2 m95 -128.08 -92.56 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 74.54 110.902 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.481 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.8 pt? -125.9 161.8 26.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 65.53 110.945 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.412 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 7.5 t -92.35 104.42 16.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 75.44 110.911 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 2.5 m -139.55 131.61 15.02 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.545 0.688 . . . . 64.31 111.143 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.79 171.1 55.38 Favored 'Cis proline' 0 C--N 1.341 0.181 0 C-N-CA 122.645 -1.814 . . . . 42.4 112.354 -0.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -85.74 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.708 2.272 . . . . 71.43 112.349 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.61 HG22 HG12 ' A' ' 26' ' ' ILE . 6.3 mt -58.45 107.17 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 71.24 111.134 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.61 HG12 HG22 ' A' ' 25' ' ' ILE . 23.8 mm 67.41 84.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.138 -0.483 . . . . 72.32 111.139 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.74 -178.07 41.15 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.719 -0.753 . . . . 64.12 112.456 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -130.02 137.32 50.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.899 0.381 . . . . 75.32 110.89 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 18.4 p -78.17 129.46 35.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 60.13 110.902 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 65.44 110.939 179.952 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.803 0.335 . . . . 55.3 110.914 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.2 mm 64.22 130.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 72.03 111.118 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.16 157.92 34.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 64.54 111.12 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -52.58 120.6 5.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.216 -0.447 . . . . 75.14 110.884 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 55.81 35.38 25.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 74.11 110.926 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.83 150.48 19.05 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 63.33 112.479 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.29 152.53 3.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 71.13 110.927 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.1 m -116.75 164.94 13.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 71.24 110.874 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.48 -17.22 29.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.181 -0.463 . . . . 53.44 110.852 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.84 -91.34 0.68 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 63.34 112.489 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.3 pp -60.08 -18.9 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 74.4 111.138 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.444 HG22 ' H ' ' A' ' 14' ' ' GLN . 53.3 mt -100.38 103.15 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 71.55 111.123 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -90.39 30.95 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 71.43 110.845 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.444 ' H ' HG22 ' A' ' 12' ' ' ILE . 10.5 tp-100 -81.31 69.89 8.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 72.15 110.926 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.1 t -109.06 103.91 13.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 73.03 110.907 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.6 m -47.5 -68.26 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 71.13 110.929 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.496 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.1 OUTLIER -120.31 160.84 41.94 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.568 0.699 . . . . 74.45 110.841 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.0 Cg_endo -69.74 -48.73 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.167 0 C-N-CA 122.698 -1.793 . . . . 65.33 112.347 -0.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.779 ' HB3' HD23 ' A' ' 20' ' ' LEU . 54.9 m95 -128.05 -92.53 0.47 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 75.41 110.924 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.779 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -125.88 161.82 26.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 73.33 110.923 179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 7.6 t -91.92 104.43 16.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 53.35 110.885 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 3.6 m -139.1 131.31 15.42 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.569 0.699 . . . . 62.23 111.163 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.79 171.06 55.6 Favored 'Cis proline' 0 C--N 1.341 0.169 0 C-N-CA 122.672 -1.803 . . . . 74.33 112.351 0.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.4 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.9 Cg_endo -69.77 -85.09 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.698 2.265 . . . . 62.12 112.339 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.601 HG22 HG12 ' A' ' 26' ' ' ILE . 5.2 mt -59.24 107.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 75.35 111.105 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.601 HG12 HG22 ' A' ' 25' ' ' ILE . 22.8 mm 67.42 83.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 73.24 111.095 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -169.61 -178.46 40.78 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.758 -0.734 . . . . 41.35 112.49 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -129.87 137.25 50.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 74.44 110.818 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 18.2 p -77.98 128.92 34.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.486 . . . . 74.11 110.889 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 75.15 110.879 -179.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.785 0.326 . . . . 61.54 110.87 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.7 mm 64.29 129.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.475 . . . . 54.32 111.142 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.5 159.92 9.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 72.12 111.123 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -55.4 120.02 6.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 72.21 110.851 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 51.84 34.28 13.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 74.53 110.923 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.25 153.03 19.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 71.14 112.496 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.62 153.13 8.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.84 0.352 . . . . 64.41 110.893 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.8 m -113.71 170.7 8.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 74.13 110.861 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.21 -16.88 23.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.478 . . . . 74.32 110.903 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.2 -89.91 0.61 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.759 -0.734 . . . . 74.14 112.451 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -58.61 -19.88 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.798 0.333 . . . . 55.23 111.135 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.49 HG22 ' HB2' ' A' ' 14' ' ' GLN . 34.9 mt -101.25 103.17 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 64.25 111.106 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.15 30.81 0.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 75.21 110.875 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HB2' HG22 ' A' ' 12' ' ' ILE . 1.2 mp0 -81.56 69.41 8.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 64.45 110.936 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.7 t -110.06 104.24 13.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 73.32 110.879 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.5 m -47.14 -72.53 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 55.22 110.863 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -115.1 161.02 31.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.55 0.691 . . . . 70.21 110.882 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.3 Cg_endo -69.74 -48.43 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.179 0 C-N-CA 122.661 -1.808 . . . . 51.45 112.35 -0.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.773 ' HB3' HD23 ' A' ' 20' ' ' LEU . 75.9 m95 -129.23 -92.54 0.45 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 72.11 110.934 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.773 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -123.41 162.0 23.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 73.03 110.972 179.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.0 t -93.35 104.43 16.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 73.35 110.827 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.522 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.71 132.49 15.19 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.599 0.714 . . . . 74.24 111.12 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.522 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.76 171.07 55.4 Favored 'Cis proline' 0 C--O 1.232 0.178 0 C-N-CA 122.702 -1.791 . . . . 75.43 112.299 -0.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.78 -85.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.704 2.269 . . . . 72.41 112.373 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.618 HG22 HG12 ' A' ' 26' ' ' ILE . 8.1 mt -59.08 108.41 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 74.54 111.13 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.618 HG12 HG22 ' A' ' 25' ' ' ILE . 27.1 mm 66.04 78.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 72.53 111.187 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.11 -179.02 37.37 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.745 -0.74 . . . . 53.24 112.475 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -130.13 137.39 50.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.37 . . . . 75.21 110.878 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.8 p -78.01 128.82 34.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 52.23 110.875 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.187 -0.46 . . . . 71.32 110.912 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.794 0.33 . . . . 73.32 110.874 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 27.7 mm 64.26 130.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 65.04 111.147 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -60.4 160.09 9.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 44.41 111.062 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.84 120.14 7.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 72.22 110.844 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 54.31 35.17 22.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 64.54 110.947 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.3 156.81 19.52 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.737 -0.744 . . . . 73.41 112.433 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.21 152.79 27.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.836 0.351 . . . . 74.52 110.867 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.2 m -113.77 170.34 8.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.898 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -59.72 -16.41 26.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 75.31 110.849 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.22 -89.67 0.6 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.719 -0.753 . . . . 65.12 112.49 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -58.34 -20.55 15.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 72.54 111.138 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.453 HG22 ' H ' ' A' ' 14' ' ' GLN . 53.3 mt -100.34 103.13 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 70.42 111.136 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.55 30.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 75.33 110.91 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.453 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -81.78 69.39 8.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 63.41 110.893 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 t -110.19 104.2 13.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 53.35 110.87 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.9 m -48.05 -70.92 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 74.31 110.926 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.498 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.16 160.83 34.1 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.591 0.71 . . . . 52.15 110.903 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.498 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 52.9 Cg_endo -69.82 -48.35 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.154 0 C-N-CA 122.658 -1.809 . . . . 52.55 112.307 0.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -128.58 -92.65 0.46 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 72.53 110.915 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.497 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.9 pt? -124.62 161.89 25.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 64.31 110.914 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 4.6 t -93.06 104.8 16.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 75.33 110.879 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.525 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.6 m -141.4 132.69 13.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.522 0.677 . . . . 60.0 111.2 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 22' ' ' THR . 54.2 Cg_endo -69.75 170.83 56.54 Favored 'Cis proline' 0 C--O 1.232 0.18 0 C-N-CA 122.712 -1.787 . . . . 74.54 112.361 -0.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 -87.43 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.686 2.257 . . . . 75.1 112.359 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.549 HG22 HG12 ' A' ' 26' ' ' ILE . 1.9 mp -55.85 107.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 70.01 111.109 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.549 HG12 HG22 ' A' ' 25' ' ' ILE . 25.4 mm 65.3 82.96 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 64.41 111.123 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.84 -178.73 39.52 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.764 -0.732 . . . . 72.13 112.483 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -129.99 137.34 50.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.936 0.398 . . . . 72.31 110.884 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.416 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.7 p -77.91 129.5 35.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.129 -0.487 . . . . 64.12 110.926 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 pt? . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.459 . . . . 75.34 110.91 179.975 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.767 0.317 . . . . 72.4 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 31.1 mm 64.5 130.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 64.41 111.106 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.7 160.17 32.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 55.22 111.091 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -53.93 120.76 6.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 70.31 110.869 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 55.72 32.4 19.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 73.5 110.878 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.21 152.0 19.2 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.796 -0.716 . . . . 73.05 112.501 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.4 151.67 2.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.804 0.335 . . . . 62.43 110.876 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 12.3 m -117.19 165.31 13.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 72.45 110.844 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.73 -16.25 25.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 74.43 110.907 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.61 -91.33 0.66 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.701 -0.761 . . . . 62.15 112.482 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -61.61 -17.34 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 74.22 111.093 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.422 HG22 ' H ' ' A' ' 14' ' ' GLN . 34.2 mt -99.42 103.4 14.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 71.15 111.095 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.552 HD22 ' N ' ' A' ' 13' ' ' ASN . 1.2 m-80 -88.17 31.77 0.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 61.23 110.853 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.422 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.1 tp60 -80.75 69.23 7.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.24 110.943 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.3 t -110.45 104.35 13.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 31.12 110.862 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 18.4 m -45.57 -64.86 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 64.13 110.857 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.49 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 2.0 m-20 -125.82 162.07 47.39 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.618 0.723 . . . . 71.24 110.856 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.49 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.78 -48.91 0.25 Allowed 'Cis proline' 0 C--N 1.342 0.207 0 C-N-CA 122.639 -1.817 . . . . 65.33 112.345 0.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.788 ' HB3' HD23 ' A' ' 20' ' ' LEU . 66.9 m95 -130.1 -92.73 0.43 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.229 -0.442 . . . . 73.41 110.927 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.788 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -119.59 162.57 18.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.26 -0.427 . . . . 70.43 110.915 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.9 t -94.86 104.56 16.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 50.53 110.899 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.526 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.3 m -138.12 133.76 17.52 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.635 0.731 . . . . 54.55 111.12 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.526 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.77 171.62 52.84 Favored 'Cis proline' 0 C--N 1.342 0.192 0 C-N-CA 122.715 -1.786 . . . . 74.33 112.331 -0.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -86.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.688 2.259 . . . . 75.5 112.347 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.591 HG22 HG12 ' A' ' 26' ' ' ILE . 5.4 mt -58.69 106.57 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.453 . . . . 74.43 111.114 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.591 HG12 HG22 ' A' ' 25' ' ' ILE . 23.2 mm 67.43 83.8 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 71.25 111.082 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.88 -177.37 39.14 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.736 -0.745 . . . . 61.2 112.493 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -130.14 137.5 50.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.852 0.358 . . . . 75.11 110.929 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.428 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 13.4 p -77.87 128.53 34.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 73.1 110.846 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.411 ' HA ' ' HG3' ' A' ' 18' ' ' PRO . 1.6 pt? . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 62.54 110.886 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.847 0.356 . . . . 73.51 110.88 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 8' ' ' CYS . 35.6 mm 64.56 130.67 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 73.13 111.094 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.11 160.4 26.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 64.31 111.125 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -56.34 120.79 8.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 64.31 110.854 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 55.94 30.01 15.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.466 . . . . 75.31 110.942 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.39 149.97 18.76 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.744 -0.741 . . . . 40.23 112.439 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 152.32 7.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.839 0.352 . . . . 52.44 110.892 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.417 ' HA ' HD12 ' A' ' 2' ' ' ILE . 6.4 m -114.27 170.36 8.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 72.23 110.889 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -59.65 -16.33 25.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.852 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.52 -89.49 0.58 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.733 . . . . 72.13 112.474 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -58.84 -19.36 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.794 0.33 . . . . 73.13 111.125 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.435 HG22 ' H ' ' A' ' 14' ' ' GLN . 42.4 mt -100.63 103.5 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 75.23 111.082 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -88.87 30.98 0.88 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 72.13 110.915 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.435 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.1 tp60 -81.57 69.29 8.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 41.42 110.907 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.9 t -110.46 104.73 13.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 55.33 110.871 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.9 m -47.28 -72.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 74.12 110.845 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.42 161.34 32.15 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.646 0.736 . . . . 75.3 110.855 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.3 Cg_endo -69.81 -48.52 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.178 0 C-N-CA 122.669 -1.804 . . . . 73.43 112.301 0.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.799 ' HB3' HD23 ' A' ' 20' ' ' LEU . 57.9 m95 -128.91 -92.63 0.45 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.226 -0.443 . . . . 71.42 110.868 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.799 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -123.99 162.07 24.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 70.11 110.898 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 3.8 t -93.12 104.19 16.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 74.11 110.922 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.525 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.54 132.78 15.48 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.588 0.709 . . . . 73.2 111.141 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.5 Cg_endo -69.73 170.77 56.74 Favored 'Cis proline' 0 C--N 1.341 0.183 0 C-N-CA 122.713 -1.786 . . . . 54.0 112.343 -0.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -87.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.697 2.265 . . . . 71.34 112.385 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.543 HG22 HG12 ' A' ' 26' ' ' ILE . 1.9 mp -55.13 107.03 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 64.44 111.103 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.543 HG12 HG22 ' A' ' 25' ' ' ILE . 26.0 mm 65.4 83.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 63.41 111.173 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.7 -178.99 39.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.688 -0.768 . . . . 75.51 112.481 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -130.17 137.84 50.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.951 0.405 . . . . 72.14 110.854 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 12.3 p -78.15 129.29 34.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 63.14 110.887 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 53.05 110.94 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.842 0.353 . . . . 63.41 110.937 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.6 mm 64.1 130.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 53.34 111.113 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.73 158.07 33.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 64.12 111.093 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -53.12 120.79 6.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.18 -0.463 . . . . 72.13 110.848 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 55.69 35.27 24.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 71.12 110.955 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.1 150.5 18.97 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.75 -0.738 . . . . 64.41 112.5 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.69 152.48 2.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.812 0.339 . . . . 74.53 110.895 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 13.7 m -116.87 165.19 13.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 73.12 110.858 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -59.67 -16.39 26.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 71.34 110.868 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.14 -90.93 0.73 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 43.43 112.516 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.39 -19.14 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.874 0.369 . . . . 53.45 111.199 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.447 HG22 ' H ' ' A' ' 14' ' ' GLN . 49.1 mt -102.04 103.3 14.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.156 -0.475 . . . . 63.41 111.114 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.58 31.27 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.03 110.916 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.447 ' H ' HG22 ' A' ' 12' ' ' ILE . 1.4 tp60 -81.26 69.76 7.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.111 -0.495 . . . . 75.43 110.893 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.2 t -109.99 103.99 12.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 70.23 110.848 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.1 m -47.62 -70.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 75.45 110.886 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.494 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -117.85 161.03 36.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 74.54 110.902 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.494 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.77 -48.66 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.171 0 C-N-CA 122.698 -1.793 . . . . 63.22 112.317 0.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -128.75 -92.6 0.46 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 64.21 110.923 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.485 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.8 pt? -124.5 161.93 25.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 73.43 110.926 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.409 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 11.0 t -93.19 104.74 16.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 70.21 110.876 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.9 m -139.35 131.9 15.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.559 0.695 . . . . 73.41 111.12 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.8 Cg_endo -69.7 171.15 54.74 Favored 'Cis proline' 0 C--N 1.341 0.159 0 C-N-CA 122.706 -1.789 . . . . 74.11 112.336 -0.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.7 Cg_endo -69.76 -83.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.686 2.257 . . . . 74.23 112.359 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.609 HG22 HG12 ' A' ' 26' ' ' ILE . 6.5 mt -60.67 107.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 63.22 111.123 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.609 HG12 HG22 ' A' ' 25' ' ' ILE . 23.6 mm 67.14 83.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 65.13 111.178 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -168.97 -177.87 40.04 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.731 -0.747 . . . . 72.13 112.49 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -130.21 137.41 50.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.402 . . . . 74.35 110.906 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.0 p -77.98 129.4 35.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 72.13 110.916 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.557 ' O ' HD12 ' A' ' 30' ' ' LEU . 3.2 pp . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 73.2 110.903 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.825 0.345 . . . . 62.02 110.866 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.8 mm 64.35 130.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 73.32 111.112 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.26 160.04 32.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 74.3 111.099 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.03 120.3 5.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 62.32 110.862 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 53.58 33.99 17.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 55.03 110.892 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.33 152.61 19.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.712 -0.756 . . . . 75.41 112.476 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.66 152.62 3.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.353 . . . . 75.02 110.894 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.6 m -116.36 164.13 14.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.454 . . . . 43.14 110.892 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -16.42 28.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.41 110.867 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.35 -90.93 0.64 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.772 -0.728 . . . . 64.22 112.444 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.22 -19.87 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.339 . . . . 75.54 111.172 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.459 HG22 ' HB2' ' A' ' 14' ' ' GLN . 52.8 mt -99.56 103.16 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 62.02 111.105 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.92 31.05 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 63.21 110.886 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.459 ' HB2' HG22 ' A' ' 12' ' ' ILE . 1.6 mp0 -81.5 70.25 8.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 74.34 110.961 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.9 t -110.02 104.45 13.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 62.25 110.878 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.1 m -45.97 -74.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 75.33 110.867 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -114.84 161.02 31.22 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.555 0.693 . . . . 64.33 110.925 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.9 Cg_endo -69.78 -48.7 0.26 Allowed 'Cis proline' 0 C--N 1.341 0.155 0 C-N-CA 122.671 -1.804 . . . . 64.01 112.326 0.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.766 ' HB3' HD23 ' A' ' 20' ' ' LEU . 78.1 m95 -129.05 -92.52 0.45 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 75.21 110.967 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.766 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -123.91 162.3 23.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 75.12 110.917 179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 7.9 t -93.41 104.75 16.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 72.44 110.907 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.52 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.0 132.37 15.92 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.602 0.715 . . . . 72.45 111.118 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.52 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.81 171.19 55.07 Favored 'Cis proline' 0 C--N 1.342 0.191 0 C-N-CA 122.701 -1.791 . . . . 72.32 112.287 0.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.7 Cg_endo -69.76 -84.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.655 2.237 . . . . 75.1 112.375 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.597 HG22 HG12 ' A' ' 26' ' ' ILE . 5.1 mt -59.45 106.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 71.23 111.149 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.597 HG12 HG22 ' A' ' 25' ' ' ILE . 20.0 mm 68.08 85.26 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 64.05 111.094 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -170.71 -178.12 41.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 54.32 112.469 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -130.18 137.64 50.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.857 0.36 . . . . 74.52 110.926 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 14.9 p -77.93 128.98 34.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 75.41 110.818 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.488 ' O ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 73.42 110.962 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.3 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.774 0.321 . . . . 74.11 110.882 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.8 mm 64.3 130.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 61.04 111.159 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.9 160.37 32.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 70.32 111.117 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -50.84 120.44 4.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.255 -0.43 . . . . 63.12 110.856 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 55.16 35.04 23.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.177 -0.465 . . . . 63.13 110.959 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.82 151.22 19.48 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.747 -0.74 . . . . 52.34 112.466 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.04 148.79 29.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 73.22 110.902 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.2 p -120.35 171.84 8.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 62.33 110.869 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -57.5 -19.22 23.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 63.34 110.852 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.9 -92.09 0.6 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.731 -0.747 . . . . 72.04 112.463 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.71 -18.76 15.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 70.25 111.165 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.495 HG22 ' H ' ' A' ' 14' ' ' GLN . 63.6 mt -90.31 103.65 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 65.34 111.13 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.458 HD22 ' N ' ' A' ' 13' ' ' ASN . 1.1 m-80 -86.62 30.51 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.452 . . . . 63.34 110.927 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.495 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.5 OUTLIER -81.38 66.91 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.483 . . . . 75.12 110.921 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.4 t -111.83 104.68 13.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 74.21 110.864 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 m -43.51 -63.62 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.167 -0.47 . . . . 72.14 110.868 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.499 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 2.0 m-20 -130.13 161.71 58.43 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.581 0.705 . . . . 71.31 110.886 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.7 Cg_endo -69.8 -47.6 0.3 Allowed 'Cis proline' 0 C--O 1.231 0.167 0 C-N-CA 122.722 -1.783 . . . . 72.34 112.343 0.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.794 ' HB3' HD23 ' A' ' 20' ' ' LEU . 67.8 m95 -127.77 -92.97 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 75.41 110.925 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.794 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -127.98 162.18 27.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.897 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.446 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -84.79 104.48 14.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 73.42 110.883 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.514 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 98.4 m -137.64 132.35 17.47 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.558 0.694 . . . . 70.4 111.127 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.514 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.6 Cg_endo -69.8 172.49 48.88 Favored 'Cis proline' 0 C--N 1.341 0.141 0 C-N-CA 122.646 -1.814 . . . . 71.25 112.333 -0.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 23' ' ' PRO . 53.3 Cg_endo -69.79 -88.66 0.0 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.643 2.229 . . . . 61.04 112.342 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 6.2 mt -52.5 102.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.2 111.092 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.6 mm 65.17 85.79 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 61.44 111.097 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.02 175.49 42.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 52.41 112.478 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -121.14 138.65 54.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.916 0.388 . . . . 75.34 110.842 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 19.9 p -77.04 128.8 35.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.108 -0.496 . . . . 64.14 110.876 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 pt? . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 73.24 110.981 179.94 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.786 0.326 . . . . 71.31 110.855 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 29.4 mm 64.25 130.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 51.15 111.139 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.78 160.04 33.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 34.11 111.085 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -51.04 120.43 4.9 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.206 -0.452 . . . . 75.23 110.905 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 55.21 35.08 24.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.23 -0.441 . . . . 64.4 110.919 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.09 150.14 19.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.739 -0.743 . . . . 31.04 112.504 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.18 149.18 24.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.854 0.359 . . . . 75.44 110.831 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.2 p -120.01 171.8 8.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 30.4 110.919 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -57.73 -19.01 24.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 63.31 110.821 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.49 -92.23 0.61 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 72.32 112.471 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.54 -18.63 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 72.23 111.124 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.5 HG22 ' H ' ' A' ' 14' ' ' GLN . 64.5 mt -91.04 103.59 14.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 71.24 111.107 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.462 HD22 ' N ' ' A' ' 13' ' ' ASN . 1.1 m-80 -86.23 30.66 0.68 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 65.11 110.914 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.5 ' H ' HG22 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -81.38 66.93 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 60.14 110.887 -179.985 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.5 t -111.77 104.78 13.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 73.02 110.885 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.1 m -43.55 -63.66 0.79 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.153 -0.476 . . . . 75.31 110.87 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.502 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 5.6 m-20 -130.01 161.72 58.15 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.612 0.72 . . . . 73.23 110.853 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.502 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 53.6 Cg_endo -69.79 -48.53 0.27 Allowed 'Cis proline' 0 C--N 1.341 0.17 0 C-N-CA 122.68 -1.8 . . . . 62.23 112.363 0.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . 0.773 ' HB3' HD23 ' A' ' 20' ' ' LEU . 95.2 m95 -126.8 -92.99 0.48 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 74.15 110.925 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.773 HD23 ' HB3' ' A' ' 19' ' ' TRP . 0.3 OUTLIER -127.57 162.28 26.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 73.13 110.921 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 0.1 OUTLIER -85.01 104.36 14.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.465 . . . . 73.41 110.892 179.899 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.515 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 98.5 m -137.52 132.41 17.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.584 0.707 . . . . 63.53 111.193 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.515 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.7 Cg_endo -69.81 172.39 49.42 Favored 'Cis proline' 0 C--O 1.231 0.168 0 C-N-CA 122.713 -1.786 . . . . 74.51 112.325 0.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.417 ' HD2' ' HB2' ' A' ' 23' ' ' PRO . 53.9 Cg_endo -69.72 -88.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.693 2.262 . . . . 34.33 112.327 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.408 HG22 HG12 ' A' ' 26' ' ' ILE . 14.0 mt -52.94 102.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 62.05 111.142 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.408 HG12 HG22 ' A' ' 25' ' ' ILE . 31.8 mm 65.92 85.81 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.47 . . . . 72.15 111.11 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.38 174.13 42.52 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.752 -0.737 . . . . 72.12 112.477 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -119.38 138.69 52.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.893 0.378 . . . . 64.3 110.934 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.451 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 18.1 p -77.02 128.69 34.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 60.23 110.889 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 64.13 110.957 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.801 0.334 . . . . 65.22 110.844 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.9 mm 64.39 130.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 64.41 111.153 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.91 160.04 32.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 64.24 111.116 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -53.0 120.52 5.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 62.21 110.828 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 55.24 32.51 18.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 71.13 110.924 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.27 150.38 18.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.755 -0.736 . . . . 63.45 112.475 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.14 152.35 2.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.363 . . . . 73.31 110.89 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.3 m -116.5 163.81 15.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.886 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -59.51 -16.37 24.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 71.21 110.893 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.8 -90.99 0.63 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 74.24 112.484 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -59.5 -19.94 17.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.756 0.312 . . . . 74.31 111.078 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.464 HG22 ' HB2' ' A' ' 14' ' ' GLN . 31.9 mt -98.99 103.25 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.236 -0.438 . . . . 75.44 111.16 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -90.34 31.1 1.04 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 74.25 110.926 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.464 ' HB2' HG22 ' A' ' 12' ' ' ILE . 1.2 mp0 -81.31 69.88 8.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 63.12 110.898 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.4 t -110.02 104.19 13.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 73.02 110.896 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.4 m -46.66 -72.71 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 71.21 110.899 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.501 ' HA ' ' C ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -115.84 161.13 32.24 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.633 0.73 . . . . 75.31 110.867 179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 17' ' ' ASP . 54.1 Cg_endo -69.71 -48.76 0.26 Allowed 'Cis proline' 0 C--N 1.342 0.194 0 C-N-CA 122.664 -1.807 . . . . 74.11 112.369 -0.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -128.64 -92.46 0.46 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 75.2 110.886 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.7 pt? -124.45 161.88 25.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 73.34 110.912 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 5.8 t -92.88 104.8 17.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 64.4 110.872 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.518 ' HA ' ' C ' ' A' ' 23' ' ' PRO . 1.8 m -139.42 132.26 15.41 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.55 0.69 . . . . 71.54 111.164 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 22' ' ' THR . 53.9 Cg_endo -69.77 171.18 54.94 Favored 'Cis proline' 0 C--O 1.231 0.151 0 C-N-CA 122.68 -1.8 . . . . 73.32 112.329 -0.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HG2' ' H ' ' A' ' 25' ' ' ILE . 53.9 Cg_endo -69.73 -82.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.689 2.259 . . . . 74.44 112.39 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.586 HG22 HG12 ' A' ' 26' ' ' ILE . 5.4 mt -61.34 106.64 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 55.25 111.115 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.586 HG12 HG22 ' A' ' 25' ' ' ILE . 23.3 mm 67.33 82.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 73.22 111.124 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -167.69 -178.0 39.47 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.731 -0.747 . . . . 62.33 112.452 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -130.21 137.43 50.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.908 0.385 . . . . 43.33 110.87 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 15.0 p -77.89 129.31 35.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 72.33 110.915 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 74.32 110.887 -179.975 . . . . . . . . 1 1 . 1 stop_ save_